REACTOME FORMATION OF LATERAL PLATE MESODERM
|
5
|
3.39e-04
|
3.10e-03
|
1.26000
|
0.925000
|
8.61e-01
|
3.39e-04
|
8.51e-04
|
REACTOME REGULATION OF GENE EXPRESSION IN EARLY PANCREATIC PRECURSOR CELLS
|
8
|
2.86e-06
|
3.81e-05
|
1.26000
|
0.931000
|
8.52e-01
|
5.09e-06
|
2.97e-05
|
REACTOME DOPAMINE RECEPTORS
|
5
|
4.36e-04
|
3.83e-03
|
1.25000
|
0.895000
|
8.66e-01
|
5.26e-04
|
7.99e-04
|
REACTOME ADRENOCEPTORS
|
9
|
1.97e-05
|
2.24e-04
|
1.08000
|
0.860000
|
6.51e-01
|
7.91e-06
|
7.22e-04
|
REACTOME VITAMINS
|
6
|
6.97e-04
|
5.73e-03
|
1.08000
|
0.869000
|
6.35e-01
|
2.26e-04
|
7.04e-03
|
REACTOME CREATION OF C4 AND C2 ACTIVATORS
|
14
|
1.20e-07
|
2.18e-06
|
1.06000
|
-0.817000
|
-6.72e-01
|
1.18e-07
|
1.33e-05
|
REACTOME FICOLINS BIND TO REPETITIVE CARBOHYDRATE STRUCTURES ON THE TARGET CELL SURFACE
|
5
|
5.66e-03
|
3.36e-02
|
0.99200
|
-0.807000
|
-5.77e-01
|
1.78e-03
|
2.54e-02
|
REACTOME REGULATION OF GENE EXPRESSION IN ENDOCRINE COMMITTED NEUROG3 PROGENITOR CELLS
|
5
|
8.75e-03
|
4.65e-02
|
0.97400
|
0.713000
|
6.63e-01
|
5.76e-03
|
1.02e-02
|
REACTOME LECTIN PATHWAY OF COMPLEMENT ACTIVATION
|
8
|
6.53e-04
|
5.51e-03
|
0.92100
|
-0.770000
|
-5.07e-01
|
1.63e-04
|
1.30e-02
|
REACTOME ORGANIC ANION TRANSPORT
|
5
|
9.27e-03
|
4.86e-02
|
0.89700
|
-0.789000
|
-4.27e-01
|
2.24e-03
|
9.85e-02
|
REACTOME FORMATION OF AXIAL MESODERM
|
13
|
4.03e-05
|
4.28e-04
|
0.88300
|
0.614000
|
6.35e-01
|
1.26e-04
|
7.31e-05
|
REACTOME CONJUGATION OF BENZOATE WITH GLYCINE
|
6
|
9.65e-03
|
5.01e-02
|
0.87200
|
-0.675000
|
-5.52e-01
|
4.18e-03
|
1.93e-02
|
REACTOME DIGESTION OF DIETARY LIPID
|
7
|
6.16e-03
|
3.61e-02
|
0.82700
|
-0.681000
|
-4.70e-01
|
1.81e-03
|
3.14e-02
|
REACTOME DIGESTION
|
17
|
3.78e-06
|
4.86e-05
|
0.82000
|
-0.692000
|
-4.41e-01
|
7.84e-07
|
1.66e-03
|
REACTOME HYALURONAN BIOSYNTHESIS AND EXPORT
|
5
|
2.92e-02
|
1.11e-01
|
0.82000
|
0.478000
|
6.66e-01
|
6.42e-02
|
9.86e-03
|
REACTOME MINERALOCORTICOID BIOSYNTHESIS
|
6
|
1.24e-02
|
6.02e-02
|
0.81900
|
-0.690000
|
-4.42e-01
|
3.41e-03
|
6.11e-02
|
REACTOME POU5F1 OCT4 SOX2 NANOG REPRESS GENES RELATED TO DIFFERENTIATION
|
10
|
1.28e-03
|
9.91e-03
|
0.81700
|
0.573000
|
5.83e-01
|
1.72e-03
|
1.40e-03
|
REACTOME NEGATIVE REGULATION OF ACTIVITY OF TFAP2 AP 2 FAMILY TRANSCRIPTION FACTORS
|
10
|
1.33e-03
|
1.02e-02
|
0.81500
|
0.563000
|
5.89e-01
|
2.05e-03
|
1.26e-03
|
REACTOME FGFRL1 MODULATION OF FGFR1 SIGNALING
|
13
|
4.29e-04
|
3.80e-03
|
0.77300
|
0.559000
|
5.34e-01
|
4.83e-04
|
8.55e-04
|
REACTOME EPITHELIAL MESENCHYMAL TRANSITION EMT DURING GASTRULATION
|
6
|
2.63e-02
|
1.03e-01
|
0.76500
|
0.610000
|
4.62e-01
|
9.61e-03
|
5.02e-02
|
REACTOME LINOLEIC ACID LA METABOLISM
|
7
|
1.09e-02
|
5.50e-02
|
0.75700
|
0.653000
|
3.82e-01
|
2.77e-03
|
7.99e-02
|
REACTOME ERYTHROPOIETIN ACTIVATES PHOSPHOLIPASE C GAMMA PLCG
|
7
|
2.08e-02
|
8.86e-02
|
0.74200
|
0.493000
|
5.55e-01
|
2.38e-02
|
1.10e-02
|
REACTOME ACTIVATION OF TRKA RECEPTORS
|
6
|
3.49e-02
|
1.23e-01
|
0.73300
|
0.589000
|
4.36e-01
|
1.24e-02
|
6.44e-02
|
REACTOME DEFECTIVE CHST6 CAUSES MCDC1
|
8
|
4.97e-03
|
3.10e-02
|
0.72400
|
-0.663000
|
-2.90e-01
|
1.16e-03
|
1.55e-01
|
REACTOME TRANSCRIPTIONAL REGULATION OF TESTIS DIFFERENTIATION
|
12
|
1.85e-03
|
1.36e-02
|
0.71500
|
0.442000
|
5.62e-01
|
8.01e-03
|
7.46e-04
|
REACTOME AMINO ACID CONJUGATION
|
9
|
9.99e-03
|
5.13e-02
|
0.71300
|
-0.537000
|
-4.69e-01
|
5.24e-03
|
1.49e-02
|
REACTOME DIGESTION AND ABSORPTION
|
22
|
2.50e-06
|
3.37e-05
|
0.71100
|
-0.625000
|
-3.39e-01
|
3.89e-07
|
5.84e-03
|
REACTOME MODULATION BY MTB OF HOST IMMUNE SYSTEM
|
6
|
3.06e-04
|
2.83e-03
|
0.71000
|
0.666000
|
-2.47e-01
|
4.72e-03
|
2.94e-01
|
REACTOME SIGNALING BY LRP5 MUTANTS
|
6
|
4.87e-02
|
1.52e-01
|
0.70900
|
0.526000
|
4.75e-01
|
2.55e-02
|
4.40e-02
|
REACTOME INITIAL TRIGGERING OF COMPLEMENT
|
21
|
1.02e-05
|
1.22e-04
|
0.70500
|
-0.599000
|
-3.72e-01
|
2.02e-06
|
3.14e-03
|
REACTOME SYNTHESIS OF LIPOXINS LX
|
6
|
4.30e-02
|
1.42e-01
|
0.69900
|
0.581000
|
3.89e-01
|
1.37e-02
|
9.91e-02
|
REACTOME CD22 MEDIATED BCR REGULATION
|
5
|
8.45e-02
|
2.25e-01
|
0.69500
|
0.545000
|
4.31e-01
|
3.49e-02
|
9.50e-02
|
REACTOME ACTIVATION OF THE TFAP2 AP 2 FAMILY OF TRANSCRIPTION FACTORS
|
11
|
5.44e-03
|
3.28e-02
|
0.68500
|
0.521000
|
4.45e-01
|
2.76e-03
|
1.06e-02
|
REACTOME REGULATION OF NPAS4 MRNA TRANSLATION
|
9
|
2.79e-03
|
1.94e-02
|
0.68100
|
0.213000
|
6.47e-01
|
2.69e-01
|
7.74e-04
|
REACTOME VASOPRESSIN LIKE RECEPTORS
|
5
|
8.26e-02
|
2.21e-01
|
0.67700
|
0.569000
|
3.67e-01
|
2.75e-02
|
1.56e-01
|
REACTOME LIGAND RECEPTOR INTERACTIONS
|
8
|
2.32e-02
|
9.55e-02
|
0.67600
|
0.535000
|
4.14e-01
|
8.83e-03
|
4.28e-02
|
REACTOME OLFACTORY SIGNALING PATHWAY
|
347
|
1.23e-80
|
2.01e-77
|
0.67400
|
-0.596000
|
-3.15e-01
|
5.89e-82
|
5.07e-24
|
REACTOME HDL CLEARANCE
|
5
|
5.55e-02
|
1.69e-01
|
0.67400
|
0.266000
|
6.19e-01
|
3.03e-01
|
1.66e-02
|
REACTOME DEFECTIVE ST3GAL3 CAUSES MCT12 AND EIEE15
|
8
|
9.22e-03
|
4.85e-02
|
0.66800
|
-0.621000
|
-2.48e-01
|
2.37e-03
|
2.24e-01
|
REACTOME CREATINE METABOLISM
|
9
|
2.05e-02
|
8.76e-02
|
0.65800
|
0.457000
|
4.74e-01
|
1.76e-02
|
1.39e-02
|
REACTOME TFAP2 AP 2 FAMILY REGULATES TRANSCRIPTION OF CELL CYCLE FACTORS
|
5
|
8.23e-02
|
2.20e-01
|
0.65800
|
0.576000
|
3.17e-01
|
2.56e-02
|
2.19e-01
|
REACTOME POST TRANSCRIPTIONAL SILENCING BY SMALL RNAS
|
7
|
5.62e-03
|
3.36e-02
|
0.65600
|
0.095000
|
6.49e-01
|
6.63e-01
|
2.94e-03
|
REACTOME NGF INDEPENDANT TRKA ACTIVATION
|
5
|
1.03e-01
|
2.53e-01
|
0.65600
|
0.537000
|
3.76e-01
|
3.75e-02
|
1.45e-01
|
REACTOME NEF AND SIGNAL TRANSDUCTION
|
8
|
3.05e-02
|
1.13e-01
|
0.65400
|
0.509000
|
4.11e-01
|
1.27e-02
|
4.41e-02
|
REACTOME DEFECTIVE B4GALT1 CAUSES B4GALT1 CDG CDG 2D
|
8
|
1.96e-02
|
8.52e-02
|
0.65300
|
-0.572000
|
-3.17e-01
|
5.11e-03
|
1.21e-01
|
REACTOME CIPROFLOXACIN ADME
|
5
|
8.04e-02
|
2.18e-01
|
0.65000
|
-0.580000
|
-2.93e-01
|
2.47e-02
|
2.56e-01
|
REACTOME RECYCLING OF BILE ACIDS AND SALTS
|
18
|
1.78e-04
|
1.70e-03
|
0.64600
|
-0.565000
|
-3.13e-01
|
3.35e-05
|
2.15e-02
|
REACTOME GERM LAYER FORMATION AT GASTRULATION
|
16
|
1.37e-03
|
1.04e-02
|
0.64300
|
0.442000
|
4.67e-01
|
2.23e-03
|
1.22e-03
|
REACTOME NFE2L2 REGULATES PENTOSE PHOSPHATE PATHWAY GENES
|
7
|
5.41e-02
|
1.67e-01
|
0.64200
|
0.492000
|
4.12e-01
|
2.43e-02
|
5.89e-02
|
REACTOME DIGESTION OF DIETARY CARBOHYDRATE
|
6
|
3.48e-02
|
1.23e-01
|
0.63700
|
-0.601000
|
-2.10e-01
|
1.07e-02
|
3.72e-01
|
REACTOME ERYTHROPOIETIN ACTIVATES STAT5
|
7
|
6.25e-02
|
1.84e-01
|
0.62700
|
0.472000
|
4.13e-01
|
3.04e-02
|
5.86e-02
|
REACTOME CHOLINE CATABOLISM
|
6
|
7.52e-02
|
2.09e-01
|
0.62500
|
0.328000
|
5.32e-01
|
1.64e-01
|
2.41e-02
|
REACTOME MECP2 REGULATES TRANSCRIPTION OF NEURONAL LIGANDS
|
7
|
5.97e-02
|
1.78e-01
|
0.62400
|
0.496000
|
3.79e-01
|
2.30e-02
|
8.24e-02
|
REACTOME FGFR1 LIGAND BINDING AND ACTIVATION
|
15
|
3.64e-03
|
2.43e-02
|
0.61300
|
0.428000
|
4.39e-01
|
4.14e-03
|
3.25e-03
|
REACTOME SEROTONIN RECEPTORS
|
11
|
1.18e-02
|
5.85e-02
|
0.60900
|
0.330000
|
5.12e-01
|
5.82e-02
|
3.25e-03
|
REACTOME FLT3 SIGNALING BY CBL MUTANTS
|
7
|
6.73e-04
|
5.63e-03
|
0.60900
|
0.545000
|
-2.70e-01
|
1.24e-02
|
2.16e-01
|
REACTOME BICARBONATE TRANSPORTERS
|
10
|
1.80e-02
|
7.99e-02
|
0.60600
|
-0.511000
|
-3.26e-01
|
5.10e-03
|
7.44e-02
|
REACTOME RUNX1 REGULATES EXPRESSION OF COMPONENTS OF TIGHT JUNCTIONS
|
5
|
1.50e-01
|
3.22e-01
|
0.60600
|
0.481000
|
3.69e-01
|
6.24e-02
|
1.53e-01
|
REACTOME SARS COV 1 MODULATES HOST TRANSLATION MACHINERY
|
33
|
3.57e-13
|
2.65e-11
|
0.60300
|
0.114000
|
-5.92e-01
|
2.56e-01
|
3.84e-09
|
REACTOME ACTIVATED NTRK2 SIGNALS THROUGH CDK5
|
6
|
5.78e-02
|
1.75e-01
|
0.60100
|
0.558000
|
2.21e-01
|
1.78e-02
|
3.49e-01
|
REACTOME LYSOSPHINGOLIPID AND LPA RECEPTORS
|
9
|
1.15e-02
|
5.77e-02
|
0.60000
|
0.566000
|
1.99e-01
|
3.26e-03
|
3.02e-01
|
REACTOME GASTRULATION
|
48
|
6.00e-08
|
1.26e-06
|
0.58800
|
0.435000
|
3.96e-01
|
1.78e-07
|
2.08e-06
|
REACTOME INTERACTION WITH CUMULUS CELLS AND THE ZONA PELLUCIDA
|
11
|
1.51e-02
|
6.87e-02
|
0.58300
|
-0.502000
|
-2.98e-01
|
3.96e-03
|
8.72e-02
|
REACTOME ASPIRIN ADME
|
42
|
3.50e-07
|
5.84e-06
|
0.57400
|
-0.478000
|
-3.17e-01
|
8.25e-08
|
3.71e-04
|
REACTOME SIGNALING BY MEMBRANE TETHERED FUSIONS OF PDGFRA OR PDGFRB
|
5
|
1.94e-01
|
3.75e-01
|
0.57300
|
0.420000
|
3.90e-01
|
1.04e-01
|
1.31e-01
|
REACTOME ELECTRIC TRANSMISSION ACROSS GAP JUNCTIONS
|
5
|
1.93e-01
|
3.75e-01
|
0.57200
|
0.376000
|
4.31e-01
|
1.46e-01
|
9.54e-02
|
REACTOME REGULATION OF PTEN MRNA TRANSLATION
|
9
|
1.23e-02
|
6.02e-02
|
0.56700
|
0.141000
|
5.49e-01
|
4.62e-01
|
4.34e-03
|
REACTOME MOLYBDENUM COFACTOR BIOSYNTHESIS
|
6
|
9.00e-02
|
2.33e-01
|
0.56500
|
0.516000
|
2.31e-01
|
2.85e-02
|
3.27e-01
|
REACTOME EUKARYOTIC TRANSLATION ELONGATION
|
87
|
4.40e-32
|
8.01e-30
|
0.56200
|
0.180000
|
-5.33e-01
|
3.71e-03
|
7.95e-18
|
REACTOME ELEVATION OF CYTOSOLIC CA2 LEVELS
|
16
|
5.93e-03
|
3.50e-02
|
0.56200
|
0.357000
|
4.33e-01
|
1.33e-02
|
2.68e-03
|
REACTOME VOLTAGE GATED POTASSIUM CHANNELS
|
42
|
2.86e-06
|
3.81e-05
|
0.54700
|
0.345000
|
4.24e-01
|
1.07e-04
|
2.00e-06
|
REACTOME ALPHA LINOLENIC OMEGA3 AND LINOLEIC OMEGA6 ACID METABOLISM
|
12
|
1.66e-02
|
7.51e-02
|
0.54500
|
0.476000
|
2.65e-01
|
4.27e-03
|
1.12e-01
|
REACTOME COMPLEMENT CASCADE
|
54
|
3.21e-08
|
7.40e-07
|
0.54300
|
-0.456000
|
-2.96e-01
|
6.91e-09
|
1.70e-04
|
REACTOME SYNTHESIS OF BILE ACIDS AND BILE SALTS VIA 27 HYDROXYCHOLESTEROL
|
15
|
7.25e-03
|
4.11e-02
|
0.54200
|
-0.465000
|
-2.79e-01
|
1.81e-03
|
6.16e-02
|
REACTOME NGF STIMULATED TRANSCRIPTION
|
38
|
2.66e-08
|
6.23e-07
|
0.54100
|
0.528000
|
1.22e-01
|
1.80e-08
|
1.94e-01
|
REACTOME RECYCLING OF EIF2 GDP
|
7
|
2.15e-03
|
1.53e-02
|
0.54100
|
0.336000
|
-4.24e-01
|
1.23e-01
|
5.22e-02
|
REACTOME INTERACTION BETWEEN L1 AND ANKYRINS
|
30
|
1.65e-04
|
1.59e-03
|
0.53900
|
-0.369000
|
-3.93e-01
|
4.61e-04
|
1.95e-04
|
REACTOME PROSTANOID LIGAND RECEPTORS
|
9
|
4.45e-02
|
1.44e-01
|
0.53800
|
0.480000
|
2.43e-01
|
1.26e-02
|
2.06e-01
|
REACTOME SRP DEPENDENT COTRANSLATIONAL PROTEIN TARGETING TO MEMBRANE
|
104
|
4.25e-35
|
1.16e-32
|
0.53700
|
0.177000
|
-5.07e-01
|
1.76e-03
|
3.94e-19
|
REACTOME EICOSANOIDS
|
12
|
3.14e-02
|
1.15e-01
|
0.53700
|
-0.360000
|
-3.98e-01
|
3.09e-02
|
1.70e-02
|
REACTOME RESPONSE OF EIF2AK4 GCN2 TO AMINO ACID DEFICIENCY
|
94
|
1.92e-32
|
3.92e-30
|
0.53500
|
0.201000
|
-4.96e-01
|
7.47e-04
|
9.19e-17
|
REACTOME TERMINAL PATHWAY OF COMPLEMENT
|
8
|
9.76e-02
|
2.45e-01
|
0.53500
|
-0.414000
|
-3.38e-01
|
4.24e-02
|
9.81e-02
|
REACTOME DEFECTIVE CHSY1 CAUSES TPBS
|
7
|
1.33e-01
|
3.00e-01
|
0.53400
|
0.407000
|
3.46e-01
|
6.23e-02
|
1.13e-01
|
REACTOME NEGATIVE REGULATION OF TCF DEPENDENT SIGNALING BY WNT LIGAND ANTAGONISTS
|
15
|
1.50e-02
|
6.87e-02
|
0.53000
|
0.378000
|
3.71e-01
|
1.13e-02
|
1.27e-02
|
REACTOME SIGNALING BY MST1
|
5
|
2.45e-01
|
4.38e-01
|
0.52900
|
0.396000
|
3.51e-01
|
1.25e-01
|
1.74e-01
|
REACTOME PHOSPHOLIPASE C MEDIATED CASCADE FGFR2
|
17
|
8.70e-03
|
4.65e-02
|
0.52600
|
0.343000
|
3.99e-01
|
1.44e-02
|
4.39e-03
|
REACTOME REGULATION OF BETA CELL DEVELOPMENT
|
41
|
1.03e-05
|
1.23e-04
|
0.52500
|
0.331000
|
4.07e-01
|
2.49e-04
|
6.32e-06
|
REACTOME ACTIVATED NTRK2 SIGNALS THROUGH PI3K
|
7
|
6.68e-02
|
1.92e-01
|
0.52400
|
0.498000
|
1.64e-01
|
2.26e-02
|
4.52e-01
|
REACTOME BIOSYNTHESIS OF EPA DERIVED SPMS
|
6
|
1.57e-01
|
3.29e-01
|
0.52000
|
0.453000
|
2.56e-01
|
5.47e-02
|
2.78e-01
|
REACTOME AMINE LIGAND BINDING RECEPTORS
|
40
|
5.29e-06
|
6.66e-05
|
0.51900
|
0.262000
|
4.48e-01
|
4.09e-03
|
9.21e-07
|
REACTOME FRUCTOSE CATABOLISM
|
5
|
2.50e-01
|
4.43e-01
|
0.51900
|
-0.411000
|
-3.18e-01
|
1.12e-01
|
2.18e-01
|
REACTOME SENSORY PERCEPTION
|
551
|
2.10e-78
|
1.71e-75
|
0.51800
|
-0.468000
|
-2.22e-01
|
1.10e-79
|
4.47e-19
|
REACTOME REGULATION OF GENE EXPRESSION IN LATE STAGE BRANCHING MORPHOGENESIS PANCREATIC BUD PRECURSOR CELLS
|
15
|
1.84e-02
|
8.13e-02
|
0.51600
|
0.381000
|
3.48e-01
|
1.07e-02
|
1.96e-02
|
REACTOME TRANSCRIPTIONAL REGULATION OF PLURIPOTENT STEM CELLS
|
30
|
3.48e-04
|
3.16e-03
|
0.51500
|
0.350000
|
3.78e-01
|
9.07e-04
|
3.34e-04
|
REACTOME BH3 ONLY PROTEINS ASSOCIATE WITH AND INACTIVATE ANTI APOPTOTIC BCL 2 MEMBERS
|
9
|
6.63e-03
|
3.86e-02
|
0.51500
|
0.514000
|
-2.37e-02
|
7.55e-03
|
9.02e-01
|
REACTOME NTRK2 ACTIVATES RAC1
|
5
|
2.12e-01
|
3.99e-01
|
0.51200
|
0.455000
|
2.35e-01
|
7.80e-02
|
3.63e-01
|
REACTOME PTK6 REGULATES CELL CYCLE
|
6
|
1.29e-02
|
6.17e-02
|
0.51200
|
0.209000
|
-4.68e-01
|
3.76e-01
|
4.73e-02
|
REACTOME RUNX1 AND FOXP3 CONTROL THE DEVELOPMENT OF REGULATORY T LYMPHOCYTES TREGS
|
9
|
6.43e-02
|
1.87e-01
|
0.51100
|
-0.240000
|
-4.51e-01
|
2.12e-01
|
1.92e-02
|
REACTOME FIBRONECTIN MATRIX FORMATION
|
6
|
1.78e-01
|
3.57e-01
|
0.50800
|
-0.436000
|
-2.62e-01
|
6.46e-02
|
2.66e-01
|
REACTOME EUKARYOTIC TRANSLATION INITIATION
|
110
|
1.61e-33
|
3.77e-31
|
0.50500
|
0.182000
|
-4.71e-01
|
9.53e-04
|
1.25e-17
|
REACTOME RUNX1 REGULATES TRANSCRIPTION OF GENES INVOLVED IN WNT SIGNALING
|
5
|
2.67e-01
|
4.61e-01
|
0.50400
|
0.303000
|
4.03e-01
|
2.41e-01
|
1.18e-01
|
REACTOME BETA OXIDATION OF LAUROYL COA TO DECANOYL COA COA
|
5
|
2.13e-01
|
4.02e-01
|
0.50400
|
0.454000
|
2.18e-01
|
7.89e-02
|
3.98e-01
|
REACTOME DRUG MEDIATED INHIBITION OF CDK4 CDK6 ACTIVITY
|
5
|
2.43e-02
|
9.82e-02
|
0.49600
|
0.347000
|
-3.54e-01
|
1.78e-01
|
1.71e-01
|
REACTOME SARS COV 2 MODULATES HOST TRANSLATION MACHINERY
|
46
|
4.59e-13
|
3.13e-11
|
0.49400
|
0.132000
|
-4.76e-01
|
1.21e-01
|
2.28e-08
|
REACTOME ACTIVATION OF THE PHOTOTRANSDUCTION CASCADE
|
11
|
1.23e-02
|
6.02e-02
|
0.49300
|
-0.485000
|
-9.02e-02
|
5.38e-03
|
6.05e-01
|
REACTOME KERATINIZATION
|
210
|
2.55e-25
|
2.60e-23
|
0.49300
|
-0.423000
|
-2.53e-01
|
3.72e-26
|
2.49e-10
|
REACTOME TRAF6 MEDIATED IRF7 ACTIVATION IN TLR7 8 OR 9 SIGNALING
|
11
|
4.50e-04
|
3.93e-03
|
0.49000
|
0.417000
|
-2.58e-01
|
1.67e-02
|
1.39e-01
|
REACTOME CD28 DEPENDENT VAV1 PATHWAY
|
11
|
2.82e-02
|
1.09e-01
|
0.48900
|
0.459000
|
1.68e-01
|
8.34e-03
|
3.33e-01
|
REACTOME SIGNALING BY ACTIVIN
|
15
|
1.45e-02
|
6.70e-02
|
0.48700
|
0.434000
|
2.20e-01
|
3.60e-03
|
1.39e-01
|
REACTOME ROLE OF SECOND MESSENGERS IN NETRIN 1 SIGNALING
|
9
|
1.21e-01
|
2.79e-01
|
0.48500
|
0.338000
|
3.48e-01
|
7.92e-02
|
7.03e-02
|
REACTOME SYNTHESIS OF EPOXY EET AND DIHYDROXYEICOSATRIENOIC ACIDS DHET
|
8
|
1.52e-01
|
3.24e-01
|
0.48500
|
-0.327000
|
-3.58e-01
|
1.09e-01
|
7.94e-02
|
REACTOME FASL CD95L SIGNALING
|
5
|
2.93e-02
|
1.11e-01
|
0.48400
|
0.321000
|
-3.62e-01
|
2.14e-01
|
1.61e-01
|
REACTOME NONSENSE MEDIATED DECAY NMD
|
107
|
1.72e-29
|
2.56e-27
|
0.48000
|
0.171000
|
-4.49e-01
|
2.18e-03
|
9.78e-16
|
REACTOME DEFECTIVE FACTOR VIII CAUSES HEMOPHILIA A
|
5
|
1.62e-01
|
3.35e-01
|
0.47900
|
-0.468000
|
-1.03e-01
|
6.98e-02
|
6.90e-01
|
REACTOME FLT3 SIGNALING THROUGH SRC FAMILY KINASES
|
6
|
4.74e-02
|
1.50e-01
|
0.47900
|
0.477000
|
-4.83e-02
|
4.31e-02
|
8.38e-01
|
REACTOME NRCAM INTERACTIONS
|
6
|
2.52e-01
|
4.44e-01
|
0.47900
|
-0.319000
|
-3.57e-01
|
1.76e-01
|
1.30e-01
|
REACTOME PI 3K CASCADE FGFR1
|
21
|
8.28e-03
|
4.53e-02
|
0.47700
|
0.354000
|
3.20e-01
|
4.96e-03
|
1.11e-02
|
REACTOME METALLOTHIONEINS BIND METALS
|
11
|
4.68e-02
|
1.49e-01
|
0.47700
|
0.431000
|
2.05e-01
|
1.34e-02
|
2.38e-01
|
REACTOME FBXW7 MUTANTS AND NOTCH1 IN CANCER
|
5
|
2.93e-01
|
4.84e-01
|
0.47300
|
0.401000
|
2.51e-01
|
1.21e-01
|
3.30e-01
|
REACTOME ATF6 ATF6 ALPHA ACTIVATES CHAPERONE GENES
|
10
|
4.60e-03
|
2.94e-02
|
0.47300
|
0.463000
|
-9.49e-02
|
1.12e-02
|
6.03e-01
|
REACTOME SHC MEDIATED CASCADE FGFR1
|
21
|
8.99e-03
|
4.74e-02
|
0.47200
|
0.356000
|
3.11e-01
|
4.76e-03
|
1.37e-02
|
REACTOME APOBEC3G MEDIATED RESISTANCE TO HIV 1 INFECTION
|
5
|
7.66e-02
|
2.11e-01
|
0.47200
|
0.069500
|
-4.67e-01
|
7.88e-01
|
7.06e-02
|
REACTOME ERYTHROPOIETIN ACTIVATES PHOSPHOINOSITIDE 3 KINASE PI3K
|
12
|
6.29e-02
|
1.84e-01
|
0.47100
|
0.281000
|
3.78e-01
|
9.16e-02
|
2.35e-02
|
REACTOME CROSS PRESENTATION OF PARTICULATE EXOGENOUS ANTIGENS PHAGOSOMES
|
6
|
2.51e-01
|
4.43e-01
|
0.47000
|
-0.379000
|
-2.78e-01
|
1.08e-01
|
2.38e-01
|
REACTOME ESTROGEN BIOSYNTHESIS
|
6
|
2.19e-01
|
4.08e-01
|
0.47000
|
-0.229000
|
-4.10e-01
|
3.32e-01
|
8.18e-02
|
REACTOME GRB7 EVENTS IN ERBB2 SIGNALING
|
5
|
3.20e-01
|
4.97e-01
|
0.46900
|
0.375000
|
2.82e-01
|
1.47e-01
|
2.76e-01
|
REACTOME MET INTERACTS WITH TNS PROTEINS
|
5
|
3.03e-01
|
4.90e-01
|
0.46800
|
-0.395000
|
-2.51e-01
|
1.27e-01
|
3.30e-01
|
REACTOME GABA SYNTHESIS RELEASE REUPTAKE AND DEGRADATION
|
19
|
6.61e-03
|
3.86e-02
|
0.46700
|
0.420000
|
2.05e-01
|
1.54e-03
|
1.22e-01
|
REACTOME SIGNALING BY RNF43 MUTANTS
|
8
|
1.76e-01
|
3.55e-01
|
0.46700
|
0.326000
|
3.33e-01
|
1.10e-01
|
1.03e-01
|
REACTOME REGULATION OF FZD BY UBIQUITINATION
|
21
|
4.88e-03
|
3.07e-02
|
0.46600
|
0.411000
|
2.19e-01
|
1.11e-03
|
8.21e-02
|
REACTOME GLUCOCORTICOID BIOSYNTHESIS
|
10
|
1.13e-01
|
2.67e-01
|
0.46500
|
-0.304000
|
-3.52e-01
|
9.55e-02
|
5.38e-02
|
REACTOME FGFR1C LIGAND BINDING AND ACTIVATION
|
11
|
9.33e-02
|
2.38e-01
|
0.46500
|
0.332000
|
3.26e-01
|
5.66e-02
|
6.14e-02
|
REACTOME OPSINS
|
7
|
4.60e-02
|
1.47e-01
|
0.46400
|
-0.464000
|
6.58e-03
|
3.33e-02
|
9.76e-01
|
REACTOME FGFR2C LIGAND BINDING AND ACTIVATION
|
12
|
7.56e-02
|
2.09e-01
|
0.46400
|
0.333000
|
3.24e-01
|
4.56e-02
|
5.23e-02
|
REACTOME HISTIDINE CATABOLISM
|
8
|
9.60e-02
|
2.43e-01
|
0.46400
|
-0.436000
|
-1.58e-01
|
3.27e-02
|
4.40e-01
|
REACTOME RELEASE OF HH NP FROM THE SECRETING CELL
|
8
|
1.78e-01
|
3.57e-01
|
0.46300
|
0.350000
|
3.03e-01
|
8.65e-02
|
1.37e-01
|
REACTOME SERINE BIOSYNTHESIS
|
9
|
2.01e-02
|
8.63e-02
|
0.46300
|
0.463000
|
-3.73e-03
|
1.62e-02
|
9.85e-01
|
REACTOME REGULATION OF BACH1 ACTIVITY
|
11
|
5.00e-03
|
3.11e-02
|
0.46200
|
0.459000
|
-5.62e-02
|
8.41e-03
|
7.47e-01
|
REACTOME DEFECTIVE CHST14 CAUSES EDS MUSCULOCONTRACTURAL TYPE
|
7
|
1.72e-01
|
3.50e-01
|
0.46200
|
0.410000
|
2.14e-01
|
6.05e-02
|
3.28e-01
|
REACTOME SELENOAMINO ACID METABOLISM
|
101
|
2.48e-25
|
2.60e-23
|
0.46000
|
0.155000
|
-4.33e-01
|
7.00e-03
|
5.13e-14
|
REACTOME TFAP2 AP 2 FAMILY REGULATES TRANSCRIPTION OF GROWTH FACTORS AND THEIR RECEPTORS
|
14
|
3.83e-02
|
1.32e-01
|
0.46000
|
0.243000
|
3.91e-01
|
1.15e-01
|
1.14e-02
|
REACTOME ACETYLCHOLINE NEUROTRANSMITTER RELEASE CYCLE
|
16
|
2.21e-02
|
9.18e-02
|
0.46000
|
0.397000
|
2.31e-01
|
5.95e-03
|
1.09e-01
|
REACTOME PHYSIOLOGICAL FACTORS
|
14
|
5.32e-02
|
1.65e-01
|
0.45800
|
0.321000
|
3.28e-01
|
3.78e-02
|
3.37e-02
|
REACTOME YAP1 AND WWTR1 TAZ STIMULATED GENE EXPRESSION
|
14
|
4.97e-02
|
1.54e-01
|
0.45800
|
0.358000
|
2.86e-01
|
2.05e-02
|
6.36e-02
|
REACTOME ACTIVATION OF THE MRNA UPON BINDING OF THE CAP BINDING COMPLEX AND EIFS AND SUBSEQUENT BINDING TO 43S
|
53
|
5.95e-13
|
3.89e-11
|
0.45800
|
0.123000
|
-4.41e-01
|
1.20e-01
|
2.77e-08
|
REACTOME FRS MEDIATED FGFR1 SIGNALING
|
23
|
7.97e-03
|
4.40e-02
|
0.45700
|
0.345000
|
3.00e-01
|
4.18e-03
|
1.29e-02
|
REACTOME LOSS OF FUNCTION OF SMAD2 3 IN CANCER
|
7
|
1.93e-01
|
3.75e-01
|
0.45600
|
0.394000
|
2.30e-01
|
7.10e-02
|
2.92e-01
|
REACTOME SIGNALING BY TGF BETA RECEPTOR COMPLEX IN CANCER
|
8
|
1.50e-01
|
3.21e-01
|
0.45500
|
0.397000
|
2.21e-01
|
5.17e-02
|
2.79e-01
|
REACTOME CHYLOMICRON ASSEMBLY
|
10
|
1.26e-01
|
2.87e-01
|
0.45300
|
-0.343000
|
-2.96e-01
|
6.02e-02
|
1.05e-01
|
REACTOME RUNX3 REGULATES BCL2L11 BIM TRANSCRIPTION
|
5
|
3.53e-01
|
5.35e-01
|
0.45300
|
0.348000
|
2.90e-01
|
1.78e-01
|
2.61e-01
|
REACTOME REGULATION OF TP53 ACTIVITY THROUGH ASSOCIATION WITH CO FACTORS
|
14
|
8.12e-03
|
4.47e-02
|
0.45200
|
0.074500
|
4.46e-01
|
6.29e-01
|
3.85e-03
|
REACTOME ANTIMICROBIAL PEPTIDES
|
76
|
1.94e-07
|
3.38e-06
|
0.45200
|
-0.317000
|
-3.22e-01
|
1.72e-06
|
1.19e-06
|
REACTOME TRAFFICKING AND PROCESSING OF ENDOSOMAL TLR
|
11
|
9.13e-02
|
2.35e-01
|
0.45100
|
0.373000
|
2.54e-01
|
3.21e-02
|
1.45e-01
|
REACTOME PI3K EVENTS IN ERBB4 SIGNALING
|
10
|
1.01e-01
|
2.50e-01
|
0.44900
|
0.390000
|
2.24e-01
|
3.28e-02
|
2.21e-01
|
REACTOME FOLDING OF ACTIN BY CCT TRIC
|
10
|
2.99e-03
|
2.07e-02
|
0.44700
|
0.230000
|
-3.83e-01
|
2.07e-01
|
3.58e-02
|
REACTOME SYNTHESIS OF BILE ACIDS AND BILE SALTS VIA 24 HYDROXYCHOLESTEROL
|
14
|
5.88e-02
|
1.76e-01
|
0.44500
|
-0.279000
|
-3.47e-01
|
7.04e-02
|
2.46e-02
|
REACTOME DEFECTIVE GALNT3 CAUSES HFTC
|
16
|
3.33e-02
|
1.19e-01
|
0.44500
|
-0.370000
|
-2.46e-01
|
1.03e-02
|
8.85e-02
|
REACTOME RELAXIN RECEPTORS
|
8
|
7.67e-02
|
2.11e-01
|
0.44400
|
-0.436000
|
-8.53e-02
|
3.28e-02
|
6.76e-01
|
REACTOME SYNTHESIS OF 12 EICOSATETRAENOIC ACID DERIVATIVES
|
7
|
6.23e-02
|
1.84e-01
|
0.44300
|
0.443000
|
-1.98e-03
|
4.23e-02
|
9.93e-01
|
REACTOME ERYTHROPOIETIN ACTIVATES RAS
|
14
|
3.77e-02
|
1.30e-01
|
0.44300
|
0.395000
|
2.00e-01
|
1.04e-02
|
1.95e-01
|
REACTOME TRANSCRIPTIONAL REGULATION BY MECP2
|
60
|
6.67e-06
|
8.20e-05
|
0.44200
|
0.280000
|
3.42e-01
|
1.71e-04
|
4.53e-06
|
REACTOME REGULATION OF GENE EXPRESSION IN BETA CELLS
|
21
|
8.36e-03
|
4.55e-02
|
0.44200
|
0.209000
|
3.90e-01
|
9.75e-02
|
1.99e-03
|
REACTOME SOS MEDIATED SIGNALLING
|
7
|
2.52e-01
|
4.45e-01
|
0.44200
|
0.334000
|
2.90e-01
|
1.26e-01
|
1.85e-01
|
REACTOME FORMATION OF THE CORNIFIED ENVELOPE
|
125
|
8.98e-13
|
5.44e-11
|
0.44000
|
-0.385000
|
-2.14e-01
|
1.05e-13
|
3.50e-05
|
REACTOME TFAP2A ACTS AS A TRANSCRIPTIONAL REPRESSOR DURING RETINOIC ACID INDUCED CELL DIFFERENTIATION
|
5
|
2.02e-01
|
3.87e-01
|
0.44000
|
0.433000
|
7.84e-02
|
9.38e-02
|
7.61e-01
|
REACTOME MITOCHONDRIAL UNCOUPLING
|
5
|
2.78e-01
|
4.71e-01
|
0.43700
|
0.409000
|
1.54e-01
|
1.13e-01
|
5.52e-01
|
REACTOME NEF MEDIATED CD8 DOWN REGULATION
|
7
|
1.86e-01
|
3.68e-01
|
0.43500
|
0.173000
|
3.99e-01
|
4.27e-01
|
6.76e-02
|
REACTOME TOXICITY OF BOTULINUM TOXIN TYPE D BOTD
|
5
|
5.85e-02
|
1.76e-01
|
0.43400
|
0.287000
|
-3.25e-01
|
2.66e-01
|
2.08e-01
|
REACTOME CHYLOMICRON REMODELING
|
10
|
1.10e-01
|
2.63e-01
|
0.43300
|
-0.384000
|
-2.02e-01
|
3.57e-02
|
2.69e-01
|
REACTOME FGFR3 LIGAND BINDING AND ACTIVATION
|
12
|
1.05e-01
|
2.57e-01
|
0.43300
|
0.286000
|
3.25e-01
|
8.67e-02
|
5.13e-02
|
REACTOME SYNTHESIS OF BILE ACIDS AND BILE SALTS VIA 7ALPHA HYDROXYCHOLESTEROL
|
24
|
8.31e-03
|
4.53e-02
|
0.43200
|
-0.358000
|
-2.41e-01
|
2.38e-03
|
4.11e-02
|
REACTOME HEME DEGRADATION
|
15
|
5.78e-02
|
1.75e-01
|
0.43200
|
-0.336000
|
-2.71e-01
|
2.41e-02
|
6.96e-02
|
REACTOME MATURATION OF PROTEIN 3A
|
9
|
1.37e-01
|
3.05e-01
|
0.43100
|
0.198000
|
3.83e-01
|
3.04e-01
|
4.64e-02
|
REACTOME BIOSYNTHESIS OF MARESIN LIKE SPMS
|
6
|
2.72e-01
|
4.64e-01
|
0.42900
|
-0.381000
|
-1.98e-01
|
1.06e-01
|
4.01e-01
|
REACTOME SYNTHESIS OF 16 20 HYDROXYEICOSATETRAENOIC ACIDS HETE
|
9
|
1.92e-01
|
3.74e-01
|
0.42900
|
-0.295000
|
-3.10e-01
|
1.25e-01
|
1.07e-01
|
REACTOME METAL SEQUESTRATION BY ANTIMICROBIAL PROTEINS
|
6
|
3.36e-01
|
5.17e-01
|
0.42700
|
-0.308000
|
-2.95e-01
|
1.91e-01
|
2.10e-01
|
REACTOME DEFECTIVE C1GALT1C1 CAUSES TNPS
|
16
|
4.06e-02
|
1.36e-01
|
0.42600
|
-0.363000
|
-2.23e-01
|
1.20e-02
|
1.22e-01
|
REACTOME FERTILIZATION
|
26
|
5.46e-03
|
3.28e-02
|
0.42500
|
-0.363000
|
-2.22e-01
|
1.36e-03
|
5.00e-02
|
REACTOME ATF6 ATF6 ALPHA ACTIVATES CHAPERONES
|
11
|
1.26e-02
|
6.05e-02
|
0.42500
|
0.423000
|
-4.00e-02
|
1.51e-02
|
8.18e-01
|
REACTOME TRAIL SIGNALING
|
8
|
3.18e-02
|
1.17e-01
|
0.42500
|
0.417000
|
-8.03e-02
|
4.09e-02
|
6.94e-01
|
REACTOME SMAC XIAP REGULATED APOPTOTIC RESPONSE
|
6
|
6.70e-02
|
1.92e-01
|
0.42500
|
0.412000
|
-1.05e-01
|
8.07e-02
|
6.56e-01
|
REACTOME INTERLEUKIN 36 PATHWAY
|
7
|
2.84e-01
|
4.77e-01
|
0.42500
|
-0.296000
|
-3.04e-01
|
1.75e-01
|
1.64e-01
|
REACTOME FGFR1B LIGAND BINDING AND ACTIVATION
|
6
|
3.12e-01
|
4.94e-01
|
0.42400
|
0.233000
|
3.55e-01
|
3.24e-01
|
1.33e-01
|
REACTOME SYNTHESIS OF 5 EICOSATETRAENOIC ACIDS
|
9
|
4.61e-02
|
1.47e-01
|
0.42400
|
0.423000
|
2.24e-02
|
2.79e-02
|
9.07e-01
|
REACTOME SYNTHESIS OF GDP MANNOSE
|
5
|
1.53e-01
|
3.26e-01
|
0.42300
|
0.422000
|
-1.79e-02
|
1.02e-01
|
9.45e-01
|
REACTOME JOSEPHIN DOMAIN DUBS
|
10
|
5.44e-03
|
3.28e-02
|
0.42000
|
0.240000
|
-3.44e-01
|
1.89e-01
|
5.93e-02
|
REACTOME REGULATION OF GENE EXPRESSION BY HYPOXIA INDUCIBLE FACTOR
|
11
|
1.31e-01
|
2.96e-01
|
0.41800
|
0.342000
|
2.41e-01
|
4.94e-02
|
1.67e-01
|
REACTOME ACTIVATED NTRK2 SIGNALS THROUGH RAS
|
9
|
8.68e-02
|
2.29e-01
|
0.41800
|
0.406000
|
9.60e-02
|
3.47e-02
|
6.18e-01
|
REACTOME GLUCURONIDATION
|
23
|
1.25e-02
|
6.02e-02
|
0.41700
|
-0.353000
|
-2.22e-01
|
3.38e-03
|
6.55e-02
|
REACTOME CLASS C 3 METABOTROPIC GLUTAMATE PHEROMONE RECEPTORS
|
39
|
7.00e-09
|
2.01e-07
|
0.41600
|
-0.378000
|
1.74e-01
|
4.37e-05
|
5.98e-02
|
REACTOME REMOVAL OF AMINOTERMINAL PROPEPTIDES FROM GAMMA CARBOXYLATED PROTEINS
|
8
|
1.73e-02
|
7.75e-02
|
0.41600
|
-0.350000
|
2.24e-01
|
8.62e-02
|
2.72e-01
|
REACTOME SLBP DEPENDENT PROCESSING OF REPLICATION DEPENDENT HISTONE PRE MRNAS
|
11
|
3.19e-03
|
2.19e-02
|
0.41600
|
0.284000
|
-3.04e-01
|
1.03e-01
|
8.12e-02
|
REACTOME SUMOYLATION OF TRANSCRIPTION FACTORS
|
20
|
3.19e-02
|
1.17e-01
|
0.41500
|
0.301000
|
2.87e-01
|
1.99e-02
|
2.65e-02
|
REACTOME NEGATIVE FEEDBACK REGULATION OF MAPK PATHWAY
|
6
|
2.83e-01
|
4.76e-01
|
0.41500
|
0.179000
|
3.75e-01
|
4.48e-01
|
1.12e-01
|
REACTOME PEXOPHAGY
|
11
|
5.39e-03
|
3.28e-02
|
0.41500
|
0.380000
|
-1.67e-01
|
2.91e-02
|
3.37e-01
|
REACTOME NUCLEAR EVENTS KINASE AND TRANSCRIPTION FACTOR ACTIVATION
|
59
|
6.49e-08
|
1.31e-06
|
0.41300
|
0.406000
|
7.54e-02
|
6.73e-08
|
3.16e-01
|
REACTOME NRIF SIGNALS CELL DEATH FROM THE NUCLEUS
|
16
|
4.17e-03
|
2.75e-02
|
0.41200
|
0.412000
|
-1.01e-03
|
4.29e-03
|
9.94e-01
|
REACTOME ACTIVATION OF CASPASES THROUGH APOPTOSOME MEDIATED CLEAVAGE
|
5
|
8.20e-02
|
2.20e-01
|
0.41000
|
0.334000
|
-2.38e-01
|
1.96e-01
|
3.56e-01
|
REACTOME NEGATIVE REGULATION OF FLT3
|
15
|
7.21e-04
|
5.87e-03
|
0.41000
|
0.359000
|
-1.98e-01
|
1.59e-02
|
1.85e-01
|
REACTOME REGULATION OF NPAS4 GENE EXPRESSION
|
13
|
8.40e-02
|
2.24e-01
|
0.40800
|
0.200000
|
3.56e-01
|
2.11e-01
|
2.64e-02
|
REACTOME DERMATAN SULFATE BIOSYNTHESIS
|
10
|
1.43e-01
|
3.12e-01
|
0.40700
|
0.360000
|
1.91e-01
|
4.87e-02
|
2.96e-01
|
REACTOME BILE ACID AND BILE SALT METABOLISM
|
45
|
5.22e-04
|
4.47e-03
|
0.40500
|
-0.318000
|
-2.50e-01
|
2.19e-04
|
3.68e-03
|
REACTOME TRNA MODIFICATION IN THE MITOCHONDRION
|
7
|
1.35e-01
|
3.02e-01
|
0.40500
|
0.401000
|
5.33e-02
|
6.59e-02
|
8.07e-01
|
REACTOME MATURATION OF SARS COV 1 SPIKE PROTEIN
|
5
|
8.50e-02
|
2.25e-01
|
0.40400
|
0.266000
|
-3.05e-01
|
3.03e-01
|
2.38e-01
|
REACTOME RRNA PROCESSING IN THE MITOCHONDRION
|
6
|
3.69e-01
|
5.50e-01
|
0.40400
|
0.255000
|
3.13e-01
|
2.79e-01
|
1.84e-01
|
REACTOME ROLE OF ABL IN ROBO SLIT SIGNALING
|
8
|
2.71e-01
|
4.64e-01
|
0.40400
|
0.273000
|
2.97e-01
|
1.81e-01
|
1.45e-01
|
REACTOME SENSORY PERCEPTION OF TASTE
|
47
|
2.41e-09
|
8.22e-08
|
0.40200
|
-0.382000
|
1.26e-01
|
5.83e-06
|
1.36e-01
|
REACTOME PINK1 PRKN MEDIATED MITOPHAGY
|
20
|
5.84e-05
|
6.01e-04
|
0.40200
|
0.265000
|
-3.02e-01
|
3.98e-02
|
1.94e-02
|
REACTOME PI 3K CASCADE FGFR2
|
22
|
2.91e-02
|
1.11e-01
|
0.40200
|
0.283000
|
2.85e-01
|
2.15e-02
|
2.07e-02
|
REACTOME DEFECTIVE CSF2RB CAUSES SMDP5
|
7
|
3.10e-01
|
4.94e-01
|
0.40100
|
-0.321000
|
-2.40e-01
|
1.41e-01
|
2.71e-01
|
REACTOME BINDING OF TCF LEF CTNNB1 TO TARGET GENE PROMOTERS
|
8
|
2.68e-01
|
4.61e-01
|
0.40100
|
0.315000
|
2.49e-01
|
1.23e-01
|
2.23e-01
|
REACTOME REGULATION OF PTEN LOCALIZATION
|
8
|
3.37e-02
|
1.21e-01
|
0.40000
|
0.377000
|
-1.34e-01
|
6.48e-02
|
5.13e-01
|
REACTOME TICAM1 DEPENDENT ACTIVATION OF IRF3 IRF7
|
12
|
5.39e-03
|
3.28e-02
|
0.40000
|
0.153000
|
-3.69e-01
|
3.59e-01
|
2.68e-02
|
REACTOME MITOCHONDRIAL IRON SULFUR CLUSTER BIOGENESIS
|
12
|
3.17e-03
|
2.19e-02
|
0.39900
|
0.266000
|
-2.97e-01
|
1.11e-01
|
7.47e-02
|
REACTOME MULTIFUNCTIONAL ANION EXCHANGERS
|
9
|
2.36e-01
|
4.28e-01
|
0.39900
|
-0.259000
|
-3.03e-01
|
1.78e-01
|
1.16e-01
|
REACTOME MYOCLONIC EPILEPSY OF LAFORA
|
9
|
2.93e-02
|
1.11e-01
|
0.39800
|
0.387000
|
-9.36e-02
|
4.43e-02
|
6.27e-01
|
REACTOME PERK REGULATES GENE EXPRESSION
|
31
|
1.09e-06
|
1.59e-05
|
0.39800
|
0.360000
|
-1.70e-01
|
5.22e-04
|
1.01e-01
|
REACTOME TRAF6 MEDIATED INDUCTION OF TAK1 COMPLEX WITHIN TLR4 COMPLEX
|
15
|
2.20e-02
|
9.18e-02
|
0.39700
|
0.389000
|
7.85e-02
|
9.12e-03
|
5.99e-01
|
REACTOME RESPONSE TO METAL IONS
|
14
|
5.47e-02
|
1.68e-01
|
0.39600
|
0.369000
|
1.45e-01
|
1.68e-02
|
3.48e-01
|
REACTOME INTESTINAL ABSORPTION
|
5
|
2.03e-01
|
3.88e-01
|
0.39600
|
-0.396000
|
4.31e-03
|
1.25e-01
|
9.87e-01
|
REACTOME SCF SKP2 MEDIATED DEGRADATION OF P27 P21
|
58
|
1.18e-12
|
6.67e-11
|
0.39600
|
0.293000
|
-2.67e-01
|
1.15e-04
|
4.32e-04
|
REACTOME NEGATIVE REGULATION OF FGFR1 SIGNALING
|
32
|
2.58e-03
|
1.80e-02
|
0.39600
|
0.353000
|
1.79e-01
|
5.55e-04
|
7.91e-02
|
REACTOME PLATELET CALCIUM HOMEOSTASIS
|
27
|
8.20e-03
|
4.50e-02
|
0.39500
|
0.195000
|
3.44e-01
|
7.89e-02
|
1.99e-03
|
REACTOME FOXO MEDIATED TRANSCRIPTION OF CELL CYCLE GENES
|
16
|
2.13e-02
|
8.99e-02
|
0.39500
|
0.383000
|
9.33e-02
|
7.91e-03
|
5.18e-01
|
REACTOME ASSEMBLY OF ACTIVE LPL AND LIPC LIPASE COMPLEXES
|
17
|
3.96e-02
|
1.35e-01
|
0.39400
|
-0.356000
|
-1.70e-01
|
1.11e-02
|
2.25e-01
|
REACTOME INFLUENZA INFECTION
|
147
|
3.75e-27
|
4.73e-25
|
0.39400
|
0.139000
|
-3.68e-01
|
3.52e-03
|
1.25e-14
|
REACTOME RHOBTB3 ATPASE CYCLE
|
8
|
2.28e-01
|
4.19e-01
|
0.39300
|
0.177000
|
3.51e-01
|
3.87e-01
|
8.56e-02
|
REACTOME NEUROTOXICITY OF CLOSTRIDIUM TOXINS
|
10
|
3.75e-02
|
1.30e-01
|
0.39200
|
0.392000
|
-2.38e-02
|
3.20e-02
|
8.96e-01
|
REACTOME CS DS DEGRADATION
|
12
|
1.57e-01
|
3.30e-01
|
0.39100
|
0.295000
|
2.57e-01
|
7.71e-02
|
1.23e-01
|
REACTOME ACTIVATED NTRK2 SIGNALS THROUGH FRS2 AND FRS3
|
11
|
8.69e-02
|
2.29e-01
|
0.39100
|
0.374000
|
1.12e-01
|
3.15e-02
|
5.20e-01
|
REACTOME TRANSPORT OF FATTY ACIDS
|
8
|
1.22e-01
|
2.81e-01
|
0.39000
|
-0.386000
|
-5.44e-02
|
5.87e-02
|
7.90e-01
|
REACTOME CHONDROITIN SULFATE BIOSYNTHESIS
|
18
|
5.90e-02
|
1.76e-01
|
0.38900
|
0.312000
|
2.32e-01
|
2.19e-02
|
8.82e-02
|
REACTOME TRANSLATION
|
261
|
1.04e-48
|
4.27e-46
|
0.38800
|
0.174000
|
-3.47e-01
|
1.21e-06
|
4.11e-22
|
REACTOME FRS MEDIATED FGFR2 SIGNALING
|
24
|
2.73e-02
|
1.06e-01
|
0.38800
|
0.280000
|
2.68e-01
|
1.75e-02
|
2.29e-02
|
REACTOME DEACTIVATION OF THE BETA CATENIN TRANSACTIVATING COMPLEX
|
39
|
2.28e-03
|
1.62e-02
|
0.38800
|
0.311000
|
2.32e-01
|
7.84e-04
|
1.22e-02
|
REACTOME ACYL CHAIN REMODELLING OF PG
|
18
|
5.35e-02
|
1.66e-01
|
0.38800
|
-0.325000
|
-2.12e-01
|
1.71e-02
|
1.20e-01
|
REACTOME REGULATION OF EXPRESSION OF SLITS AND ROBOS
|
158
|
1.46e-31
|
2.38e-29
|
0.38700
|
0.245000
|
-3.00e-01
|
1.02e-07
|
7.32e-11
|
REACTOME THYROXINE BIOSYNTHESIS
|
10
|
1.08e-01
|
2.61e-01
|
0.38700
|
0.105000
|
3.73e-01
|
5.67e-01
|
4.13e-02
|
REACTOME MAPK3 ERK1 ACTIVATION
|
10
|
2.19e-01
|
4.08e-01
|
0.38600
|
0.243000
|
3.00e-01
|
1.83e-01
|
1.00e-01
|
REACTOME MELANIN BIOSYNTHESIS
|
5
|
3.66e-01
|
5.46e-01
|
0.38600
|
-0.362000
|
-1.34e-01
|
1.61e-01
|
6.03e-01
|
REACTOME MITOCHONDRIAL FATTY ACID BETA OXIDATION OF UNSATURATED FATTY ACIDS
|
6
|
2.43e-01
|
4.35e-01
|
0.38500
|
0.376000
|
8.14e-02
|
1.10e-01
|
7.30e-01
|
REACTOME P75NTR NEGATIVELY REGULATES CELL CYCLE VIA SC1
|
6
|
4.12e-01
|
5.87e-01
|
0.38500
|
0.279000
|
2.64e-01
|
2.36e-01
|
2.62e-01
|
REACTOME MECP2 REGULATES NEURONAL RECEPTORS AND CHANNELS
|
17
|
8.14e-02
|
2.19e-01
|
0.38400
|
0.259000
|
2.83e-01
|
6.41e-02
|
4.32e-02
|
REACTOME TRANSCRIPTIONAL REGULATION BY THE AP 2 TFAP2 FAMILY OF TRANSCRIPTION FACTORS
|
36
|
4.29e-03
|
2.79e-02
|
0.38300
|
0.304000
|
2.33e-01
|
1.57e-03
|
1.57e-02
|
REACTOME NEUROTRANSMITTER CLEARANCE
|
9
|
2.07e-01
|
3.92e-01
|
0.38200
|
0.172000
|
3.42e-01
|
3.72e-01
|
7.60e-02
|
REACTOME VITAMIN C ASCORBATE METABOLISM
|
8
|
2.76e-01
|
4.69e-01
|
0.38200
|
0.325000
|
2.02e-01
|
1.12e-01
|
3.23e-01
|
REACTOME RESPONSE OF EIF2AK1 HRI TO HEME DEFICIENCY
|
14
|
2.08e-03
|
1.49e-02
|
0.38200
|
0.260000
|
-2.80e-01
|
9.16e-02
|
7.00e-02
|
REACTOME SYNTHESIS OF 15 EICOSATETRAENOIC ACID DERIVATIVES
|
6
|
2.07e-01
|
3.92e-01
|
0.38200
|
0.380000
|
3.97e-02
|
1.07e-01
|
8.66e-01
|
REACTOME AMPK INHIBITS CHREBP TRANSCRIPTIONAL ACTIVATION ACTIVITY
|
8
|
3.11e-01
|
4.94e-01
|
0.38100
|
0.254000
|
2.84e-01
|
2.13e-01
|
1.64e-01
|
REACTOME P75NTR RECRUITS SIGNALLING COMPLEXES
|
12
|
2.10e-02
|
8.93e-02
|
0.38100
|
0.379000
|
-3.87e-02
|
2.29e-02
|
8.17e-01
|
REACTOME AUF1 HNRNP D0 BINDS AND DESTABILIZES MRNA
|
53
|
8.31e-11
|
4.00e-09
|
0.38100
|
0.268000
|
-2.71e-01
|
7.45e-04
|
6.47e-04
|
REACTOME FATTY ACIDS
|
15
|
1.10e-01
|
2.63e-01
|
0.38100
|
-0.242000
|
-2.94e-01
|
1.05e-01
|
4.87e-02
|
REACTOME ACYL CHAIN REMODELLING OF PS
|
21
|
2.38e-02
|
9.72e-02
|
0.37900
|
-0.344000
|
-1.59e-01
|
6.32e-03
|
2.07e-01
|
REACTOME INTERLEUKIN 18 SIGNALING
|
8
|
3.09e-01
|
4.93e-01
|
0.37900
|
-0.297000
|
-2.35e-01
|
1.46e-01
|
2.50e-01
|
REACTOME IRAK1 RECRUITS IKK COMPLEX
|
12
|
1.23e-02
|
6.02e-02
|
0.37800
|
0.363000
|
-1.08e-01
|
2.96e-02
|
5.19e-01
|
REACTOME SCAVENGING OF HEME FROM PLASMA
|
13
|
1.08e-01
|
2.59e-01
|
0.37800
|
-0.338000
|
-1.69e-01
|
3.47e-02
|
2.91e-01
|
REACTOME SYNTHESIS OF PIPS AT THE EARLY ENDOSOME MEMBRANE
|
15
|
6.26e-02
|
1.84e-01
|
0.37800
|
0.144000
|
3.49e-01
|
3.34e-01
|
1.92e-02
|
REACTOME PREVENTION OF PHAGOSOMAL LYSOSOMAL FUSION
|
9
|
2.12e-02
|
8.99e-02
|
0.37700
|
0.241000
|
-2.90e-01
|
2.10e-01
|
1.32e-01
|
REACTOME CD163 MEDIATING AN ANTI INFLAMMATORY RESPONSE
|
9
|
2.64e-01
|
4.58e-01
|
0.37700
|
0.225000
|
3.03e-01
|
2.43e-01
|
1.15e-01
|
REACTOME CLASS B 2 SECRETIN FAMILY RECEPTORS
|
93
|
6.92e-07
|
1.07e-05
|
0.37700
|
0.314000
|
2.09e-01
|
1.64e-07
|
5.03e-04
|
REACTOME ATF4 ACTIVATES GENES IN RESPONSE TO ENDOPLASMIC RETICULUM STRESS
|
27
|
4.34e-05
|
4.55e-04
|
0.37700
|
0.357000
|
-1.20e-01
|
1.31e-03
|
2.82e-01
|
REACTOME ACTIVATION OF C3 AND C5
|
6
|
9.74e-02
|
2.45e-01
|
0.37700
|
-0.347000
|
1.47e-01
|
1.41e-01
|
5.34e-01
|
REACTOME CHREBP ACTIVATES METABOLIC GENE EXPRESSION
|
8
|
2.55e-01
|
4.47e-01
|
0.37600
|
0.167000
|
3.38e-01
|
4.14e-01
|
9.83e-02
|
REACTOME ALPHA DEFENSINS
|
6
|
4.09e-01
|
5.84e-01
|
0.37500
|
-0.308000
|
-2.14e-01
|
1.91e-01
|
3.63e-01
|
REACTOME G2 PHASE
|
5
|
2.03e-01
|
3.88e-01
|
0.37500
|
0.371000
|
-4.93e-02
|
1.50e-01
|
8.49e-01
|
REACTOME POU5F1 OCT4 SOX2 NANOG ACTIVATE GENES RELATED TO PROLIFERATION
|
12
|
1.70e-01
|
3.49e-01
|
0.37400
|
0.217000
|
3.05e-01
|
1.94e-01
|
6.73e-02
|
REACTOME WNT LIGAND BIOGENESIS AND TRAFFICKING
|
25
|
1.56e-02
|
7.06e-02
|
0.37400
|
0.333000
|
1.70e-01
|
3.91e-03
|
1.41e-01
|
REACTOME DOWNSTREAM SIGNALING OF ACTIVATED FGFR1
|
31
|
1.25e-02
|
6.02e-02
|
0.37400
|
0.287000
|
2.40e-01
|
5.74e-03
|
2.06e-02
|
REACTOME SODIUM COUPLED SULPHATE DI AND TRI CARBOXYLATE TRANSPORTERS
|
5
|
4.69e-01
|
6.31e-01
|
0.37400
|
-0.313000
|
-2.04e-01
|
2.25e-01
|
4.30e-01
|
REACTOME NEUROTRANSMITTER RELEASE CYCLE
|
47
|
9.80e-04
|
7.86e-03
|
0.37300
|
0.307000
|
2.12e-01
|
2.75e-04
|
1.19e-02
|
REACTOME NOTCH3 INTRACELLULAR DOMAIN REGULATES TRANSCRIPTION
|
24
|
3.60e-02
|
1.26e-01
|
0.37300
|
0.261000
|
2.66e-01
|
2.69e-02
|
2.39e-02
|
REACTOME MISCELLANEOUS SUBSTRATES
|
12
|
1.86e-01
|
3.68e-01
|
0.37300
|
-0.283000
|
-2.42e-01
|
8.94e-02
|
1.46e-01
|
REACTOME FGFR2 LIGAND BINDING AND ACTIVATION
|
19
|
6.54e-02
|
1.89e-01
|
0.37100
|
0.298000
|
2.21e-01
|
2.43e-02
|
9.55e-02
|
REACTOME SYNTHESIS OF PIPS AT THE LATE ENDOSOME MEMBRANE
|
10
|
1.07e-01
|
2.58e-01
|
0.37100
|
0.071800
|
3.64e-01
|
6.94e-01
|
4.63e-02
|
REACTOME REVERSIBLE HYDRATION OF CARBON DIOXIDE
|
11
|
2.20e-01
|
4.10e-01
|
0.36800
|
0.285000
|
2.33e-01
|
1.02e-01
|
1.81e-01
|
REACTOME MRNA DECAY BY 3 TO 5 EXORIBONUCLEASE
|
13
|
6.68e-03
|
3.86e-02
|
0.36700
|
0.323000
|
-1.75e-01
|
4.38e-02
|
2.75e-01
|
REACTOME PI 3K CASCADE FGFR3
|
17
|
1.01e-01
|
2.50e-01
|
0.36600
|
0.279000
|
2.37e-01
|
4.68e-02
|
9.05e-02
|
REACTOME INTERLEUKIN 7 SIGNALING
|
21
|
3.10e-02
|
1.14e-01
|
0.36500
|
0.332000
|
1.52e-01
|
8.50e-03
|
2.29e-01
|
REACTOME DEFECTIVE CHST3 CAUSES SEDCJD
|
7
|
3.95e-01
|
5.73e-01
|
0.36400
|
0.266000
|
2.49e-01
|
2.23e-01
|
2.53e-01
|
REACTOME ATORVASTATIN ADME
|
9
|
2.86e-01
|
4.77e-01
|
0.36400
|
-0.296000
|
-2.11e-01
|
1.24e-01
|
2.74e-01
|
REACTOME HDL ASSEMBLY
|
8
|
5.43e-02
|
1.67e-01
|
0.36300
|
-0.147000
|
3.32e-01
|
4.70e-01
|
1.04e-01
|
REACTOME LOSS OF FUNCTION OF MECP2 IN RETT SYNDROME
|
11
|
2.33e-01
|
4.26e-01
|
0.36300
|
0.273000
|
2.39e-01
|
1.17e-01
|
1.71e-01
|
REACTOME SHC1 EVENTS IN ERBB4 SIGNALING
|
14
|
1.07e-01
|
2.58e-01
|
0.36200
|
0.326000
|
1.57e-01
|
3.45e-02
|
3.09e-01
|
REACTOME GOLGI CISTERNAE PERICENTRIOLAR STACK REORGANIZATION
|
14
|
3.67e-02
|
1.28e-01
|
0.36200
|
0.360000
|
3.72e-02
|
1.97e-02
|
8.10e-01
|
REACTOME REGULATION OF KIT SIGNALING
|
16
|
1.22e-01
|
2.81e-01
|
0.36000
|
0.276000
|
2.32e-01
|
5.57e-02
|
1.09e-01
|
REACTOME NF KB IS ACTIVATED AND SIGNALS SURVIVAL
|
12
|
2.94e-02
|
1.11e-01
|
0.36000
|
0.357000
|
-4.56e-02
|
3.20e-02
|
7.85e-01
|
REACTOME SENSORY PERCEPTION OF SALTY TASTE
|
6
|
1.17e-01
|
2.73e-01
|
0.36000
|
-0.146000
|
3.29e-01
|
5.35e-01
|
1.63e-01
|
REACTOME SHC MEDIATED CASCADE FGFR3
|
17
|
1.06e-01
|
2.58e-01
|
0.36000
|
0.281000
|
2.25e-01
|
4.52e-02
|
1.08e-01
|
REACTOME ZINC EFFLUX AND COMPARTMENTALIZATION BY THE SLC30 FAMILY
|
5
|
1.89e-01
|
3.70e-01
|
0.35900
|
0.107000
|
-3.43e-01
|
6.78e-01
|
1.85e-01
|
REACTOME TRIF MEDIATED PROGRAMMED CELL DEATH
|
9
|
1.42e-01
|
3.11e-01
|
0.35900
|
0.354000
|
5.91e-02
|
6.58e-02
|
7.59e-01
|
REACTOME GRB2 EVENTS IN ERBB2 SIGNALING
|
16
|
1.10e-01
|
2.63e-01
|
0.35900
|
0.297000
|
2.00e-01
|
3.94e-02
|
1.65e-01
|
REACTOME LIPOPHAGY
|
9
|
2.86e-01
|
4.77e-01
|
0.35800
|
0.300000
|
1.95e-01
|
1.19e-01
|
3.10e-01
|
REACTOME DEFECTIVE CFTR CAUSES CYSTIC FIBROSIS
|
59
|
1.34e-10
|
6.25e-09
|
0.35800
|
0.266000
|
-2.39e-01
|
4.14e-04
|
1.47e-03
|
REACTOME SUMO IS CONJUGATED TO E1 UBA2 SAE1
|
5
|
2.56e-01
|
4.48e-01
|
0.35800
|
0.357000
|
-2.20e-02
|
1.67e-01
|
9.32e-01
|
REACTOME KERATAN SULFATE DEGRADATION
|
13
|
1.61e-01
|
3.34e-01
|
0.35700
|
-0.304000
|
-1.87e-01
|
5.79e-02
|
2.42e-01
|
REACTOME OAS ANTIVIRAL RESPONSE
|
7
|
1.22e-01
|
2.81e-01
|
0.35600
|
0.063800
|
-3.51e-01
|
7.70e-01
|
1.08e-01
|
REACTOME SUMOYLATION OF INTRACELLULAR RECEPTORS
|
29
|
2.21e-02
|
9.18e-02
|
0.35600
|
0.212000
|
2.85e-01
|
4.79e-02
|
7.81e-03
|
REACTOME SYNTHESIS OF WYBUTOSINE AT G37 OF TRNA PHE
|
6
|
1.73e-01
|
3.52e-01
|
0.35500
|
0.054200
|
-3.51e-01
|
8.18e-01
|
1.37e-01
|
REACTOME RELEASE OF APOPTOTIC FACTORS FROM THE MITOCHONDRIA
|
5
|
2.48e-01
|
4.41e-01
|
0.35400
|
0.352000
|
-3.77e-02
|
1.73e-01
|
8.84e-01
|
REACTOME ERYTHROCYTES TAKE UP OXYGEN AND RELEASE CARBON DIOXIDE
|
9
|
2.51e-01
|
4.43e-01
|
0.35400
|
-0.151000
|
-3.20e-01
|
4.34e-01
|
9.64e-02
|
REACTOME FRS MEDIATED FGFR3 SIGNALING
|
19
|
8.92e-02
|
2.32e-01
|
0.35300
|
0.275000
|
2.21e-01
|
3.77e-02
|
9.53e-02
|
REACTOME THE ROLE OF NEF IN HIV 1 REPLICATION AND DISEASE PATHOGENESIS
|
27
|
3.28e-02
|
1.18e-01
|
0.35200
|
0.275000
|
2.21e-01
|
1.35e-02
|
4.72e-02
|
REACTOME KILLING MECHANISMS
|
11
|
2.36e-01
|
4.28e-01
|
0.35200
|
0.289000
|
2.01e-01
|
9.70e-02
|
2.48e-01
|
REACTOME VLDLR INTERNALISATION AND DEGRADATION
|
16
|
4.46e-02
|
1.44e-01
|
0.35100
|
0.342000
|
7.58e-02
|
1.78e-02
|
5.99e-01
|
REACTOME CELLULAR RESPONSE TO STARVATION
|
144
|
1.24e-22
|
1.12e-20
|
0.35000
|
0.168000
|
-3.07e-01
|
4.89e-04
|
1.86e-10
|
REACTOME HYDROLYSIS OF LPC
|
9
|
9.30e-02
|
2.38e-01
|
0.35000
|
-0.349000
|
2.51e-02
|
6.97e-02
|
8.96e-01
|
REACTOME G BETA GAMMA SIGNALLING THROUGH CDC42
|
19
|
6.97e-02
|
1.99e-01
|
0.34900
|
0.305000
|
1.69e-01
|
2.12e-02
|
2.02e-01
|
REACTOME ANTIGEN ACTIVATES B CELL RECEPTOR BCR LEADING TO GENERATION OF SECOND MESSENGERS
|
28
|
3.01e-02
|
1.12e-01
|
0.34900
|
0.276000
|
2.13e-01
|
1.15e-02
|
5.09e-02
|
REACTOME NEGATIVE REGULATION OF NOTCH4 SIGNALING
|
52
|
5.70e-09
|
1.70e-07
|
0.34800
|
0.260000
|
-2.32e-01
|
1.19e-03
|
3.84e-03
|
REACTOME ACTIVATED NTRK2 SIGNALS THROUGH FYN
|
7
|
4.21e-01
|
5.90e-01
|
0.34800
|
0.272000
|
2.17e-01
|
2.13e-01
|
3.21e-01
|
REACTOME DISINHIBITION OF SNARE FORMATION
|
5
|
4.24e-01
|
5.92e-01
|
0.34700
|
0.331000
|
1.06e-01
|
2.00e-01
|
6.82e-01
|
REACTOME PHOSPHOLIPASE C MEDIATED CASCADE FGFR4
|
14
|
1.82e-01
|
3.63e-01
|
0.34700
|
0.224000
|
2.65e-01
|
1.47e-01
|
8.57e-02
|
REACTOME CALNEXIN CALRETICULIN CYCLE
|
25
|
4.23e-04
|
3.76e-03
|
0.34700
|
0.331000
|
-1.03e-01
|
4.18e-03
|
3.71e-01
|
REACTOME SCF BETA TRCP MEDIATED DEGRADATION OF EMI1
|
53
|
4.88e-09
|
1.53e-07
|
0.34600
|
0.263000
|
-2.25e-01
|
9.16e-04
|
4.52e-03
|
REACTOME RRNA PROCESSING
|
184
|
4.67e-27
|
5.45e-25
|
0.34600
|
0.140000
|
-3.17e-01
|
1.03e-03
|
1.21e-13
|
REACTOME TYPE I HEMIDESMOSOME ASSEMBLY
|
11
|
2.41e-01
|
4.33e-01
|
0.34600
|
-0.289000
|
-1.89e-01
|
9.67e-02
|
2.78e-01
|
REACTOME FREE FATTY ACIDS REGULATE INSULIN SECRETION
|
10
|
9.66e-02
|
2.44e-01
|
0.34500
|
-0.345000
|
-7.82e-03
|
5.90e-02
|
9.66e-01
|
REACTOME NEGATIVE REGULATION OF FGFR2 SIGNALING
|
33
|
9.95e-03
|
5.13e-02
|
0.34500
|
0.305000
|
1.60e-01
|
2.40e-03
|
1.11e-01
|
REACTOME RAB GERANYLGERANYLATION
|
57
|
1.07e-04
|
1.05e-03
|
0.34400
|
0.323000
|
1.18e-01
|
2.41e-05
|
1.22e-01
|
REACTOME ACTIVATION OF RAC1 DOWNSTREAM OF NMDARS
|
7
|
3.91e-01
|
5.69e-01
|
0.34400
|
0.171000
|
2.98e-01
|
4.32e-01
|
1.72e-01
|
REACTOME MITOCHONDRIAL TRANSLATION
|
93
|
4.68e-15
|
3.65e-13
|
0.34400
|
0.222000
|
-2.62e-01
|
2.11e-04
|
1.23e-05
|
REACTOME LDL REMODELING
|
6
|
3.64e-01
|
5.44e-01
|
0.34300
|
-0.328000
|
-1.03e-01
|
1.65e-01
|
6.62e-01
|
REACTOME ER QUALITY CONTROL COMPARTMENT ERQC
|
20
|
5.31e-03
|
3.25e-02
|
0.34300
|
0.341000
|
-3.62e-02
|
8.20e-03
|
7.79e-01
|
REACTOME STABILIZATION OF P53
|
54
|
5.67e-09
|
1.70e-07
|
0.34300
|
0.271000
|
-2.10e-01
|
5.66e-04
|
7.54e-03
|
REACTOME PURINE RIBONUCLEOSIDE MONOPHOSPHATE BIOSYNTHESIS
|
9
|
8.74e-02
|
2.29e-01
|
0.34200
|
0.051900
|
-3.38e-01
|
7.87e-01
|
7.90e-02
|
REACTOME NOTCH4 ACTIVATION AND TRANSMISSION OF SIGNAL TO THE NUCLEUS
|
11
|
5.57e-02
|
1.70e-01
|
0.34200
|
0.340000
|
-3.99e-02
|
5.11e-02
|
8.19e-01
|
REACTOME REGULATION OF INNATE IMMUNE RESPONSES TO CYTOSOLIC DNA
|
14
|
2.53e-02
|
1.01e-01
|
0.34200
|
0.040600
|
-3.39e-01
|
7.92e-01
|
2.79e-02
|
REACTOME ONCOGENE INDUCED SENESCENCE
|
35
|
1.57e-03
|
1.17e-02
|
0.34100
|
0.333000
|
7.27e-02
|
6.44e-04
|
4.57e-01
|
REACTOME FORMATION OF PARAXIAL MESODERM
|
21
|
8.82e-02
|
2.30e-01
|
0.34100
|
0.243000
|
2.39e-01
|
5.40e-02
|
5.81e-02
|
REACTOME TRANSCRIPTIONAL REGULATION OF GRANULOPOIESIS
|
30
|
2.66e-02
|
1.04e-01
|
0.34000
|
0.275000
|
1.99e-01
|
9.06e-03
|
5.89e-02
|
REACTOME HORMONE LIGAND BINDING RECEPTORS
|
12
|
3.58e-02
|
1.26e-01
|
0.33900
|
-0.331000
|
7.03e-02
|
4.70e-02
|
6.73e-01
|
REACTOME G PROTEIN ACTIVATION
|
24
|
4.65e-02
|
1.48e-01
|
0.33800
|
0.290000
|
1.74e-01
|
1.38e-02
|
1.40e-01
|
REACTOME INTERLEUKIN 9 SIGNALING
|
7
|
2.75e-01
|
4.69e-01
|
0.33800
|
0.332000
|
6.81e-02
|
1.29e-01
|
7.55e-01
|
REACTOME SARS COV 1 HOST INTERACTIONS
|
88
|
1.03e-12
|
6.00e-11
|
0.33800
|
0.135000
|
-3.10e-01
|
2.84e-02
|
5.03e-07
|
REACTOME GAMMA CARBOXYLATION TRANSPORT AND AMINO TERMINAL CLEAVAGE OF PROTEINS
|
9
|
4.61e-02
|
1.47e-01
|
0.33600
|
-0.237000
|
2.39e-01
|
2.19e-01
|
2.14e-01
|
REACTOME NOSTRIN MEDIATED ENOS TRAFFICKING
|
5
|
5.46e-01
|
6.92e-01
|
0.33600
|
-0.188000
|
-2.78e-01
|
4.66e-01
|
2.81e-01
|
REACTOME DOWNSTREAM SIGNALING OF ACTIVATED FGFR2
|
29
|
3.62e-02
|
1.26e-01
|
0.33600
|
0.260000
|
2.13e-01
|
1.55e-02
|
4.73e-02
|
REACTOME DISPLACEMENT OF DNA GLYCOSYLASE BY APEX1
|
9
|
4.80e-02
|
1.51e-01
|
0.33500
|
0.257000
|
-2.15e-01
|
1.82e-01
|
2.65e-01
|
REACTOME ACTIVATION OF IRF3 IRF7 MEDIATED BY TBK1 IKK EPSILON
|
17
|
7.05e-03
|
4.03e-02
|
0.33400
|
0.318000
|
-1.04e-01
|
2.32e-02
|
4.60e-01
|
REACTOME NONCANONICAL ACTIVATION OF NOTCH3
|
8
|
1.68e-01
|
3.45e-01
|
0.33300
|
0.333000
|
-7.98e-04
|
1.03e-01
|
9.97e-01
|
REACTOME ACYL CHAIN REMODELLING OF PC
|
26
|
1.17e-02
|
5.85e-02
|
0.33200
|
-0.323000
|
-7.78e-02
|
4.34e-03
|
4.92e-01
|
REACTOME STAT5 ACTIVATION
|
7
|
1.18e-01
|
2.76e-01
|
0.33200
|
0.302000
|
-1.37e-01
|
1.66e-01
|
5.32e-01
|
REACTOME GENE AND PROTEIN EXPRESSION BY JAK STAT SIGNALING AFTER INTERLEUKIN 12 STIMULATION
|
35
|
9.47e-06
|
1.15e-04
|
0.33100
|
0.251000
|
-2.16e-01
|
1.01e-02
|
2.68e-02
|
REACTOME IKK COMPLEX RECRUITMENT MEDIATED BY RIP1
|
22
|
4.53e-03
|
2.92e-02
|
0.33100
|
0.329000
|
-3.76e-02
|
7.56e-03
|
7.60e-01
|
REACTOME PURINE CATABOLISM
|
17
|
1.30e-01
|
2.96e-01
|
0.33100
|
0.280000
|
1.77e-01
|
4.60e-02
|
2.06e-01
|
REACTOME FOXO MEDIATED TRANSCRIPTION OF CELL DEATH GENES
|
15
|
7.14e-02
|
2.01e-01
|
0.33100
|
0.324000
|
6.72e-02
|
2.98e-02
|
6.52e-01
|
REACTOME RIPK1 MEDIATED REGULATED NECROSIS
|
29
|
7.06e-05
|
7.22e-04
|
0.33000
|
0.239000
|
-2.28e-01
|
2.60e-02
|
3.34e-02
|
REACTOME OREXIN AND NEUROPEPTIDES FF AND QRFP BIND TO THEIR RESPECTIVE RECEPTORS
|
8
|
3.20e-01
|
4.97e-01
|
0.33000
|
0.123000
|
3.06e-01
|
5.46e-01
|
1.34e-01
|
REACTOME P2Y RECEPTORS
|
9
|
3.22e-01
|
4.99e-01
|
0.33000
|
-0.290000
|
-1.58e-01
|
1.32e-01
|
4.13e-01
|
REACTOME CYTOSOLIC TRNA AMINOACYLATION
|
6
|
4.13e-01
|
5.87e-01
|
0.32900
|
-0.113000
|
-3.09e-01
|
6.31e-01
|
1.89e-01
|
REACTOME REGULATION BY C FLIP
|
11
|
3.25e-02
|
1.18e-01
|
0.32900
|
0.161000
|
-2.87e-01
|
3.55e-01
|
9.90e-02
|
REACTOME LRR FLII INTERACTING PROTEIN 1 LRRFIP1 ACTIVATES TYPE I IFN PRODUCTION
|
5
|
5.71e-01
|
7.15e-01
|
0.32900
|
0.197000
|
2.63e-01
|
4.45e-01
|
3.09e-01
|
REACTOME FORMATION OF THE BETA CATENIN TCF TRANSACTIVATING COMPLEX
|
31
|
3.41e-02
|
1.22e-01
|
0.32800
|
0.210000
|
2.52e-01
|
4.34e-02
|
1.51e-02
|
REACTOME FREE FATTY ACID RECEPTORS
|
5
|
4.58e-01
|
6.22e-01
|
0.32700
|
-0.314000
|
-9.28e-02
|
2.25e-01
|
7.19e-01
|
REACTOME ASYMMETRIC LOCALIZATION OF PCP PROTEINS
|
62
|
3.30e-08
|
7.49e-07
|
0.32700
|
0.311000
|
-1.01e-01
|
2.28e-05
|
1.69e-01
|
REACTOME BIOSYNTHESIS OF MARESINS
|
8
|
4.01e-01
|
5.78e-01
|
0.32600
|
-0.271000
|
-1.82e-01
|
1.85e-01
|
3.72e-01
|
REACTOME EARLY PHASE OF HIV LIFE CYCLE
|
14
|
4.03e-02
|
1.36e-01
|
0.32600
|
0.023700
|
-3.25e-01
|
8.78e-01
|
3.51e-02
|
REACTOME PHOSPHORYLATION OF EMI1
|
6
|
1.56e-01
|
3.28e-01
|
0.32600
|
0.275000
|
-1.74e-01
|
2.43e-01
|
4.62e-01
|
REACTOME NEGATIVE REGULATION OF FGFR3 SIGNALING
|
28
|
1.73e-02
|
7.75e-02
|
0.32500
|
0.306000
|
1.09e-01
|
5.00e-03
|
3.19e-01
|
REACTOME ACROSOME REACTION AND SPERM OOCYTE MEMBRANE BINDING
|
6
|
5.03e-01
|
6.60e-01
|
0.32500
|
-0.272000
|
-1.77e-01
|
2.48e-01
|
4.52e-01
|
REACTOME REGULATION OF NPAS4 GENE TRANSCRIPTION
|
5
|
2.85e-01
|
4.77e-01
|
0.32500
|
0.319000
|
-6.06e-02
|
2.17e-01
|
8.14e-01
|
REACTOME ACYL CHAIN REMODELLING OF PI
|
16
|
1.88e-01
|
3.70e-01
|
0.32300
|
-0.217000
|
-2.39e-01
|
1.34e-01
|
9.72e-02
|
REACTOME SMALL INTERFERING RNA SIRNA BIOGENESIS
|
9
|
3.89e-01
|
5.67e-01
|
0.32200
|
0.209000
|
2.46e-01
|
2.78e-01
|
2.02e-01
|
REACTOME CROSSLINKING OF COLLAGEN FIBRILS
|
16
|
1.46e-01
|
3.16e-01
|
0.32200
|
0.154000
|
2.83e-01
|
2.87e-01
|
4.99e-02
|
REACTOME ASSEMBLY OF THE ORC COMPLEX AT THE ORIGIN OF REPLICATION
|
9
|
1.07e-01
|
2.58e-01
|
0.32200
|
-0.316000
|
6.33e-02
|
1.01e-01
|
7.42e-01
|
REACTOME G1 S DNA DAMAGE CHECKPOINTS
|
65
|
2.21e-09
|
7.87e-08
|
0.32200
|
0.263000
|
-1.86e-01
|
2.46e-04
|
9.62e-03
|
REACTOME ROBO RECEPTORS BIND AKAP5
|
9
|
3.17e-01
|
4.95e-01
|
0.32100
|
0.135000
|
2.92e-01
|
4.84e-01
|
1.30e-01
|
REACTOME HEDGEHOG LIGAND BIOGENESIS
|
63
|
7.74e-09
|
2.18e-07
|
0.32100
|
0.278000
|
-1.61e-01
|
1.39e-04
|
2.75e-02
|
REACTOME REGULATION OF RUNX3 EXPRESSION AND ACTIVITY
|
53
|
1.03e-07
|
1.89e-06
|
0.32000
|
0.259000
|
-1.88e-01
|
1.11e-03
|
1.80e-02
|
REACTOME METABOLISM OF POLYAMINES
|
55
|
4.97e-08
|
1.07e-06
|
0.31900
|
0.205000
|
-2.44e-01
|
8.42e-03
|
1.73e-03
|
REACTOME DRUG ADME
|
103
|
2.29e-05
|
2.55e-04
|
0.31800
|
-0.251000
|
-1.95e-01
|
1.04e-05
|
6.22e-04
|
REACTOME XENOBIOTICS
|
22
|
9.76e-02
|
2.45e-01
|
0.31800
|
-0.257000
|
-1.87e-01
|
3.68e-02
|
1.29e-01
|
REACTOME PHENYLALANINE METABOLISM
|
5
|
6.03e-01
|
7.38e-01
|
0.31800
|
0.231000
|
2.18e-01
|
3.70e-01
|
3.98e-01
|
REACTOME SPRY REGULATION OF FGF SIGNALING
|
16
|
1.88e-02
|
8.26e-02
|
0.31800
|
0.310000
|
-7.21e-02
|
3.20e-02
|
6.17e-01
|
REACTOME PRE NOTCH PROCESSING IN THE ENDOPLASMIC RETICULUM
|
6
|
1.65e-01
|
3.40e-01
|
0.31800
|
-0.187000
|
2.57e-01
|
4.27e-01
|
2.76e-01
|
REACTOME DEGRADATION OF AXIN
|
53
|
1.41e-07
|
2.53e-06
|
0.31700
|
0.256000
|
-1.86e-01
|
1.24e-03
|
1.93e-02
|
REACTOME SIGNALING BY WNT IN CANCER
|
32
|
4.12e-02
|
1.38e-01
|
0.31600
|
0.228000
|
2.19e-01
|
2.56e-02
|
3.18e-02
|
REACTOME CD28 CO STIMULATION
|
32
|
4.07e-02
|
1.36e-01
|
0.31600
|
0.210000
|
2.36e-01
|
4.00e-02
|
2.08e-02
|
REACTOME IRS MEDIATED SIGNALLING
|
47
|
7.84e-03
|
4.38e-02
|
0.31500
|
0.186000
|
2.54e-01
|
2.72e-02
|
2.62e-03
|
REACTOME APC C CDH1 MEDIATED DEGRADATION OF CDC20 AND OTHER APC C CDH1 TARGETED PROTEINS IN LATE MITOSIS EARLY G1
|
72
|
5.05e-10
|
2.07e-08
|
0.31500
|
0.240000
|
-2.03e-01
|
4.17e-04
|
2.90e-03
|
REACTOME SENSING OF DNA DOUBLE STRAND BREAKS
|
5
|
3.88e-01
|
5.66e-01
|
0.31500
|
-0.014700
|
-3.14e-01
|
9.55e-01
|
2.24e-01
|
REACTOME ACYL CHAIN REMODELLING OF PE
|
24
|
5.78e-02
|
1.75e-01
|
0.31300
|
-0.281000
|
-1.38e-01
|
1.70e-02
|
2.42e-01
|
REACTOME BETA OXIDATION OF OCTANOYL COA TO HEXANOYL COA
|
5
|
4.44e-01
|
6.11e-01
|
0.31300
|
0.308000
|
5.62e-02
|
2.33e-01
|
8.28e-01
|
REACTOME MITOCHONDRIAL PROTEIN IMPORT
|
54
|
1.45e-07
|
2.57e-06
|
0.31300
|
0.188000
|
-2.50e-01
|
1.70e-02
|
1.45e-03
|
REACTOME CROSS PRESENTATION OF SOLUBLE EXOGENOUS ANTIGENS ENDOSOMES
|
45
|
1.72e-06
|
2.37e-05
|
0.31300
|
0.208000
|
-2.34e-01
|
1.59e-02
|
6.59e-03
|
REACTOME TRISTETRAPROLIN TTP ZFP36 BINDS AND DESTABILIZES MRNA
|
17
|
1.05e-02
|
5.32e-02
|
0.31200
|
0.287000
|
-1.24e-01
|
4.07e-02
|
3.77e-01
|
REACTOME IRAK2 MEDIATED ACTIVATION OF TAK1 COMPLEX
|
9
|
1.12e-01
|
2.66e-01
|
0.31200
|
0.302000
|
-7.80e-02
|
1.17e-01
|
6.85e-01
|
REACTOME REGULATION OF MRNA STABILITY BY PROTEINS THAT BIND AU RICH ELEMENTS
|
85
|
2.34e-11
|
1.23e-09
|
0.31100
|
0.252000
|
-1.84e-01
|
6.00e-05
|
3.44e-03
|
REACTOME EPHA MEDIATED GROWTH CONE COLLAPSE
|
29
|
5.82e-02
|
1.75e-01
|
0.31100
|
0.239000
|
2.00e-01
|
2.61e-02
|
6.23e-02
|
REACTOME POTASSIUM CHANNELS
|
102
|
5.47e-05
|
5.70e-04
|
0.31100
|
0.223000
|
2.17e-01
|
9.98e-05
|
1.50e-04
|
REACTOME NUCLEAR EVENTS MEDIATED BY NFE2L2
|
76
|
2.31e-09
|
8.05e-08
|
0.31100
|
0.289000
|
-1.16e-01
|
1.33e-05
|
8.15e-02
|
REACTOME DECTIN 1 MEDIATED NONCANONICAL NF KB SIGNALING
|
60
|
2.48e-08
|
6.12e-07
|
0.31100
|
0.225000
|
-2.14e-01
|
2.52e-03
|
4.09e-03
|
REACTOME ACTIVATION OF RAC1
|
11
|
2.26e-01
|
4.17e-01
|
0.31100
|
0.098200
|
2.95e-01
|
5.73e-01
|
9.06e-02
|
REACTOME NOTCH1 INTRACELLULAR DOMAIN REGULATES TRANSCRIPTION
|
44
|
4.89e-03
|
3.07e-02
|
0.31100
|
0.284000
|
1.27e-01
|
1.13e-03
|
1.46e-01
|
REACTOME REGULATION OF RUNX2 EXPRESSION AND ACTIVITY
|
71
|
6.02e-08
|
1.26e-06
|
0.31000
|
0.303000
|
-6.66e-02
|
9.88e-06
|
3.32e-01
|
REACTOME SCAVENGING BY CLASS A RECEPTORS
|
19
|
7.20e-02
|
2.02e-01
|
0.30900
|
-0.089700
|
-2.96e-01
|
4.99e-01
|
2.55e-02
|
REACTOME SIGNALING BY ERYTHROPOIETIN
|
25
|
7.15e-02
|
2.01e-01
|
0.30900
|
0.263000
|
1.62e-01
|
2.27e-02
|
1.61e-01
|
REACTOME P75NTR SIGNALS VIA NF KB
|
15
|
3.26e-02
|
1.18e-01
|
0.30900
|
0.303000
|
-5.94e-02
|
4.21e-02
|
6.91e-01
|
REACTOME SYNTHESIS OF BILE ACIDS AND BILE SALTS
|
34
|
3.71e-02
|
1.29e-01
|
0.30800
|
-0.241000
|
-1.92e-01
|
1.51e-02
|
5.23e-02
|
REACTOME CONDENSATION OF PROMETAPHASE CHROMOSOMES
|
11
|
4.53e-02
|
1.46e-01
|
0.30800
|
0.252000
|
-1.78e-01
|
1.49e-01
|
3.08e-01
|
REACTOME NR1H2 NR1H3 REGULATE GENE EXPRESSION LINKED TO LIPOGENESIS
|
9
|
1.24e-01
|
2.83e-01
|
0.30800
|
-0.068700
|
3.00e-01
|
7.21e-01
|
1.19e-01
|
REACTOME EGFR DOWNREGULATION
|
30
|
3.31e-02
|
1.19e-01
|
0.30800
|
0.275000
|
1.37e-01
|
9.04e-03
|
1.93e-01
|
REACTOME PI3K EVENTS IN ERBB2 SIGNALING
|
16
|
1.63e-01
|
3.37e-01
|
0.30700
|
0.275000
|
1.37e-01
|
5.68e-02
|
3.42e-01
|
REACTOME GABA RECEPTOR ACTIVATION
|
57
|
4.46e-03
|
2.88e-02
|
0.30700
|
0.233000
|
2.00e-01
|
2.35e-03
|
8.91e-03
|
REACTOME COHESIN LOADING ONTO CHROMATIN
|
7
|
1.51e-01
|
3.23e-01
|
0.30600
|
-0.267000
|
1.50e-01
|
2.21e-01
|
4.92e-01
|
REACTOME POLO LIKE KINASE MEDIATED EVENTS
|
16
|
3.76e-02
|
1.30e-01
|
0.30600
|
0.305000
|
-2.75e-02
|
3.49e-02
|
8.49e-01
|
REACTOME TICAM1 RIP1 MEDIATED IKK COMPLEX RECRUITMENT
|
18
|
6.16e-03
|
3.61e-02
|
0.30600
|
0.217000
|
-2.16e-01
|
1.12e-01
|
1.13e-01
|
REACTOME APC C CDC20 MEDIATED DEGRADATION OF CYCLIN B
|
24
|
1.45e-03
|
1.09e-02
|
0.30600
|
0.260000
|
-1.61e-01
|
2.76e-02
|
1.72e-01
|
REACTOME SIRT1 NEGATIVELY REGULATES RRNA EXPRESSION
|
7
|
1.50e-01
|
3.21e-01
|
0.30500
|
0.159000
|
-2.60e-01
|
4.66e-01
|
2.33e-01
|
REACTOME REPRESSION OF WNT TARGET GENES
|
13
|
2.87e-01
|
4.78e-01
|
0.30500
|
0.241000
|
1.87e-01
|
1.32e-01
|
2.43e-01
|
REACTOME 2 LTR CIRCLE FORMATION
|
7
|
1.69e-01
|
3.48e-01
|
0.30500
|
0.117000
|
-2.82e-01
|
5.92e-01
|
1.97e-01
|
REACTOME SIGNALING BY FGFR1
|
49
|
3.63e-03
|
2.43e-02
|
0.30500
|
0.276000
|
1.28e-01
|
8.12e-04
|
1.21e-01
|
REACTOME FRUCTOSE METABOLISM
|
7
|
5.22e-01
|
6.77e-01
|
0.30400
|
-0.224000
|
-2.06e-01
|
3.05e-01
|
3.45e-01
|
REACTOME CELLULAR RESPONSE TO HYPOXIA
|
71
|
2.25e-08
|
5.74e-07
|
0.30400
|
0.284000
|
-1.08e-01
|
3.40e-05
|
1.15e-01
|
REACTOME ABERRANT REGULATION OF MITOTIC G1 S TRANSITION IN CANCER DUE TO RB1 DEFECTS
|
17
|
1.29e-02
|
6.15e-02
|
0.30400
|
0.277000
|
-1.25e-01
|
4.77e-02
|
3.73e-01
|
REACTOME APEX1 INDEPENDENT RESOLUTION OF AP SITES VIA THE SINGLE NUCLEOTIDE REPLACEMENT PATHWAY
|
7
|
5.26e-01
|
6.80e-01
|
0.30300
|
0.215000
|
2.15e-01
|
3.25e-01
|
3.26e-01
|
REACTOME ERKS ARE INACTIVATED
|
13
|
7.86e-02
|
2.14e-01
|
0.30300
|
0.303000
|
-1.73e-02
|
5.86e-02
|
9.14e-01
|
REACTOME RUNX3 REGULATES WNT SIGNALING
|
8
|
4.27e-01
|
5.94e-01
|
0.30300
|
0.266000
|
1.46e-01
|
1.93e-01
|
4.76e-01
|
REACTOME APC C MEDIATED DEGRADATION OF CELL CYCLE PROTEINS
|
86
|
5.82e-11
|
2.88e-09
|
0.30300
|
0.239000
|
-1.86e-01
|
1.26e-04
|
2.84e-03
|
REACTOME DEGRADATION OF GLI1 BY THE PROTEASOME
|
58
|
1.79e-07
|
3.14e-06
|
0.30300
|
0.255000
|
-1.63e-01
|
7.92e-04
|
3.14e-02
|
REACTOME ACTIVATION OF SMO
|
17
|
1.85e-01
|
3.68e-01
|
0.30200
|
0.254000
|
1.62e-01
|
6.97e-02
|
2.46e-01
|
REACTOME UNBLOCKING OF NMDA RECEPTORS GLUTAMATE BINDING AND ACTIVATION
|
19
|
1.80e-01
|
3.60e-01
|
0.30100
|
0.209000
|
2.17e-01
|
1.15e-01
|
1.02e-01
|
REACTOME DOWNSTREAM SIGNALING OF ACTIVATED FGFR3
|
24
|
9.63e-02
|
2.44e-01
|
0.30000
|
0.251000
|
1.64e-01
|
3.30e-02
|
1.65e-01
|
REACTOME FGFR1 MUTANT RECEPTOR ACTIVATION
|
30
|
6.83e-02
|
1.95e-01
|
0.30000
|
0.212000
|
2.12e-01
|
4.46e-02
|
4.44e-02
|
REACTOME TLR3 MEDIATED TICAM1 DEPENDENT PROGRAMMED CELL DEATH
|
6
|
2.26e-01
|
4.17e-01
|
0.29900
|
0.122000
|
-2.73e-01
|
6.04e-01
|
2.46e-01
|
REACTOME NR1H2 NR1H3 REGULATE GENE EXPRESSION TO CONTROL BILE ACID HOMEOSTASIS
|
9
|
2.07e-01
|
3.92e-01
|
0.29900
|
-0.299000
|
-8.43e-03
|
1.20e-01
|
9.65e-01
|
REACTOME INTERLEUKIN 6 SIGNALING
|
11
|
3.54e-01
|
5.35e-01
|
0.29900
|
0.244000
|
1.73e-01
|
1.61e-01
|
3.20e-01
|
REACTOME PASSIVE TRANSPORT BY AQUAPORINS
|
13
|
3.09e-01
|
4.93e-01
|
0.29900
|
-0.228000
|
-1.93e-01
|
1.54e-01
|
2.28e-01
|
REACTOME SPERM MOTILITY AND TAXES
|
9
|
4.14e-01
|
5.88e-01
|
0.29900
|
-0.253000
|
-1.59e-01
|
1.89e-01
|
4.09e-01
|
REACTOME SMAD2 SMAD3 SMAD4 HETEROTRIMER REGULATES TRANSCRIPTION
|
36
|
7.74e-04
|
6.26e-03
|
0.29800
|
0.296000
|
-3.43e-02
|
2.10e-03
|
7.22e-01
|
REACTOME TRANSLESION SYNTHESIS BY POLH
|
18
|
1.96e-02
|
8.53e-02
|
0.29800
|
0.290000
|
-6.77e-02
|
3.30e-02
|
6.19e-01
|
REACTOME REGULATION OF TLR BY ENDOGENOUS LIGAND
|
20
|
1.48e-01
|
3.20e-01
|
0.29800
|
-0.164000
|
-2.48e-01
|
2.04e-01
|
5.46e-02
|
REACTOME NEGATIVE REGULATION OF NMDA RECEPTOR MEDIATED NEURONAL TRANSMISSION
|
20
|
1.70e-01
|
3.49e-01
|
0.29700
|
0.201000
|
2.19e-01
|
1.19e-01
|
8.99e-02
|
REACTOME STAT5 ACTIVATION DOWNSTREAM OF FLT3 ITD MUTANTS
|
10
|
9.36e-02
|
2.38e-01
|
0.29700
|
0.278000
|
-1.05e-01
|
1.28e-01
|
5.66e-01
|
REACTOME RUNX3 REGULATES NOTCH SIGNALING
|
13
|
3.10e-01
|
4.94e-01
|
0.29700
|
0.233000
|
1.84e-01
|
1.46e-01
|
2.52e-01
|
REACTOME G2 M DNA REPLICATION CHECKPOINT
|
5
|
2.67e-01
|
4.61e-01
|
0.29600
|
0.200000
|
-2.18e-01
|
4.38e-01
|
3.99e-01
|
REACTOME TICAM1 TRAF6 DEPENDENT INDUCTION OF TAK1 COMPLEX
|
10
|
7.11e-02
|
2.01e-01
|
0.29600
|
0.216000
|
-2.02e-01
|
2.37e-01
|
2.68e-01
|
REACTOME VEGFR2 MEDIATED CELL PROLIFERATION
|
19
|
1.80e-01
|
3.60e-01
|
0.29600
|
0.178000
|
2.36e-01
|
1.78e-01
|
7.53e-02
|
REACTOME DEGRADATION OF DVL
|
55
|
5.60e-07
|
8.99e-06
|
0.29600
|
0.230000
|
-1.86e-01
|
3.18e-03
|
1.72e-02
|
REACTOME N GLYCAN ANTENNAE ELONGATION
|
15
|
2.71e-01
|
4.64e-01
|
0.29500
|
0.203000
|
2.15e-01
|
1.74e-01
|
1.49e-01
|
REACTOME TRAF6 MEDIATED IRF7 ACTIVATION
|
26
|
3.40e-02
|
1.21e-01
|
0.29500
|
-0.285000
|
-7.82e-02
|
1.19e-02
|
4.90e-01
|
REACTOME HIGHLY SODIUM PERMEABLE POSTSYNAPTIC ACETYLCHOLINE NICOTINIC RECEPTORS
|
7
|
4.36e-01
|
6.03e-01
|
0.29500
|
0.277000
|
1.01e-01
|
2.04e-01
|
6.44e-01
|
REACTOME IRF3 MEDIATED INDUCTION OF TYPE I IFN
|
11
|
3.62e-01
|
5.43e-01
|
0.29500
|
-0.168000
|
-2.43e-01
|
3.35e-01
|
1.64e-01
|
REACTOME G ALPHA Z SIGNALLING EVENTS
|
48
|
1.43e-02
|
6.66e-02
|
0.29500
|
0.229000
|
1.85e-01
|
5.99e-03
|
2.62e-02
|
REACTOME PROSTACYCLIN SIGNALLING THROUGH PROSTACYCLIN RECEPTOR
|
19
|
1.75e-01
|
3.54e-01
|
0.29500
|
0.241000
|
1.70e-01
|
6.91e-02
|
2.00e-01
|
REACTOME RETROGRADE NEUROTROPHIN SIGNALLING
|
14
|
2.99e-01
|
4.89e-01
|
0.29400
|
0.212000
|
2.04e-01
|
1.69e-01
|
1.87e-01
|
REACTOME SIGNALING BY ROBO RECEPTORS
|
202
|
1.62e-23
|
1.56e-21
|
0.29400
|
0.205000
|
-2.11e-01
|
4.86e-07
|
2.42e-07
|
REACTOME ORGANIC ANION TRANSPORTERS
|
10
|
4.21e-01
|
5.90e-01
|
0.29400
|
0.198000
|
2.17e-01
|
2.78e-01
|
2.34e-01
|
REACTOME APOPTOSIS INDUCED DNA FRAGMENTATION
|
7
|
2.11e-01
|
3.98e-01
|
0.29300
|
0.086900
|
-2.80e-01
|
6.91e-01
|
1.99e-01
|
REACTOME RAS PROCESSING
|
22
|
7.70e-03
|
4.33e-02
|
0.29300
|
0.281000
|
-8.48e-02
|
2.25e-02
|
4.91e-01
|
REACTOME CHK1 CHK2 CDS1 MEDIATED INACTIVATION OF CYCLIN B CDK1 COMPLEX
|
13
|
3.46e-02
|
1.23e-01
|
0.29300
|
0.197000
|
-2.16e-01
|
2.18e-01
|
1.77e-01
|
REACTOME MAP3K8 TPL2 DEPENDENT MAPK1 3 ACTIVATION
|
15
|
8.48e-02
|
2.25e-01
|
0.29200
|
0.292000
|
1.23e-02
|
5.01e-02
|
9.34e-01
|
REACTOME SYNTHESIS OF DOLICHYL PHOSPHATE
|
6
|
5.13e-01
|
6.70e-01
|
0.29200
|
0.271000
|
1.09e-01
|
2.51e-01
|
6.44e-01
|
REACTOME SULFIDE OXIDATION TO SULFATE
|
5
|
5.94e-01
|
7.33e-01
|
0.29200
|
0.125000
|
2.63e-01
|
6.28e-01
|
3.08e-01
|
REACTOME RUNX1 REGULATES TRANSCRIPTION OF GENES INVOLVED IN BCR SIGNALING
|
6
|
6.02e-01
|
7.37e-01
|
0.29100
|
0.199000
|
2.13e-01
|
3.99e-01
|
3.67e-01
|
REACTOME PLASMA LIPOPROTEIN REMODELING
|
32
|
1.99e-02
|
8.59e-02
|
0.29100
|
-0.278000
|
-8.45e-02
|
6.41e-03
|
4.08e-01
|
REACTOME RAS SIGNALING DOWNSTREAM OF NF1 LOSS OF FUNCTION VARIANTS
|
7
|
4.82e-01
|
6.42e-01
|
0.29100
|
0.263000
|
1.23e-01
|
2.28e-01
|
5.72e-01
|
REACTOME KSRP KHSRP BINDS AND DESTABILIZES MRNA
|
17
|
1.86e-02
|
8.18e-02
|
0.29100
|
0.265000
|
-1.20e-01
|
5.89e-02
|
3.90e-01
|
REACTOME PROLONGED ERK ACTIVATION EVENTS
|
14
|
3.07e-01
|
4.92e-01
|
0.29000
|
0.196000
|
2.14e-01
|
2.04e-01
|
1.66e-01
|
REACTOME SENESCENCE ASSOCIATED SECRETORY PHENOTYPE SASP
|
51
|
2.05e-04
|
1.95e-03
|
0.29000
|
0.290000
|
4.52e-03
|
3.34e-04
|
9.55e-01
|
REACTOME SYNTHESIS OF PI
|
5
|
4.21e-01
|
5.90e-01
|
0.29000
|
-0.006480
|
2.90e-01
|
9.80e-01
|
2.61e-01
|
REACTOME REGULATION OF RAS BY GAPS
|
65
|
9.48e-08
|
1.76e-06
|
0.29000
|
0.235000
|
-1.69e-01
|
1.03e-03
|
1.84e-02
|
REACTOME TACHYKININ RECEPTORS BIND TACHYKININS
|
5
|
6.58e-01
|
7.79e-01
|
0.29000
|
0.206000
|
2.04e-01
|
4.25e-01
|
4.30e-01
|
REACTOME GLUCONEOGENESIS
|
32
|
2.35e-02
|
9.62e-02
|
0.28900
|
-0.091500
|
-2.74e-01
|
3.70e-01
|
7.22e-03
|
REACTOME REGULATION OF SIGNALING BY CBL
|
22
|
1.31e-02
|
6.19e-02
|
0.28900
|
0.284000
|
-5.11e-02
|
2.09e-02
|
6.78e-01
|
REACTOME ADENYLATE CYCLASE ACTIVATING PATHWAY
|
10
|
3.66e-01
|
5.46e-01
|
0.28900
|
0.128000
|
2.59e-01
|
4.84e-01
|
1.56e-01
|
REACTOME INLA MEDIATED ENTRY OF LISTERIA MONOCYTOGENES INTO HOST CELLS
|
9
|
1.72e-01
|
3.50e-01
|
0.28900
|
0.284000
|
-4.88e-02
|
1.39e-01
|
8.00e-01
|
REACTOME SIGNALING BY NODAL
|
21
|
1.74e-01
|
3.52e-01
|
0.28800
|
0.211000
|
1.96e-01
|
9.35e-02
|
1.19e-01
|
REACTOME CARNITINE METABOLISM
|
13
|
2.06e-01
|
3.91e-01
|
0.28800
|
0.079400
|
2.76e-01
|
6.20e-01
|
8.45e-02
|
REACTOME N GLYCAN TRIMMING IN THE ER AND CALNEXIN CALRETICULIN CYCLE
|
34
|
4.00e-04
|
3.58e-03
|
0.28800
|
0.261000
|
-1.21e-01
|
8.53e-03
|
2.20e-01
|
REACTOME THROMBOXANE SIGNALLING THROUGH TP RECEPTOR
|
24
|
8.10e-02
|
2.18e-01
|
0.28700
|
0.264000
|
1.15e-01
|
2.54e-02
|
3.30e-01
|
REACTOME METABOLISM OF ANGIOTENSINOGEN TO ANGIOTENSINS
|
15
|
2.92e-01
|
4.83e-01
|
0.28700
|
-0.203000
|
-2.03e-01
|
1.73e-01
|
1.74e-01
|
REACTOME PARACETAMOL ADME
|
26
|
6.20e-02
|
1.84e-01
|
0.28700
|
-0.266000
|
-1.09e-01
|
1.91e-02
|
3.37e-01
|
REACTOME BINDING AND UPTAKE OF LIGANDS BY SCAVENGER RECEPTORS
|
42
|
2.76e-02
|
1.07e-01
|
0.28700
|
-0.171000
|
-2.30e-01
|
5.47e-02
|
9.82e-03
|
REACTOME SCAVENGING BY CLASS F RECEPTORS
|
6
|
2.26e-01
|
4.17e-01
|
0.28700
|
0.190000
|
-2.15e-01
|
4.20e-01
|
3.62e-01
|
REACTOME SIGNALING BY NTRKS
|
132
|
3.12e-07
|
5.31e-06
|
0.28600
|
0.271000
|
9.15e-02
|
7.65e-08
|
6.94e-02
|
REACTOME RNA POLYMERASE III CHAIN ELONGATION
|
18
|
1.21e-02
|
5.98e-02
|
0.28500
|
0.196000
|
-2.07e-01
|
1.50e-01
|
1.29e-01
|
REACTOME RNA POLYMERASE I PROMOTER ESCAPE
|
27
|
1.41e-03
|
1.06e-02
|
0.28500
|
0.223000
|
-1.77e-01
|
4.49e-02
|
1.11e-01
|
REACTOME MAPK6 MAPK4 SIGNALING
|
89
|
7.19e-08
|
1.43e-06
|
0.28500
|
0.282000
|
-3.93e-02
|
4.24e-06
|
5.22e-01
|
REACTOME CASPASE ACTIVATION VIA DEATH RECEPTORS IN THE PRESENCE OF LIGAND
|
16
|
2.47e-02
|
9.93e-02
|
0.28400
|
0.250000
|
-1.35e-01
|
8.32e-02
|
3.48e-01
|
REACTOME CYCLIN A CDK2 ASSOCIATED EVENTS AT S PHASE ENTRY
|
83
|
2.82e-09
|
9.42e-08
|
0.28400
|
0.236000
|
-1.58e-01
|
1.95e-04
|
1.31e-02
|
REACTOME REGULATION OF TP53 ACTIVITY THROUGH METHYLATION
|
18
|
6.27e-02
|
1.84e-01
|
0.28400
|
0.283000
|
1.37e-02
|
3.74e-02
|
9.20e-01
|
REACTOME RUNX1 REGULATES TRANSCRIPTION OF GENES INVOLVED IN DIFFERENTIATION OF HSCS
|
67
|
6.81e-07
|
1.06e-05
|
0.28300
|
0.267000
|
-9.40e-02
|
1.54e-04
|
1.83e-01
|
REACTOME BETA OXIDATION OF BUTANOYL COA TO ACETYL COA
|
5
|
4.23e-01
|
5.91e-01
|
0.28300
|
-0.283000
|
1.89e-02
|
2.74e-01
|
9.42e-01
|
REACTOME UCH PROTEINASES
|
81
|
1.59e-08
|
4.20e-07
|
0.28300
|
0.257000
|
-1.18e-01
|
6.19e-05
|
6.73e-02
|
REACTOME NEPHRIN FAMILY INTERACTIONS
|
21
|
1.74e-01
|
3.52e-01
|
0.28200
|
0.166000
|
2.28e-01
|
1.88e-01
|
7.03e-02
|
REACTOME SIGNALING BY LEPTIN
|
11
|
3.28e-01
|
5.07e-01
|
0.28100
|
0.259000
|
1.10e-01
|
1.37e-01
|
5.27e-01
|
REACTOME UPTAKE OF DIETARY COBALAMINS INTO ENTEROCYTES
|
9
|
1.17e-01
|
2.73e-01
|
0.28100
|
-0.189000
|
2.08e-01
|
3.25e-01
|
2.80e-01
|
REACTOME GLUCAGON LIKE PEPTIDE 1 GLP1 REGULATES INSULIN SECRETION
|
42
|
3.62e-02
|
1.26e-01
|
0.28100
|
0.208000
|
1.89e-01
|
1.95e-02
|
3.42e-02
|
REACTOME SIGNALING BY NOTCH4
|
79
|
8.23e-08
|
1.60e-06
|
0.28100
|
0.266000
|
-8.98e-02
|
4.31e-05
|
1.67e-01
|
REACTOME ACTIVATION OF NOXA AND TRANSLOCATION TO MITOCHONDRIA
|
5
|
6.73e-01
|
7.91e-01
|
0.28100
|
0.210000
|
1.86e-01
|
4.15e-01
|
4.71e-01
|
REACTOME VISUAL PHOTOTRANSDUCTION
|
93
|
8.71e-05
|
8.69e-04
|
0.28000
|
-0.258000
|
-1.09e-01
|
1.67e-05
|
6.95e-02
|
REACTOME DECTIN 2 FAMILY
|
26
|
1.25e-01
|
2.86e-01
|
0.28000
|
-0.219000
|
-1.75e-01
|
5.36e-02
|
1.23e-01
|
REACTOME INTERLEUKIN 6 FAMILY SIGNALING
|
24
|
9.83e-02
|
2.46e-01
|
0.27900
|
0.254000
|
1.15e-01
|
3.15e-02
|
3.27e-01
|
REACTOME SIGNALING BY NTRK2 TRKB
|
25
|
4.39e-02
|
1.44e-01
|
0.27800
|
0.273000
|
5.57e-02
|
1.82e-02
|
6.30e-01
|
REACTOME REGULATION OF FOXO TRANSCRIPTIONAL ACTIVITY BY ACETYLATION
|
9
|
4.08e-01
|
5.83e-01
|
0.27800
|
0.257000
|
1.07e-01
|
1.83e-01
|
5.77e-01
|
REACTOME FATTY ACIDS BOUND TO GPR40 FFAR1 REGULATE INSULIN SECRETION
|
8
|
2.87e-01
|
4.78e-01
|
0.27800
|
-0.278000
|
1.47e-03
|
1.74e-01
|
9.94e-01
|
REACTOME THE ROLE OF GTSE1 IN G2 M PROGRESSION AFTER G2 CHECKPOINT
|
76
|
2.54e-08
|
6.12e-07
|
0.27800
|
0.219000
|
-1.70e-01
|
9.54e-04
|
1.02e-02
|
REACTOME LTC4 CYSLTR MEDIATED IL4 PRODUCTION
|
6
|
3.22e-01
|
4.99e-01
|
0.27700
|
-0.270000
|
6.26e-02
|
2.52e-01
|
7.91e-01
|
REACTOME ORGANIC CATION ANION ZWITTERION TRANSPORT
|
15
|
9.71e-02
|
2.45e-01
|
0.27700
|
-0.277000
|
1.50e-03
|
6.29e-02
|
9.92e-01
|
REACTOME DEFECTIVE INTRINSIC PATHWAY FOR APOPTOSIS
|
25
|
3.34e-03
|
2.27e-02
|
0.27700
|
0.226000
|
-1.61e-01
|
5.05e-02
|
1.64e-01
|
REACTOME RECOGNITION OF DNA DAMAGE BY PCNA CONTAINING REPLICATION COMPLEX
|
29
|
1.48e-02
|
6.82e-02
|
0.27700
|
0.276000
|
1.55e-02
|
9.97e-03
|
8.85e-01
|
REACTOME SYNTHESIS OF ACTIVE UBIQUITIN ROLES OF E1 AND E2 ENZYMES
|
27
|
5.50e-03
|
3.29e-02
|
0.27700
|
0.267000
|
-7.17e-02
|
1.62e-02
|
5.19e-01
|
REACTOME REGULATION OF CYTOSKELETAL REMODELING AND CELL SPREADING BY IPP COMPLEX COMPONENTS
|
7
|
5.86e-01
|
7.25e-01
|
0.27700
|
0.190000
|
2.01e-01
|
3.83e-01
|
3.57e-01
|
REACTOME MITOPHAGY
|
26
|
2.55e-03
|
1.79e-02
|
0.27700
|
0.214000
|
-1.75e-01
|
5.89e-02
|
1.22e-01
|
REACTOME FLT3 SIGNALING
|
38
|
3.64e-03
|
2.43e-02
|
0.27600
|
0.276000
|
9.60e-03
|
3.23e-03
|
9.18e-01
|
REACTOME G BETA GAMMA SIGNALLING THROUGH PI3KGAMMA
|
25
|
1.46e-01
|
3.16e-01
|
0.27600
|
0.178000
|
2.11e-01
|
1.22e-01
|
6.81e-02
|
REACTOME RUNX1 REGULATES GENES INVOLVED IN MEGAKARYOCYTE DIFFERENTIATION AND PLATELET FUNCTION
|
37
|
1.31e-02
|
6.19e-02
|
0.27600
|
0.066100
|
2.68e-01
|
4.87e-01
|
4.76e-03
|
REACTOME TRANSLESION SYNTHESIS BY POLK
|
17
|
6.02e-02
|
1.79e-01
|
0.27500
|
0.274000
|
-2.34e-02
|
5.02e-02
|
8.67e-01
|
REACTOME ARMS MEDIATED ACTIVATION
|
7
|
5.83e-01
|
7.24e-01
|
0.27500
|
0.174000
|
2.13e-01
|
4.25e-01
|
3.29e-01
|
REACTOME RESPIRATORY ELECTRON TRANSPORT
|
90
|
5.93e-09
|
1.73e-07
|
0.27500
|
0.117000
|
-2.49e-01
|
5.57e-02
|
4.37e-05
|
REACTOME SYNTHESIS OF GLYCOSYLPHOSPHATIDYLINOSITOL GPI
|
17
|
2.60e-02
|
1.03e-01
|
0.27500
|
0.127000
|
-2.44e-01
|
3.65e-01
|
8.15e-02
|
REACTOME REGULATION OF MECP2 EXPRESSION AND ACTIVITY
|
30
|
6.38e-02
|
1.86e-01
|
0.27400
|
0.118000
|
2.47e-01
|
2.62e-01
|
1.90e-02
|
REACTOME METABOLISM OF PORPHYRINS
|
26
|
1.18e-01
|
2.76e-01
|
0.27400
|
-0.147000
|
-2.31e-01
|
1.95e-01
|
4.11e-02
|
REACTOME CONSTITUTIVE SIGNALING BY OVEREXPRESSED ERBB2
|
10
|
2.09e-01
|
3.95e-01
|
0.27400
|
0.273000
|
-1.12e-02
|
1.34e-01
|
9.51e-01
|
REACTOME CLEC7A INFLAMMASOME PATHWAY
|
6
|
4.84e-01
|
6.43e-01
|
0.27400
|
0.268000
|
5.41e-02
|
2.55e-01
|
8.19e-01
|
REACTOME NEURONAL SYSTEM
|
387
|
4.39e-13
|
3.12e-11
|
0.27300
|
0.183000
|
2.02e-01
|
5.73e-10
|
8.09e-12
|
REACTOME IRF3 MEDIATED ACTIVATION OF TYPE 1 IFN
|
5
|
6.78e-01
|
7.96e-01
|
0.27200
|
-0.160000
|
-2.20e-01
|
5.35e-01
|
3.94e-01
|
REACTOME METABOLISM OF STEROID HORMONES
|
33
|
8.75e-02
|
2.29e-01
|
0.27200
|
-0.189000
|
-1.96e-01
|
6.03e-02
|
5.14e-02
|
REACTOME CYCLIN D ASSOCIATED EVENTS IN G1
|
46
|
5.53e-05
|
5.72e-04
|
0.27200
|
0.236000
|
-1.35e-01
|
5.59e-03
|
1.13e-01
|
REACTOME AKT PHOSPHORYLATES TARGETS IN THE NUCLEUS
|
9
|
1.61e-01
|
3.34e-01
|
0.27200
|
-0.250000
|
1.07e-01
|
1.94e-01
|
5.78e-01
|
REACTOME RNA POLYMERASE II TRANSCRIPTION
|
1262
|
1.45e-49
|
7.90e-47
|
0.27200
|
0.249000
|
1.10e-01
|
1.42e-50
|
4.93e-11
|
REACTOME NOTCH4 INTRACELLULAR DOMAIN REGULATES TRANSCRIPTION
|
19
|
2.40e-01
|
4.31e-01
|
0.27200
|
0.172000
|
2.11e-01
|
1.95e-01
|
1.12e-01
|
REACTOME INTERLEUKIN RECEPTOR SHC SIGNALING
|
24
|
1.65e-01
|
3.41e-01
|
0.27200
|
-0.210000
|
-1.72e-01
|
7.47e-02
|
1.44e-01
|
REACTOME PLASMA LIPOPROTEIN ASSEMBLY
|
19
|
1.46e-01
|
3.16e-01
|
0.27200
|
-0.256000
|
-9.04e-02
|
5.31e-02
|
4.95e-01
|
REACTOME DNA DAMAGE RECOGNITION IN GG NER
|
36
|
1.93e-03
|
1.40e-02
|
0.27100
|
0.267000
|
-4.76e-02
|
5.52e-03
|
6.21e-01
|
REACTOME SIGNALING BY TYPE 1 INSULIN LIKE GROWTH FACTOR 1 RECEPTOR IGF1R
|
52
|
2.00e-02
|
8.59e-02
|
0.27100
|
0.168000
|
2.13e-01
|
3.55e-02
|
7.95e-03
|
REACTOME TRANSCRIPTIONAL REGULATION BY VENTX
|
41
|
4.72e-02
|
1.50e-01
|
0.27100
|
0.174000
|
2.08e-01
|
5.36e-02
|
2.12e-02
|
REACTOME NEF MEDIATES DOWN MODULATION OF CELL SURFACE RECEPTORS BY RECRUITING THEM TO CLATHRIN ADAPTERS
|
20
|
2.23e-01
|
4.13e-01
|
0.27100
|
0.212000
|
1.70e-01
|
1.01e-01
|
1.89e-01
|
REACTOME INTEGRATION OF PROVIRUS
|
9
|
1.90e-01
|
3.73e-01
|
0.27100
|
0.068800
|
-2.62e-01
|
7.21e-01
|
1.73e-01
|
REACTOME ACTIVATION OF NMDA RECEPTORS AND POSTSYNAPTIC EVENTS
|
87
|
1.76e-03
|
1.31e-02
|
0.27100
|
0.191000
|
1.92e-01
|
2.05e-03
|
1.98e-03
|
REACTOME DEFENSINS
|
33
|
8.99e-02
|
2.33e-01
|
0.27000
|
-0.198000
|
-1.84e-01
|
4.88e-02
|
6.74e-02
|
REACTOME RNA POLYMERASE I TRANSCRIPTION TERMINATION
|
26
|
3.77e-03
|
2.50e-02
|
0.27000
|
0.225000
|
-1.49e-01
|
4.69e-02
|
1.88e-01
|
REACTOME CONSTITUTIVE SIGNALING BY LIGAND RESPONSIVE EGFR CANCER VARIANTS
|
19
|
2.18e-02
|
9.15e-02
|
0.27000
|
0.247000
|
-1.10e-01
|
6.25e-02
|
4.08e-01
|
REACTOME EPH EPHRIN MEDIATED REPULSION OF CELLS
|
50
|
1.73e-02
|
7.75e-02
|
0.27000
|
0.231000
|
1.38e-01
|
4.65e-03
|
9.02e-02
|
REACTOME TP53 REGULATES TRANSCRIPTION OF GENES INVOLVED IN G1 CELL CYCLE ARREST
|
14
|
9.09e-02
|
2.35e-01
|
0.26900
|
0.265000
|
-4.82e-02
|
8.64e-02
|
7.55e-01
|
REACTOME NEUREXINS AND NEUROLIGINS
|
51
|
2.55e-02
|
1.02e-01
|
0.26800
|
0.182000
|
1.98e-01
|
2.48e-02
|
1.46e-02
|
REACTOME TETRAHYDROBIOPTERIN BH4 SYNTHESIS RECYCLING SALVAGE AND REGULATION
|
10
|
1.14e-01
|
2.69e-01
|
0.26800
|
0.177000
|
-2.01e-01
|
3.31e-01
|
2.70e-01
|
REACTOME NUCLEAR EVENTS STIMULATED BY ALK SIGNALING IN CANCER
|
18
|
2.08e-02
|
8.86e-02
|
0.26800
|
0.213000
|
-1.63e-01
|
1.18e-01
|
2.30e-01
|
REACTOME FLT3 SIGNALING IN DISEASE
|
28
|
1.39e-02
|
6.51e-02
|
0.26800
|
0.268000
|
-1.52e-02
|
1.41e-02
|
8.89e-01
|
REACTOME SIGNALING BY FGFR1 IN DISEASE
|
37
|
7.01e-02
|
1.99e-01
|
0.26800
|
0.181000
|
1.97e-01
|
5.62e-02
|
3.77e-02
|
REACTOME SIGNALING BY SCF KIT
|
42
|
2.93e-02
|
1.11e-01
|
0.26800
|
0.237000
|
1.25e-01
|
7.89e-03
|
1.60e-01
|
REACTOME PI3K AKT ACTIVATION
|
9
|
5.23e-01
|
6.77e-01
|
0.26800
|
0.178000
|
2.00e-01
|
3.54e-01
|
2.99e-01
|
REACTOME TNF RECEPTOR SUPERFAMILY TNFSF MEMBERS MEDIATING NON CANONICAL NF KB PATHWAY
|
16
|
3.33e-02
|
1.19e-01
|
0.26800
|
0.217000
|
-1.56e-01
|
1.32e-01
|
2.80e-01
|
REACTOME DOWNREGULATION OF SMAD2 3 SMAD4 TRANSCRIPTIONAL ACTIVITY
|
29
|
7.10e-02
|
2.01e-01
|
0.26700
|
0.246000
|
1.05e-01
|
2.20e-02
|
3.28e-01
|
REACTOME PYRIMIDINE SALVAGE
|
10
|
3.44e-01
|
5.24e-01
|
0.26700
|
-0.069800
|
-2.58e-01
|
7.02e-01
|
1.58e-01
|
REACTOME TCF DEPENDENT SIGNALING IN RESPONSE TO WNT
|
167
|
2.16e-07
|
3.73e-06
|
0.26700
|
0.247000
|
1.01e-01
|
3.64e-08
|
2.41e-02
|
REACTOME MUCOPOLYSACCHARIDOSES
|
10
|
4.07e-01
|
5.83e-01
|
0.26700
|
0.107000
|
2.44e-01
|
5.57e-01
|
1.81e-01
|
REACTOME MET ACTIVATES PTPN11
|
5
|
5.55e-01
|
6.99e-01
|
0.26600
|
-0.046500
|
-2.62e-01
|
8.57e-01
|
3.10e-01
|
REACTOME SIGNALING BY PDGFR IN DISEASE
|
20
|
2.47e-01
|
4.40e-01
|
0.26500
|
0.187000
|
1.88e-01
|
1.47e-01
|
1.46e-01
|
REACTOME IL 6 TYPE CYTOKINE RECEPTOR LIGAND INTERACTIONS
|
17
|
3.04e-01
|
4.91e-01
|
0.26500
|
0.195000
|
1.79e-01
|
1.64e-01
|
2.01e-01
|
REACTOME HEPARAN SULFATE HEPARIN HS GAG METABOLISM
|
50
|
2.86e-02
|
1.10e-01
|
0.26400
|
0.166000
|
2.05e-01
|
4.19e-02
|
1.20e-02
|
REACTOME PP2A MEDIATED DEPHOSPHORYLATION OF KEY METABOLIC FACTORS
|
6
|
3.12e-01
|
4.94e-01
|
0.26400
|
0.240000
|
-1.11e-01
|
3.09e-01
|
6.39e-01
|
REACTOME DEGRADATION OF BETA CATENIN BY THE DESTRUCTION COMPLEX
|
81
|
4.37e-07
|
7.15e-06
|
0.26400
|
0.252000
|
-8.04e-02
|
9.00e-05
|
2.11e-01
|
REACTOME BUTYRATE RESPONSE FACTOR 1 BRF1 BINDS AND DESTABILIZES MRNA
|
17
|
3.20e-02
|
1.17e-01
|
0.26400
|
0.226000
|
-1.36e-01
|
1.06e-01
|
3.31e-01
|
REACTOME GLUTAMATE NEUROTRANSMITTER RELEASE CYCLE
|
23
|
1.35e-01
|
3.02e-01
|
0.26400
|
0.241000
|
1.09e-01
|
4.58e-02
|
3.67e-01
|
REACTOME RUNX2 REGULATES GENES INVOLVED IN CELL MIGRATION
|
8
|
1.99e-01
|
3.83e-01
|
0.26400
|
-0.227000
|
1.35e-01
|
2.67e-01
|
5.09e-01
|
REACTOME N GLYCAN TRIMMING AND ELONGATION IN THE CIS GOLGI
|
5
|
7.04e-01
|
8.10e-01
|
0.26400
|
0.200000
|
1.72e-01
|
4.38e-01
|
5.07e-01
|
REACTOME NOREPINEPHRINE NEUROTRANSMITTER RELEASE CYCLE
|
16
|
3.06e-01
|
4.92e-01
|
0.26400
|
0.217000
|
1.49e-01
|
1.32e-01
|
3.03e-01
|
REACTOME RESPIRATORY ELECTRON TRANSPORT ATP SYNTHESIS BY CHEMIOSMOTIC COUPLING AND HEAT PRODUCTION BY UNCOUPLING PROTEINS
|
95
|
5.58e-09
|
1.70e-07
|
0.26300
|
0.132000
|
-2.28e-01
|
2.60e-02
|
1.22e-04
|
REACTOME GLYCOGEN SYNTHESIS
|
13
|
1.94e-01
|
3.75e-01
|
0.26300
|
0.262000
|
2.49e-02
|
1.02e-01
|
8.76e-01
|
REACTOME G0 AND EARLY G1
|
27
|
1.92e-02
|
8.38e-02
|
0.26300
|
0.263000
|
-1.37e-02
|
1.80e-02
|
9.02e-01
|
REACTOME SARS COV 1 ACTIVATES MODULATES INNATE IMMUNE RESPONSES
|
36
|
6.03e-04
|
5.11e-03
|
0.26300
|
0.155000
|
-2.13e-01
|
1.08e-01
|
2.71e-02
|
REACTOME FCGR ACTIVATION
|
11
|
3.78e-01
|
5.58e-01
|
0.26300
|
0.242000
|
1.03e-01
|
1.65e-01
|
5.53e-01
|
REACTOME SIGNALING BY CYTOSOLIC FGFR1 FUSION MUTANTS
|
17
|
2.72e-01
|
4.64e-01
|
0.26200
|
0.135000
|
2.25e-01
|
3.34e-01
|
1.09e-01
|
REACTOME ALPHA OXIDATION OF PHYTANATE
|
6
|
3.23e-01
|
5.00e-01
|
0.26200
|
0.104000
|
-2.40e-01
|
6.60e-01
|
3.08e-01
|
REACTOME CGMP EFFECTS
|
15
|
3.37e-01
|
5.18e-01
|
0.26200
|
-0.150000
|
-2.14e-01
|
3.13e-01
|
1.51e-01
|
REACTOME ENOS ACTIVATION
|
11
|
3.98e-01
|
5.75e-01
|
0.26200
|
0.236000
|
1.13e-01
|
1.75e-01
|
5.18e-01
|
REACTOME CDC6 ASSOCIATION WITH THE ORC ORIGIN COMPLEX
|
8
|
2.47e-01
|
4.40e-01
|
0.26100
|
-0.251000
|
7.33e-02
|
2.19e-01
|
7.20e-01
|
REACTOME TRANSMISSION ACROSS CHEMICAL SYNAPSES
|
254
|
4.01e-08
|
8.99e-07
|
0.26100
|
0.186000
|
1.83e-01
|
3.46e-07
|
5.05e-07
|
REACTOME DEFECTIVE LFNG CAUSES SCDO3
|
5
|
4.61e-01
|
6.23e-01
|
0.26000
|
-0.035400
|
2.58e-01
|
8.91e-01
|
3.18e-01
|
REACTOME TNFR2 NON CANONICAL NF KB PATHWAY
|
95
|
1.07e-08
|
2.91e-07
|
0.26000
|
0.229000
|
-1.24e-01
|
1.15e-04
|
3.65e-02
|
REACTOME ORC1 REMOVAL FROM CHROMATIN
|
69
|
7.78e-07
|
1.18e-05
|
0.26000
|
0.193000
|
-1.74e-01
|
5.54e-03
|
1.22e-02
|
REACTOME LONG TERM POTENTIATION
|
22
|
2.27e-01
|
4.17e-01
|
0.26000
|
0.183000
|
1.85e-01
|
1.37e-01
|
1.33e-01
|
REACTOME ANTIGEN PROCESSING CROSS PRESENTATION
|
97
|
4.03e-09
|
1.29e-07
|
0.25900
|
0.153000
|
-2.09e-01
|
9.07e-03
|
3.74e-04
|
REACTOME APOPTOTIC FACTOR MEDIATED RESPONSE
|
17
|
7.83e-02
|
2.14e-01
|
0.25900
|
0.257000
|
-2.88e-02
|
6.61e-02
|
8.37e-01
|
REACTOME DOPAMINE NEUROTRANSMITTER RELEASE CYCLE
|
20
|
1.20e-01
|
2.78e-01
|
0.25900
|
0.253000
|
5.53e-02
|
5.04e-02
|
6.69e-01
|
REACTOME ERBB2 REGULATES CELL MOTILITY
|
15
|
3.39e-01
|
5.19e-01
|
0.25900
|
0.216000
|
1.43e-01
|
1.48e-01
|
3.39e-01
|
REACTOME REGULATION OF COMMISSURAL AXON PATHFINDING BY SLIT AND ROBO
|
10
|
4.75e-01
|
6.36e-01
|
0.25900
|
0.133000
|
2.21e-01
|
4.65e-01
|
2.25e-01
|
REACTOME HUR ELAVL1 BINDS AND STABILIZES MRNA
|
8
|
5.75e-01
|
7.18e-01
|
0.25800
|
0.154000
|
2.07e-01
|
4.50e-01
|
3.11e-01
|
REACTOME INSULIN RECEPTOR SIGNALLING CASCADE
|
53
|
2.71e-02
|
1.06e-01
|
0.25800
|
0.159000
|
2.03e-01
|
4.48e-02
|
1.07e-02
|
REACTOME SIGNALING BY FGFR3
|
39
|
2.18e-02
|
9.15e-02
|
0.25800
|
0.248000
|
7.00e-02
|
7.38e-03
|
4.49e-01
|
REACTOME MYOGENESIS
|
29
|
1.14e-01
|
2.70e-01
|
0.25800
|
0.130000
|
2.22e-01
|
2.26e-01
|
3.81e-02
|
REACTOME NA CL DEPENDENT NEUROTRANSMITTER TRANSPORTERS
|
18
|
2.32e-01
|
4.25e-01
|
0.25700
|
0.110000
|
2.32e-01
|
4.18e-01
|
8.77e-02
|
REACTOME NEGATIVE REGULATION OF FGFR4 SIGNALING
|
30
|
5.68e-02
|
1.73e-01
|
0.25700
|
0.246000
|
7.38e-02
|
1.98e-02
|
4.84e-01
|
REACTOME RMTS METHYLATE HISTONE ARGININES
|
29
|
1.41e-01
|
3.10e-01
|
0.25600
|
0.203000
|
1.56e-01
|
5.84e-02
|
1.46e-01
|
REACTOME SIGNALING BY ERBB2 IN CANCER
|
25
|
8.02e-02
|
2.18e-01
|
0.25600
|
0.248000
|
6.02e-02
|
3.16e-02
|
6.02e-01
|
REACTOME ASSEMBLY OF THE HIV VIRION
|
16
|
1.22e-01
|
2.81e-01
|
0.25500
|
0.255000
|
-7.07e-04
|
7.69e-02
|
9.96e-01
|
REACTOME INTERLEUKIN 12 SIGNALING
|
43
|
2.36e-04
|
2.22e-03
|
0.25500
|
0.204000
|
-1.53e-01
|
2.04e-02
|
8.25e-02
|
REACTOME SHC1 EVENTS IN ERBB2 SIGNALING
|
22
|
1.73e-01
|
3.52e-01
|
0.25500
|
0.230000
|
1.08e-01
|
6.13e-02
|
3.79e-01
|
REACTOME MAPK1 ERK2 ACTIVATION
|
9
|
4.88e-01
|
6.47e-01
|
0.25400
|
0.107000
|
2.30e-01
|
5.77e-01
|
2.31e-01
|
REACTOME ABC TRANSPORTER DISORDERS
|
75
|
5.36e-07
|
8.67e-06
|
0.25400
|
0.154000
|
-2.02e-01
|
2.09e-02
|
2.48e-03
|
REACTOME ETHANOL OXIDATION
|
12
|
4.55e-01
|
6.18e-01
|
0.25400
|
-0.197000
|
-1.60e-01
|
2.36e-01
|
3.39e-01
|
REACTOME RUNX1 REGULATES TRANSCRIPTION OF GENES INVOLVED IN DIFFERENTIATION OF MYELOID CELLS
|
7
|
6.21e-01
|
7.52e-01
|
0.25300
|
0.143000
|
2.08e-01
|
5.13e-01
|
3.40e-01
|
REACTOME DISASSEMBLY OF THE DESTRUCTION COMPLEX AND RECRUITMENT OF AXIN TO THE MEMBRANE
|
30
|
1.30e-01
|
2.94e-01
|
0.25300
|
0.209000
|
1.42e-01
|
4.75e-02
|
1.78e-01
|
REACTOME CARGO CONCENTRATION IN THE ER
|
32
|
6.65e-02
|
1.92e-01
|
0.25300
|
-0.090900
|
-2.36e-01
|
3.73e-01
|
2.11e-02
|
REACTOME APC CDC20 MEDIATED DEGRADATION OF NEK2A
|
26
|
7.07e-03
|
4.03e-02
|
0.25200
|
0.195000
|
-1.59e-01
|
8.49e-02
|
1.60e-01
|
REACTOME RUNX3 REGULATES P14 ARF
|
10
|
4.18e-01
|
5.90e-01
|
0.25200
|
0.238000
|
8.33e-02
|
1.93e-01
|
6.48e-01
|
REACTOME P130CAS LINKAGE TO MAPK SIGNALING FOR INTEGRINS
|
15
|
2.93e-01
|
4.84e-01
|
0.25100
|
-0.232000
|
-9.62e-02
|
1.19e-01
|
5.19e-01
|
REACTOME VLDL CLEARANCE
|
6
|
6.08e-01
|
7.41e-01
|
0.25100
|
0.233000
|
9.25e-02
|
3.22e-01
|
6.95e-01
|
REACTOME RUNX1 INTERACTS WITH CO FACTORS WHOSE PRECISE EFFECT ON RUNX1 TARGETS IS NOT KNOWN
|
37
|
9.35e-02
|
2.38e-01
|
0.25100
|
0.157000
|
1.95e-01
|
9.76e-02
|
3.99e-02
|
REACTOME PI 3K CASCADE FGFR4
|
19
|
3.02e-01
|
4.90e-01
|
0.25100
|
0.186000
|
1.68e-01
|
1.61e-01
|
2.04e-01
|
REACTOME REGULATION OF RUNX1 EXPRESSION AND ACTIVITY
|
17
|
2.81e-01
|
4.74e-01
|
0.25100
|
0.114000
|
2.23e-01
|
4.16e-01
|
1.11e-01
|
REACTOME GLUCAGON SIGNALING IN METABOLIC REGULATION
|
32
|
1.36e-01
|
3.02e-01
|
0.25000
|
0.176000
|
1.78e-01
|
8.52e-02
|
8.10e-02
|
REACTOME DOWNSTREAM SIGNALING EVENTS OF B CELL RECEPTOR BCR
|
78
|
7.85e-07
|
1.18e-05
|
0.25000
|
0.217000
|
-1.24e-01
|
9.05e-04
|
5.77e-02
|
REACTOME FRS MEDIATED FGFR4 SIGNALING
|
21
|
2.65e-01
|
4.59e-01
|
0.25000
|
0.192000
|
1.60e-01
|
1.28e-01
|
2.03e-01
|
REACTOME CASPASE MEDIATED CLEAVAGE OF CYTOSKELETAL PROTEINS
|
12
|
4.18e-01
|
5.90e-01
|
0.25000
|
0.220000
|
1.18e-01
|
1.87e-01
|
4.79e-01
|
REACTOME PCP CE PATHWAY
|
90
|
3.34e-06
|
4.41e-05
|
0.25000
|
0.248000
|
-3.04e-02
|
4.83e-05
|
6.18e-01
|
REACTOME HEDGEHOG ON STATE
|
83
|
3.75e-06
|
4.86e-05
|
0.24900
|
0.243000
|
-5.39e-02
|
1.30e-04
|
3.96e-01
|
REACTOME PTK6 REGULATES PROTEINS INVOLVED IN RNA PROCESSING
|
5
|
4.75e-01
|
6.36e-01
|
0.24900
|
0.049400
|
-2.44e-01
|
8.48e-01
|
3.45e-01
|
REACTOME ARYL HYDROCARBON RECEPTOR SIGNALLING
|
6
|
4.63e-01
|
6.25e-01
|
0.24900
|
0.008040
|
-2.48e-01
|
9.73e-01
|
2.92e-01
|
REACTOME VITAMIN D CALCIFEROL METABOLISM
|
12
|
4.61e-01
|
6.23e-01
|
0.24900
|
0.201000
|
1.47e-01
|
2.29e-01
|
3.79e-01
|
REACTOME BBSOME MEDIATED CARGO TARGETING TO CILIUM
|
23
|
1.85e-02
|
8.14e-02
|
0.24800
|
0.110000
|
-2.23e-01
|
3.63e-01
|
6.41e-02
|
REACTOME FCGR3A MEDIATED IL10 SYNTHESIS
|
36
|
9.93e-02
|
2.48e-01
|
0.24800
|
0.148000
|
2.00e-01
|
1.25e-01
|
3.81e-02
|
REACTOME SIGNALING BY CSF3 G CSF
|
28
|
8.97e-03
|
4.74e-02
|
0.24800
|
0.229000
|
-9.64e-02
|
3.62e-02
|
3.77e-01
|
REACTOME SIGNALING BY ERBB4
|
57
|
1.04e-02
|
5.28e-02
|
0.24800
|
0.230000
|
9.35e-02
|
2.68e-03
|
2.22e-01
|
REACTOME BETA DEFENSINS
|
27
|
1.91e-01
|
3.73e-01
|
0.24800
|
-0.174000
|
-1.77e-01
|
1.18e-01
|
1.11e-01
|
REACTOME TRAFFICKING OF GLUR2 CONTAINING AMPA RECEPTORS
|
15
|
2.34e-01
|
4.26e-01
|
0.24800
|
0.054700
|
2.42e-01
|
7.14e-01
|
1.05e-01
|
REACTOME WNT5A DEPENDENT INTERNALIZATION OF FZD2 FZD5 AND ROR2
|
13
|
4.49e-01
|
6.16e-01
|
0.24600
|
0.157000
|
1.90e-01
|
3.26e-01
|
2.36e-01
|
REACTOME DEFECTIVE RIPK1 MEDIATED REGULATED NECROSIS
|
7
|
4.05e-01
|
5.82e-01
|
0.24600
|
0.246000
|
-1.45e-02
|
2.60e-01
|
9.47e-01
|
REACTOME HIGHLY CALCIUM PERMEABLE NICOTINIC ACETYLCHOLINE RECEPTORS
|
9
|
4.98e-01
|
6.56e-01
|
0.24600
|
0.226000
|
9.59e-02
|
2.40e-01
|
6.18e-01
|
REACTOME SHC MEDIATED CASCADE FGFR4
|
19
|
3.15e-01
|
4.95e-01
|
0.24500
|
0.188000
|
1.58e-01
|
1.57e-01
|
2.33e-01
|
REACTOME CATION COUPLED CHLORIDE COTRANSPORTERS
|
7
|
2.81e-01
|
4.74e-01
|
0.24500
|
-0.166000
|
1.81e-01
|
4.47e-01
|
4.08e-01
|
REACTOME CLASS I PEROXISOMAL MEMBRANE PROTEIN IMPORT
|
19
|
4.35e-02
|
1.43e-01
|
0.24500
|
0.224000
|
-9.83e-02
|
9.08e-02
|
4.58e-01
|
REACTOME RNA POLYMERASE III TRANSCRIPTION INITIATION FROM TYPE 1 PROMOTER
|
28
|
1.04e-02
|
5.28e-02
|
0.24500
|
0.226000
|
-9.40e-02
|
3.86e-02
|
3.89e-01
|
REACTOME INACTIVATION OF CSF3 G CSF SIGNALING
|
23
|
2.72e-02
|
1.06e-01
|
0.24400
|
0.231000
|
-7.85e-02
|
5.46e-02
|
5.15e-01
|
REACTOME REGULATION OF IFNG SIGNALING
|
14
|
2.48e-01
|
4.41e-01
|
0.24400
|
0.241000
|
4.16e-02
|
1.19e-01
|
7.87e-01
|
REACTOME NEF MEDIATED CD4 DOWN REGULATION
|
9
|
5.44e-01
|
6.92e-01
|
0.24400
|
0.122000
|
2.12e-01
|
5.28e-01
|
2.72e-01
|
REACTOME CD209 DC SIGN SIGNALING
|
20
|
2.95e-01
|
4.85e-01
|
0.24400
|
0.149000
|
1.93e-01
|
2.48e-01
|
1.36e-01
|
REACTOME ASSEMBLY AND CELL SURFACE PRESENTATION OF NMDA RECEPTORS
|
41
|
8.89e-02
|
2.32e-01
|
0.24300
|
0.176000
|
1.68e-01
|
5.15e-02
|
6.21e-02
|
REACTOME RUNX1 REGULATES TRANSCRIPTION OF GENES INVOLVED IN DIFFERENTIATION OF KERATINOCYTES
|
8
|
4.22e-01
|
5.90e-01
|
0.24300
|
0.242000
|
2.22e-02
|
2.36e-01
|
9.13e-01
|
REACTOME FCERI MEDIATED NF KB ACTIVATION
|
77
|
1.35e-06
|
1.93e-05
|
0.24300
|
0.195000
|
-1.45e-01
|
3.08e-03
|
2.79e-02
|
REACTOME ABC TRANSPORTERS IN LIPID HOMEOSTASIS
|
17
|
1.88e-01
|
3.70e-01
|
0.24300
|
-0.239000
|
-4.14e-02
|
8.76e-02
|
7.68e-01
|
REACTOME NEUROTRANSMITTER RECEPTORS AND POSTSYNAPTIC SIGNAL TRANSMISSION
|
193
|
1.25e-05
|
1.45e-04
|
0.24300
|
0.165000
|
1.78e-01
|
7.97e-05
|
1.90e-05
|
REACTOME CHEMOKINE RECEPTORS BIND CHEMOKINES
|
55
|
3.99e-02
|
1.35e-01
|
0.24300
|
-0.174000
|
-1.69e-01
|
2.57e-02
|
3.00e-02
|
REACTOME DOWNREGULATION OF ERBB4 SIGNALING
|
9
|
2.97e-01
|
4.87e-01
|
0.24200
|
0.240000
|
-3.50e-02
|
2.13e-01
|
8.56e-01
|
REACTOME SIGNALING BY PDGFRA TRANSMEMBRANE JUXTAMEMBRANE AND KINASE DOMAIN MUTANTS
|
12
|
4.90e-01
|
6.50e-01
|
0.24200
|
0.186000
|
1.55e-01
|
2.64e-01
|
3.53e-01
|
REACTOME COENZYME A BIOSYNTHESIS
|
8
|
2.53e-01
|
4.45e-01
|
0.24200
|
0.130000
|
-2.04e-01
|
5.24e-01
|
3.17e-01
|
REACTOME TGF BETA RECEPTOR SIGNALING IN EMT EPITHELIAL TO MESENCHYMAL TRANSITION
|
16
|
2.07e-01
|
3.92e-01
|
0.24200
|
0.239000
|
3.99e-02
|
9.83e-02
|
7.82e-01
|
REACTOME CRISTAE FORMATION
|
9
|
5.78e-01
|
7.19e-01
|
0.24200
|
0.194000
|
1.44e-01
|
3.13e-01
|
4.53e-01
|
REACTOME EICOSANOID LIGAND BINDING RECEPTORS
|
14
|
4.43e-01
|
6.10e-01
|
0.24200
|
0.172000
|
1.69e-01
|
2.64e-01
|
2.73e-01
|
REACTOME SIALIC ACID METABOLISM
|
33
|
1.39e-01
|
3.07e-01
|
0.24100
|
0.190000
|
1.48e-01
|
5.85e-02
|
1.40e-01
|
REACTOME KEAP1 NFE2L2 PATHWAY
|
102
|
6.01e-07
|
9.54e-06
|
0.24100
|
0.236000
|
-5.05e-02
|
3.87e-05
|
3.78e-01
|
REACTOME FGFR2 MUTANT RECEPTOR ACTIVATION
|
32
|
1.11e-01
|
2.64e-01
|
0.24100
|
0.214000
|
1.11e-01
|
3.61e-02
|
2.79e-01
|
REACTOME CONSTITUTIVE SIGNALING BY ABERRANT PI3K IN CANCER
|
77
|
8.64e-03
|
4.65e-02
|
0.24100
|
0.199000
|
1.35e-01
|
2.52e-03
|
4.01e-02
|
REACTOME METABOLISM OF RNA
|
653
|
1.35e-48
|
4.42e-46
|
0.24000
|
0.144000
|
-1.92e-01
|
2.93e-10
|
4.03e-17
|
REACTOME G PROTEIN BETA GAMMA SIGNALLING
|
30
|
1.56e-01
|
3.28e-01
|
0.24000
|
0.134000
|
2.00e-01
|
2.04e-01
|
5.85e-02
|
REACTOME ENDOSOMAL VACUOLAR PATHWAY
|
11
|
1.48e-01
|
3.19e-01
|
0.24000
|
0.158000
|
-1.81e-01
|
3.64e-01
|
2.99e-01
|
REACTOME PTK6 REGULATES RTKS AND THEIR EFFECTORS AKT1 AND DOK1
|
9
|
2.20e-01
|
4.09e-01
|
0.24000
|
0.204000
|
-1.27e-01
|
2.89e-01
|
5.11e-01
|
REACTOME TRANSCRIPTIONAL ACTIVITY OF SMAD2 SMAD3 SMAD4 HETEROTRIMER
|
49
|
7.78e-03
|
4.36e-02
|
0.24000
|
0.237000
|
3.40e-02
|
4.03e-03
|
6.80e-01
|
REACTOME CYTOCHROME C MEDIATED APOPTOTIC RESPONSE
|
12
|
1.93e-01
|
3.75e-01
|
0.24000
|
0.235000
|
-4.49e-02
|
1.58e-01
|
7.87e-01
|
REACTOME TRANSLATION OF SARS COV 1 STRUCTURAL PROTEINS
|
29
|
3.07e-02
|
1.14e-01
|
0.23900
|
0.239000
|
-1.02e-02
|
2.57e-02
|
9.25e-01
|
REACTOME PKA MEDIATED PHOSPHORYLATION OF CREB
|
19
|
2.26e-01
|
4.17e-01
|
0.23900
|
0.080700
|
2.25e-01
|
5.43e-01
|
8.91e-02
|
REACTOME INTERLEUKIN 12 FAMILY SIGNALING
|
53
|
1.22e-04
|
1.20e-03
|
0.23900
|
0.193000
|
-1.42e-01
|
1.52e-02
|
7.46e-02
|
REACTOME THE PHOTOTRANSDUCTION CASCADE
|
32
|
2.97e-02
|
1.12e-01
|
0.23900
|
-0.239000
|
-1.00e-02
|
1.94e-02
|
9.22e-01
|
REACTOME THE CANONICAL RETINOID CYCLE IN RODS TWILIGHT VISION
|
23
|
2.50e-01
|
4.43e-01
|
0.23900
|
-0.195000
|
-1.38e-01
|
1.05e-01
|
2.53e-01
|
REACTOME SARS COV 1 INFECTION
|
132
|
1.54e-10
|
6.62e-09
|
0.23900
|
0.160000
|
-1.77e-01
|
1.48e-03
|
4.46e-04
|
REACTOME MRNA SPLICING MINOR PATHWAY
|
48
|
3.49e-04
|
3.16e-03
|
0.23800
|
0.127000
|
-2.01e-01
|
1.27e-01
|
1.57e-02
|
REACTOME PROCESSING OF CAPPED INTRONLESS PRE MRNA
|
28
|
8.74e-03
|
4.65e-02
|
0.23800
|
0.190000
|
-1.43e-01
|
8.12e-02
|
1.89e-01
|
REACTOME ACYL CHAIN REMODELING OF DAG AND TAG
|
5
|
6.19e-01
|
7.51e-01
|
0.23800
|
0.038400
|
2.35e-01
|
8.82e-01
|
3.63e-01
|
REACTOME SUMOYLATION OF DNA METHYLATION PROTEINS
|
16
|
3.73e-01
|
5.54e-01
|
0.23800
|
0.129000
|
2.00e-01
|
3.71e-01
|
1.66e-01
|
REACTOME PRESYNAPTIC FUNCTION OF KAINATE RECEPTORS
|
21
|
2.85e-01
|
4.77e-01
|
0.23700
|
0.195000
|
1.35e-01
|
1.22e-01
|
2.83e-01
|
REACTOME MRNA EDITING C TO U CONVERSION
|
8
|
2.94e-01
|
4.85e-01
|
0.23700
|
0.088400
|
-2.20e-01
|
6.65e-01
|
2.80e-01
|
REACTOME SIGNALING BY THE B CELL RECEPTOR BCR
|
105
|
1.13e-06
|
1.64e-05
|
0.23700
|
0.235000
|
-3.68e-02
|
3.24e-05
|
5.15e-01
|
REACTOME SIGNALING BY WNT
|
262
|
8.14e-08
|
1.60e-06
|
0.23700
|
0.204000
|
1.22e-01
|
1.35e-08
|
6.61e-04
|
REACTOME E3 UBIQUITIN LIGASES UBIQUITINATE TARGET PROTEINS
|
41
|
1.15e-03
|
8.99e-03
|
0.23700
|
0.196000
|
-1.33e-01
|
3.02e-02
|
1.40e-01
|
REACTOME TRANSCRIPTIONAL REGULATION BY RUNX3
|
92
|
2.26e-06
|
3.08e-05
|
0.23600
|
0.228000
|
-6.35e-02
|
1.58e-04
|
2.93e-01
|
REACTOME PHASE 4 RESTING MEMBRANE POTENTIAL
|
19
|
3.48e-01
|
5.30e-01
|
0.23600
|
0.165000
|
1.69e-01
|
2.13e-01
|
2.03e-01
|
REACTOME THROMBIN SIGNALLING THROUGH PROTEINASE ACTIVATED RECEPTORS PARS
|
32
|
1.33e-01
|
3.00e-01
|
0.23600
|
0.204000
|
1.17e-01
|
4.53e-02
|
2.51e-01
|
REACTOME ROLE OF PHOSPHOLIPIDS IN PHAGOCYTOSIS
|
22
|
2.01e-01
|
3.86e-01
|
0.23500
|
0.086500
|
2.19e-01
|
4.83e-01
|
7.54e-02
|
REACTOME SWITCHING OF ORIGINS TO A POST REPLICATIVE STATE
|
90
|
3.65e-07
|
6.04e-06
|
0.23500
|
0.188000
|
-1.41e-01
|
2.03e-03
|
2.05e-02
|
REACTOME SIGNALING BY EGFR IN CANCER
|
25
|
4.00e-02
|
1.35e-01
|
0.23500
|
0.232000
|
-3.75e-02
|
4.44e-02
|
7.46e-01
|
REACTOME PHASE 0 RAPID DEPOLARISATION
|
31
|
1.81e-01
|
3.62e-01
|
0.23500
|
-0.167000
|
-1.65e-01
|
1.07e-01
|
1.11e-01
|
REACTOME FORMATION OF APOPTOSOME
|
10
|
2.37e-01
|
4.28e-01
|
0.23500
|
0.223000
|
-7.32e-02
|
2.22e-01
|
6.88e-01
|
REACTOME UPTAKE AND FUNCTION OF ANTHRAX TOXINS
|
11
|
2.26e-01
|
4.17e-01
|
0.23400
|
-0.228000
|
5.41e-02
|
1.91e-01
|
7.56e-01
|
REACTOME TRANSCRIPTIONAL REGULATION BY NPAS4
|
32
|
1.74e-01
|
3.52e-01
|
0.23400
|
0.173000
|
1.57e-01
|
8.94e-02
|
1.25e-01
|
REACTOME TNFS BIND THEIR PHYSIOLOGICAL RECEPTORS
|
26
|
2.02e-01
|
3.87e-01
|
0.23300
|
0.202000
|
1.16e-01
|
7.45e-02
|
3.04e-01
|
REACTOME REGULATED PROTEOLYSIS OF P75NTR
|
11
|
4.69e-01
|
6.31e-01
|
0.23300
|
0.214000
|
9.36e-02
|
2.20e-01
|
5.91e-01
|
REACTOME SODIUM COUPLED PHOSPHATE COTRANSPORTERS
|
5
|
7.62e-01
|
8.50e-01
|
0.23300
|
-0.159000
|
-1.70e-01
|
5.37e-01
|
5.10e-01
|
REACTOME ADORA2B MEDIATED ANTI INFLAMMATORY CYTOKINES PRODUCTION
|
42
|
1.01e-01
|
2.50e-01
|
0.23300
|
0.152000
|
1.77e-01
|
8.86e-02
|
4.76e-02
|
REACTOME ACTIVATION OF RAS IN B CELLS
|
5
|
6.23e-01
|
7.53e-01
|
0.23300
|
0.231000
|
3.08e-02
|
3.71e-01
|
9.05e-01
|
REACTOME BETA OXIDATION OF HEXANOYL COA TO BUTANOYL COA
|
5
|
6.47e-01
|
7.72e-01
|
0.23300
|
0.228000
|
4.70e-02
|
3.77e-01
|
8.56e-01
|
REACTOME SYNTHESIS SECRETION AND INACTIVATION OF GLUCOSE DEPENDENT INSULINOTROPIC POLYPEPTIDE GIP
|
12
|
2.06e-01
|
3.91e-01
|
0.23300
|
0.227000
|
-5.01e-02
|
1.73e-01
|
7.64e-01
|
REACTOME PLASMA LIPOPROTEIN CLEARANCE
|
37
|
7.13e-02
|
2.01e-01
|
0.23300
|
0.217000
|
8.49e-02
|
2.26e-02
|
3.72e-01
|
REACTOME GRB2 SOS PROVIDES LINKAGE TO MAPK SIGNALING FOR INTEGRINS
|
15
|
3.70e-01
|
5.51e-01
|
0.23200
|
-0.210000
|
-9.84e-02
|
1.59e-01
|
5.09e-01
|
REACTOME NEGATIVE EPIGENETIC REGULATION OF RRNA EXPRESSION
|
44
|
9.93e-04
|
7.92e-03
|
0.23200
|
0.196000
|
-1.24e-01
|
2.44e-02
|
1.55e-01
|
REACTOME DISEASES ASSOCIATED WITH GLYCOSYLATION PRECURSOR BIOSYNTHESIS
|
15
|
1.03e-01
|
2.53e-01
|
0.23200
|
0.207000
|
-1.04e-01
|
1.64e-01
|
4.86e-01
|
REACTOME BETA OXIDATION OF DECANOYL COA TO OCTANOYL COA COA
|
6
|
5.90e-01
|
7.29e-01
|
0.23200
|
0.228000
|
4.35e-02
|
3.34e-01
|
8.54e-01
|
REACTOME TRANSCRIPTIONAL REGULATION BY RUNX2
|
116
|
1.07e-06
|
1.57e-05
|
0.23200
|
0.231000
|
-2.34e-02
|
1.76e-05
|
6.63e-01
|
REACTOME SIGNALING BY FGFR2 IN DISEASE
|
42
|
7.87e-02
|
2.14e-01
|
0.23200
|
0.200000
|
1.17e-01
|
2.48e-02
|
1.90e-01
|
REACTOME PHASE 3 RAPID REPOLARISATION
|
8
|
3.93e-01
|
5.72e-01
|
0.23100
|
-0.019200
|
2.31e-01
|
9.25e-01
|
2.59e-01
|
REACTOME PHOSPHORYLATION OF THE APC C
|
20
|
6.28e-02
|
1.84e-01
|
0.23100
|
0.220000
|
-6.97e-02
|
8.80e-02
|
5.89e-01
|
REACTOME GENERATION OF SECOND MESSENGER MOLECULES
|
29
|
1.51e-01
|
3.22e-01
|
0.23100
|
0.209000
|
9.94e-02
|
5.19e-02
|
3.54e-01
|
REACTOME RUNX1 REGULATES ESTROGEN RECEPTOR MEDIATED TRANSCRIPTION
|
6
|
6.95e-01
|
8.05e-01
|
0.23100
|
0.114000
|
2.01e-01
|
6.30e-01
|
3.95e-01
|
REACTOME TRANSPORT OF NUCLEOTIDE SUGARS
|
8
|
5.78e-01
|
7.19e-01
|
0.23000
|
0.213000
|
8.89e-02
|
2.98e-01
|
6.63e-01
|
REACTOME VLDL ASSEMBLY
|
5
|
7.52e-01
|
8.41e-01
|
0.23000
|
-0.127000
|
-1.92e-01
|
6.23e-01
|
4.58e-01
|
REACTOME RORA ACTIVATES GENE EXPRESSION
|
17
|
2.80e-01
|
4.73e-01
|
0.23000
|
0.070100
|
2.19e-01
|
6.17e-01
|
1.19e-01
|
REACTOME DISEASES OF MITOTIC CELL CYCLE
|
37
|
6.98e-03
|
4.01e-02
|
0.22900
|
0.220000
|
-6.37e-02
|
2.03e-02
|
5.02e-01
|
REACTOME STAT3 NUCLEAR EVENTS DOWNSTREAM OF ALK SIGNALING
|
9
|
3.38e-01
|
5.19e-01
|
0.22900
|
0.227000
|
-3.18e-02
|
2.38e-01
|
8.69e-01
|
REACTOME SYNTHESIS OF PA
|
35
|
4.44e-02
|
1.44e-01
|
0.22900
|
-0.226000
|
-3.54e-02
|
2.06e-02
|
7.17e-01
|
REACTOME SIGNALING BY NOTCH3
|
48
|
4.15e-02
|
1.38e-01
|
0.22800
|
0.210000
|
9.06e-02
|
1.19e-02
|
2.77e-01
|
REACTOME TRANSCRIPTION OF E2F TARGETS UNDER NEGATIVE CONTROL BY P107 RBL1 AND P130 RBL2 IN COMPLEX WITH HDAC1
|
16
|
1.39e-01
|
3.07e-01
|
0.22800
|
0.225000
|
-4.01e-02
|
1.19e-01
|
7.81e-01
|
REACTOME MRNA DECAY BY 5 TO 3 EXORIBONUCLEASE
|
15
|
1.36e-01
|
3.02e-01
|
0.22800
|
0.063700
|
-2.19e-01
|
6.69e-01
|
1.41e-01
|
REACTOME DEX H BOX HELICASES ACTIVATE TYPE I IFN AND INFLAMMATORY CYTOKINES PRODUCTION
|
7
|
3.83e-01
|
5.63e-01
|
0.22800
|
0.074600
|
-2.16e-01
|
7.32e-01
|
3.23e-01
|
REACTOME CIRCADIAN CLOCK
|
66
|
2.42e-02
|
9.81e-02
|
0.22800
|
0.192000
|
1.24e-01
|
7.12e-03
|
8.18e-02
|
REACTOME CITRIC ACID CYCLE TCA CYCLE
|
21
|
3.99e-02
|
1.35e-01
|
0.22800
|
0.129000
|
-1.88e-01
|
3.05e-01
|
1.37e-01
|
REACTOME FORMATION OF XYLULOSE 5 PHOSPHATE
|
5
|
5.33e-01
|
6.84e-01
|
0.22800
|
0.223000
|
-4.80e-02
|
3.89e-01
|
8.53e-01
|
REACTOME NETRIN MEDIATED REPULSION SIGNALS
|
8
|
6.51e-01
|
7.76e-01
|
0.22800
|
0.182000
|
1.37e-01
|
3.73e-01
|
5.03e-01
|
REACTOME TP53 REGULATES TRANSCRIPTION OF CASPASE ACTIVATORS AND CASPASES
|
12
|
3.63e-01
|
5.43e-01
|
0.22800
|
0.043100
|
2.23e-01
|
7.96e-01
|
1.80e-01
|
REACTOME TP53 REGULATES TRANSCRIPTION OF DEATH RECEPTORS AND LIGANDS
|
12
|
5.35e-01
|
6.85e-01
|
0.22800
|
0.172000
|
1.49e-01
|
3.01e-01
|
3.73e-01
|
REACTOME SUPPRESSION OF PHAGOSOMAL MATURATION
|
13
|
1.39e-01
|
3.07e-01
|
0.22700
|
0.125000
|
-1.90e-01
|
4.36e-01
|
2.35e-01
|
REACTOME TRANSPORT OF CONNEXONS TO THE PLASMA MEMBRANE
|
20
|
3.34e-01
|
5.15e-01
|
0.22700
|
0.187000
|
1.29e-01
|
1.48e-01
|
3.18e-01
|
REACTOME GABA B RECEPTOR ACTIVATION
|
43
|
9.98e-02
|
2.48e-01
|
0.22700
|
0.183000
|
1.35e-01
|
3.82e-02
|
1.26e-01
|
REACTOME METABOLISM OF COFACTORS
|
19
|
6.05e-02
|
1.80e-01
|
0.22600
|
0.196000
|
-1.14e-01
|
1.40e-01
|
3.92e-01
|
REACTOME HEME BIOSYNTHESIS
|
13
|
2.56e-01
|
4.49e-01
|
0.22600
|
0.004520
|
-2.26e-01
|
9.77e-01
|
1.58e-01
|
REACTOME WNT5A DEPENDENT INTERNALIZATION OF FZD4
|
15
|
4.57e-01
|
6.21e-01
|
0.22600
|
0.177000
|
1.41e-01
|
2.36e-01
|
3.45e-01
|
REACTOME PREDNISONE ADME
|
10
|
5.73e-01
|
7.16e-01
|
0.22600
|
-0.191000
|
-1.21e-01
|
2.96e-01
|
5.08e-01
|
REACTOME SIGNALING BY KIT IN DISEASE
|
20
|
3.16e-01
|
4.95e-01
|
0.22500
|
0.196000
|
1.12e-01
|
1.30e-01
|
3.87e-01
|
REACTOME VASOPRESSIN REGULATES RENAL WATER HOMEOSTASIS VIA AQUAPORINS
|
42
|
1.20e-01
|
2.78e-01
|
0.22500
|
0.163000
|
1.55e-01
|
6.79e-02
|
8.12e-02
|
REACTOME PCNA DEPENDENT LONG PATCH BASE EXCISION REPAIR
|
21
|
1.58e-01
|
3.30e-01
|
0.22500
|
0.223000
|
3.06e-02
|
7.69e-02
|
8.08e-01
|
REACTOME ANTIGEN PRESENTATION FOLDING ASSEMBLY AND PEPTIDE LOADING OF CLASS I MHC
|
28
|
4.74e-02
|
1.50e-01
|
0.22500
|
0.015900
|
-2.24e-01
|
8.84e-01
|
3.98e-02
|
REACTOME DOWNREGULATION OF ERBB2 SIGNALING
|
28
|
8.12e-02
|
2.19e-01
|
0.22500
|
0.223000
|
2.60e-02
|
4.09e-02
|
8.12e-01
|
REACTOME PKA ACTIVATION IN GLUCAGON SIGNALLING
|
17
|
3.07e-01
|
4.92e-01
|
0.22400
|
0.073200
|
2.12e-01
|
6.01e-01
|
1.31e-01
|
REACTOME SIGNALING BY FGFR4
|
40
|
4.14e-02
|
1.38e-01
|
0.22400
|
0.219000
|
4.72e-02
|
1.67e-02
|
6.05e-01
|
REACTOME ACETYLCHOLINE INHIBITS CONTRACTION OF OUTER HAIR CELLS
|
5
|
5.23e-01
|
6.77e-01
|
0.22400
|
-0.213000
|
6.73e-02
|
4.09e-01
|
7.94e-01
|
REACTOME SEROTONIN NEUROTRANSMITTER RELEASE CYCLE
|
16
|
2.78e-01
|
4.71e-01
|
0.22400
|
0.219000
|
4.59e-02
|
1.30e-01
|
7.50e-01
|
REACTOME RNA POLYMERASE III TRANSCRIPTION INITIATION FROM TYPE 3 PROMOTER
|
28
|
1.48e-02
|
6.82e-02
|
0.22300
|
0.148000
|
-1.67e-01
|
1.75e-01
|
1.26e-01
|
REACTOME NADE MODULATES DEATH SIGNALLING
|
5
|
7.04e-01
|
8.10e-01
|
0.22300
|
0.212000
|
6.95e-02
|
4.11e-01
|
7.88e-01
|
REACTOME INTERLEUKIN 2 SIGNALING
|
11
|
2.30e-01
|
4.21e-01
|
0.22300
|
0.208000
|
-7.96e-02
|
2.31e-01
|
6.48e-01
|
REACTOME ALPHA PROTEIN KINASE 1 SIGNALING PATHWAY
|
10
|
2.61e-01
|
4.55e-01
|
0.22300
|
0.207000
|
-8.18e-02
|
2.56e-01
|
6.54e-01
|
REACTOME REGULATION OF TP53 EXPRESSION AND DEGRADATION
|
37
|
7.57e-02
|
2.09e-01
|
0.22300
|
0.211000
|
6.95e-02
|
2.60e-02
|
4.64e-01
|
REACTOME DISEASES ASSOCIATED WITH N GLYCOSYLATION OF PROTEINS
|
19
|
9.19e-02
|
2.35e-01
|
0.22300
|
0.214000
|
-6.00e-02
|
1.06e-01
|
6.51e-01
|
REACTOME MITOTIC G1 PHASE AND G1 S TRANSITION
|
144
|
1.34e-09
|
4.99e-08
|
0.22300
|
0.194000
|
-1.09e-01
|
5.83e-05
|
2.35e-02
|
REACTOME NUCLEAR RECEPTOR TRANSCRIPTION PATHWAY
|
51
|
7.85e-02
|
2.14e-01
|
0.22200
|
0.170000
|
1.42e-01
|
3.51e-02
|
7.87e-02
|
REACTOME NOTCH2 ACTIVATION AND TRANSMISSION OF SIGNAL TO THE NUCLEUS
|
22
|
7.36e-02
|
2.05e-01
|
0.22200
|
0.217000
|
-4.47e-02
|
7.75e-02
|
7.17e-01
|
REACTOME ACTIVATION OF ANTERIOR HOX GENES IN HINDBRAIN DEVELOPMENT DURING EARLY EMBRYOGENESIS
|
59
|
4.05e-02
|
1.36e-01
|
0.22200
|
0.189000
|
1.16e-01
|
1.20e-02
|
1.23e-01
|
REACTOME RNA POLYMERASE III TRANSCRIPTION TERMINATION
|
23
|
3.48e-02
|
1.23e-01
|
0.22200
|
0.180000
|
-1.29e-01
|
1.34e-01
|
2.84e-01
|
REACTOME HOST INTERACTIONS OF HIV FACTORS
|
122
|
2.44e-08
|
6.12e-07
|
0.22200
|
0.186000
|
-1.21e-01
|
3.86e-04
|
2.13e-02
|
REACTOME ACTIVATED NTRK3 SIGNALS THROUGH RAS
|
8
|
5.56e-01
|
6.99e-01
|
0.22100
|
0.214000
|
5.80e-02
|
2.95e-01
|
7.76e-01
|
REACTOME SIGNALING BY NOTCH1 PEST DOMAIN MUTANTS IN CANCER
|
54
|
2.86e-02
|
1.10e-01
|
0.22100
|
0.207000
|
7.74e-02
|
8.39e-03
|
3.25e-01
|
REACTOME ABACAVIR TRANSMEMBRANE TRANSPORT
|
5
|
5.06e-01
|
6.63e-01
|
0.22100
|
-0.092400
|
2.01e-01
|
7.21e-01
|
4.36e-01
|
REACTOME DOWNSTREAM SIGNALING OF ACTIVATED FGFR4
|
26
|
2.52e-01
|
4.44e-01
|
0.22100
|
0.186000
|
1.19e-01
|
1.01e-01
|
2.93e-01
|
REACTOME ANTI INFLAMMATORY RESPONSE FAVOURING LEISHMANIA PARASITE INFECTION
|
74
|
2.42e-02
|
9.81e-02
|
0.22100
|
0.133000
|
1.76e-01
|
4.77e-02
|
8.82e-03
|
REACTOME PHASE I FUNCTIONALIZATION OF COMPOUNDS
|
98
|
8.54e-03
|
4.62e-02
|
0.22000
|
-0.146000
|
-1.65e-01
|
1.27e-02
|
4.66e-03
|
REACTOME SIGNALING BY NOTCH1
|
69
|
1.43e-02
|
6.66e-02
|
0.22000
|
0.202000
|
8.71e-02
|
3.69e-03
|
2.11e-01
|
REACTOME THE ACTIVATION OF ARYLSULFATASES
|
8
|
5.42e-01
|
6.92e-01
|
0.22000
|
0.215000
|
4.76e-02
|
2.93e-01
|
8.16e-01
|
REACTOME REGULATION OF PTEN STABILITY AND ACTIVITY
|
66
|
7.70e-05
|
7.82e-04
|
0.22000
|
0.178000
|
-1.29e-01
|
1.24e-02
|
6.93e-02
|
REACTOME PROTEIN LOCALIZATION
|
147
|
7.36e-10
|
2.87e-08
|
0.22000
|
0.129000
|
-1.78e-01
|
6.75e-03
|
1.97e-04
|
REACTOME PEROXISOMAL PROTEIN IMPORT
|
62
|
6.87e-04
|
5.67e-03
|
0.22000
|
0.047400
|
-2.15e-01
|
5.19e-01
|
3.46e-03
|
REACTOME NOTCH2 INTRACELLULAR DOMAIN REGULATES TRANSCRIPTION
|
11
|
5.88e-01
|
7.28e-01
|
0.22000
|
0.161000
|
1.49e-01
|
3.55e-01
|
3.91e-01
|
REACTOME GAP FILLING DNA REPAIR SYNTHESIS AND LIGATION IN GG NER
|
25
|
9.00e-02
|
2.33e-01
|
0.21900
|
0.219000
|
3.95e-04
|
5.78e-02
|
9.97e-01
|
REACTOME SIGNALING BY EGFR
|
49
|
5.85e-02
|
1.76e-01
|
0.21900
|
0.197000
|
9.55e-02
|
1.72e-02
|
2.47e-01
|
REACTOME ADP SIGNALLING THROUGH P2Y PURINOCEPTOR 1
|
25
|
2.44e-01
|
4.37e-01
|
0.21900
|
0.194000
|
1.01e-01
|
9.32e-02
|
3.83e-01
|
REACTOME REGULATION OF TP53 ACTIVITY THROUGH PHOSPHORYLATION
|
88
|
2.07e-05
|
2.32e-04
|
0.21900
|
0.209000
|
-6.35e-02
|
6.94e-04
|
3.03e-01
|
REACTOME REGULATION OF PTEN GENE TRANSCRIPTION
|
59
|
3.24e-02
|
1.18e-01
|
0.21800
|
0.197000
|
9.38e-02
|
8.84e-03
|
2.13e-01
|
REACTOME PROTEIN UBIQUITINATION
|
59
|
4.52e-04
|
3.93e-03
|
0.21700
|
0.198000
|
-8.90e-02
|
8.38e-03
|
2.37e-01
|
REACTOME PROTEIN PROTEIN INTERACTIONS AT SYNAPSES
|
77
|
2.59e-02
|
1.03e-01
|
0.21700
|
0.140000
|
1.66e-01
|
3.33e-02
|
1.20e-02
|
REACTOME NUCLEAR SIGNALING BY ERBB4
|
32
|
1.94e-01
|
3.75e-01
|
0.21700
|
0.183000
|
1.16e-01
|
7.34e-02
|
2.54e-01
|
REACTOME PI5P REGULATES TP53 ACETYLATION
|
8
|
4.82e-01
|
6.42e-01
|
0.21700
|
0.217000
|
7.22e-03
|
2.89e-01
|
9.72e-01
|
REACTOME ORGANIC CATION TRANSPORT
|
10
|
3.55e-01
|
5.36e-01
|
0.21700
|
-0.021300
|
2.16e-01
|
9.07e-01
|
2.38e-01
|
REACTOME RUNX2 REGULATES CHONDROCYTE MATURATION
|
5
|
7.68e-01
|
8.55e-01
|
0.21700
|
0.109000
|
1.87e-01
|
6.73e-01
|
4.69e-01
|
REACTOME CASPASE ACTIVATION VIA EXTRINSIC APOPTOTIC SIGNALLING PATHWAY
|
25
|
4.41e-02
|
1.44e-01
|
0.21600
|
0.203000
|
-7.48e-02
|
7.88e-02
|
5.17e-01
|
REACTOME REDUCTION OF CYTOSOLIC CA LEVELS
|
11
|
2.93e-01
|
4.84e-01
|
0.21600
|
-0.040500
|
2.12e-01
|
8.16e-01
|
2.22e-01
|
REACTOME SIGNALING BY CTNNB1 PHOSPHO SITE MUTANTS
|
14
|
4.81e-01
|
6.42e-01
|
0.21600
|
0.186000
|
1.10e-01
|
2.29e-01
|
4.75e-01
|
REACTOME CD28 DEPENDENT PI3K AKT SIGNALING
|
22
|
3.06e-01
|
4.92e-01
|
0.21600
|
0.103000
|
1.89e-01
|
4.01e-01
|
1.24e-01
|
REACTOME ERBB2 ACTIVATES PTK6 SIGNALING
|
13
|
4.50e-01
|
6.16e-01
|
0.21500
|
0.201000
|
7.85e-02
|
2.10e-01
|
6.24e-01
|
REACTOME CREB1 PHOSPHORYLATION THROUGH THE ACTIVATION OF ADENYLATE CYCLASE
|
11
|
5.20e-01
|
6.75e-01
|
0.21500
|
0.084300
|
1.98e-01
|
6.28e-01
|
2.55e-01
|
REACTOME CHAPERONE MEDIATED AUTOPHAGY
|
20
|
1.11e-01
|
2.64e-01
|
0.21500
|
0.039500
|
-2.12e-01
|
7.59e-01
|
1.01e-01
|
REACTOME ADP SIGNALLING THROUGH P2Y PURINOCEPTOR 12
|
22
|
3.02e-01
|
4.90e-01
|
0.21500
|
0.190000
|
1.00e-01
|
1.22e-01
|
4.17e-01
|
REACTOME EFFECTS OF PIP2 HYDROLYSIS
|
26
|
2.46e-01
|
4.40e-01
|
0.21500
|
0.102000
|
1.90e-01
|
3.70e-01
|
9.44e-02
|
REACTOME SIGNALING BY FGFR2
|
72
|
1.05e-03
|
8.29e-03
|
0.21500
|
0.215000
|
-6.38e-03
|
1.63e-03
|
9.25e-01
|
REACTOME REGULATION OF TP53 ACTIVITY THROUGH ACETYLATION
|
28
|
2.32e-01
|
4.24e-01
|
0.21500
|
0.107000
|
1.86e-01
|
3.27e-01
|
8.83e-02
|
REACTOME LYSOSOME VESICLE BIOGENESIS
|
33
|
6.40e-02
|
1.86e-01
|
0.21400
|
0.213000
|
2.08e-02
|
3.39e-02
|
8.36e-01
|
REACTOME INLB MEDIATED ENTRY OF LISTERIA MONOCYTOGENES INTO HOST CELL
|
14
|
1.84e-01
|
3.67e-01
|
0.21400
|
0.203000
|
-6.97e-02
|
1.89e-01
|
6.52e-01
|
REACTOME DEFECTIVE EXT2 CAUSES EXOSTOSES 2
|
12
|
5.28e-01
|
6.81e-01
|
0.21400
|
-0.188000
|
-1.02e-01
|
2.59e-01
|
5.41e-01
|
REACTOME STING MEDIATED INDUCTION OF HOST IMMUNE RESPONSES
|
13
|
5.19e-01
|
6.74e-01
|
0.21400
|
-0.113000
|
-1.82e-01
|
4.79e-01
|
2.57e-01
|
REACTOME SIGNALING BY FLT3 ITD AND TKD MUTANTS
|
16
|
1.58e-01
|
3.31e-01
|
0.21400
|
0.207000
|
-5.55e-02
|
1.53e-01
|
7.01e-01
|
REACTOME ADENYLATE CYCLASE INHIBITORY PATHWAY
|
14
|
4.45e-01
|
6.11e-01
|
0.21400
|
0.085900
|
1.96e-01
|
5.78e-01
|
2.05e-01
|
REACTOME LGI ADAM INTERACTIONS
|
14
|
3.52e-01
|
5.34e-01
|
0.21400
|
0.210000
|
4.05e-02
|
1.74e-01
|
7.93e-01
|
REACTOME PHASE II CONJUGATION OF COMPOUNDS
|
101
|
1.00e-02
|
5.13e-02
|
0.21400
|
-0.143000
|
-1.59e-01
|
1.33e-02
|
5.75e-03
|
REACTOME ANCHORING FIBRIL FORMATION
|
13
|
5.45e-01
|
6.92e-01
|
0.21300
|
0.132000
|
1.68e-01
|
4.10e-01
|
2.96e-01
|
REACTOME METABOLISM OF FAT SOLUBLE VITAMINS
|
46
|
1.15e-01
|
2.70e-01
|
0.21300
|
-0.171000
|
-1.27e-01
|
4.49e-02
|
1.36e-01
|
REACTOME MET RECEPTOR RECYCLING
|
10
|
2.72e-01
|
4.65e-01
|
0.21300
|
0.186000
|
-1.03e-01
|
3.08e-01
|
5.71e-01
|
REACTOME FGFR3B LIGAND BINDING AND ACTIVATION
|
7
|
7.26e-01
|
8.25e-01
|
0.21300
|
0.137000
|
1.62e-01
|
5.29e-01
|
4.57e-01
|
REACTOME BETA CATENIN PHOSPHORYLATION CASCADE
|
16
|
4.35e-01
|
6.03e-01
|
0.21200
|
0.186000
|
1.02e-01
|
1.97e-01
|
4.80e-01
|
REACTOME RESOLUTION OF ABASIC SITES AP SITES
|
37
|
7.87e-02
|
2.14e-01
|
0.21200
|
0.206000
|
5.18e-02
|
3.04e-02
|
5.85e-01
|
REACTOME ADRENALINE NORADRENALINE INHIBITS INSULIN SECRETION
|
28
|
2.41e-01
|
4.32e-01
|
0.21000
|
0.184000
|
1.02e-01
|
9.20e-02
|
3.51e-01
|
REACTOME INTERLEUKIN 21 SIGNALING
|
9
|
3.10e-01
|
4.94e-01
|
0.21000
|
0.117000
|
-1.75e-01
|
5.44e-01
|
3.64e-01
|
REACTOME SUMO IS TRANSFERRED FROM E1 TO E2 UBE2I UBC9
|
7
|
4.59e-01
|
6.22e-01
|
0.21000
|
0.202000
|
-5.53e-02
|
3.54e-01
|
8.00e-01
|
REACTOME CA2 PATHWAY
|
62
|
4.84e-02
|
1.52e-01
|
0.21000
|
0.108000
|
1.79e-01
|
1.41e-01
|
1.45e-02
|
REACTOME RNA POLYMERASE II TRANSCRIPTION TERMINATION
|
61
|
3.11e-04
|
2.86e-03
|
0.21000
|
0.153000
|
-1.43e-01
|
3.88e-02
|
5.30e-02
|
REACTOME SYNTHESIS OF PIPS AT THE ER MEMBRANE
|
5
|
7.93e-01
|
8.71e-01
|
0.20900
|
0.121000
|
1.71e-01
|
6.39e-01
|
5.08e-01
|
REACTOME HIV ELONGATION ARREST AND RECOVERY
|
29
|
2.29e-02
|
9.46e-02
|
0.20900
|
0.123000
|
-1.69e-01
|
2.50e-01
|
1.15e-01
|
REACTOME DNA REPLICATION INITIATION
|
7
|
6.28e-01
|
7.57e-01
|
0.20900
|
0.203000
|
5.22e-02
|
3.53e-01
|
8.11e-01
|
REACTOME SIGNALING BY PTK6
|
54
|
9.35e-03
|
4.89e-02
|
0.20900
|
0.209000
|
2.30e-03
|
7.93e-03
|
9.77e-01
|
REACTOME SUMOYLATION OF TRANSCRIPTION COFACTORS
|
42
|
1.61e-01
|
3.34e-01
|
0.20900
|
0.143000
|
1.53e-01
|
1.10e-01
|
8.70e-02
|
REACTOME BIOSYNTHESIS OF SPECIALIZED PRORESOLVING MEDIATORS SPMS
|
19
|
3.03e-01
|
4.90e-01
|
0.20900
|
0.200000
|
6.09e-02
|
1.32e-01
|
6.46e-01
|
REACTOME NF KB ACTIVATION THROUGH FADD RIP 1 PATHWAY MEDIATED BY CASPASE 8 AND 10
|
11
|
5.32e-01
|
6.83e-01
|
0.20800
|
0.194000
|
7.63e-02
|
2.65e-01
|
6.61e-01
|
REACTOME DOWNSTREAM SIGNAL TRANSDUCTION
|
29
|
2.40e-01
|
4.31e-01
|
0.20800
|
0.181000
|
1.03e-01
|
9.20e-02
|
3.35e-01
|
REACTOME B WICH COMPLEX POSITIVELY REGULATES RRNA EXPRESSION
|
28
|
3.08e-02
|
1.14e-01
|
0.20800
|
0.182000
|
-1.01e-01
|
9.60e-02
|
3.53e-01
|
REACTOME INITIATION OF NUCLEAR ENVELOPE NE REFORMATION
|
18
|
1.24e-01
|
2.84e-01
|
0.20800
|
0.073300
|
-1.95e-01
|
5.90e-01
|
1.53e-01
|
REACTOME CLATHRIN MEDIATED ENDOCYTOSIS
|
137
|
3.59e-04
|
3.22e-03
|
0.20800
|
0.195000
|
7.28e-02
|
8.19e-05
|
1.41e-01
|
REACTOME TRANSPORT OF ORGANIC ANIONS
|
10
|
6.32e-01
|
7.60e-01
|
0.20800
|
-0.171000
|
-1.18e-01
|
3.49e-01
|
5.17e-01
|
REACTOME CREB1 PHOSPHORYLATION THROUGH THE ACTIVATION OF CAMKII CAMKK CAMKIV CASCASDE
|
8
|
4.98e-01
|
6.56e-01
|
0.20800
|
-0.000522
|
2.08e-01
|
9.98e-01
|
3.09e-01
|
REACTOME ENERGY DEPENDENT REGULATION OF MTOR BY LKB1 AMPK
|
28
|
2.93e-01
|
4.84e-01
|
0.20800
|
0.160000
|
1.32e-01
|
1.42e-01
|
2.25e-01
|
REACTOME DNA DAMAGE REVERSAL
|
8
|
3.96e-01
|
5.73e-01
|
0.20800
|
-0.194000
|
7.42e-02
|
3.42e-01
|
7.16e-01
|
REACTOME NEGATIVE REGULATION OF MAPK PATHWAY
|
41
|
1.39e-02
|
6.54e-02
|
0.20700
|
0.202000
|
-4.42e-02
|
2.49e-02
|
6.24e-01
|
REACTOME LDL CLEARANCE
|
19
|
3.98e-01
|
5.75e-01
|
0.20700
|
0.179000
|
1.04e-01
|
1.77e-01
|
4.33e-01
|
REACTOME EPH EPHRIN SIGNALING
|
90
|
5.66e-03
|
3.36e-02
|
0.20700
|
0.194000
|
7.25e-02
|
1.47e-03
|
2.35e-01
|
REACTOME RHO GTPASES ACTIVATE PAKS
|
19
|
4.35e-01
|
6.03e-01
|
0.20700
|
0.163000
|
1.28e-01
|
2.20e-01
|
3.34e-01
|
REACTOME SYNTHESIS OF SUBSTRATES IN N GLYCAN BIOSYTHESIS
|
60
|
3.91e-02
|
1.33e-01
|
0.20700
|
0.189000
|
8.30e-02
|
1.11e-02
|
2.66e-01
|
REACTOME CALCITONIN LIKE LIGAND RECEPTORS
|
10
|
4.22e-01
|
5.90e-01
|
0.20700
|
0.207000
|
-8.67e-04
|
2.58e-01
|
9.96e-01
|
REACTOME GLUTAMATE AND GLUTAMINE METABOLISM
|
11
|
3.83e-01
|
5.63e-01
|
0.20700
|
0.207000
|
-3.51e-03
|
2.36e-01
|
9.84e-01
|
REACTOME CRMPS IN SEMA3A SIGNALING
|
15
|
4.99e-01
|
6.56e-01
|
0.20700
|
0.174000
|
1.12e-01
|
2.44e-01
|
4.54e-01
|
REACTOME CARGO RECOGNITION FOR CLATHRIN MEDIATED ENDOCYTOSIS
|
98
|
3.28e-03
|
2.23e-02
|
0.20600
|
0.195000
|
6.85e-02
|
8.64e-04
|
2.41e-01
|
REACTOME TRNA PROCESSING IN THE NUCLEUS
|
55
|
1.00e-03
|
7.98e-03
|
0.20600
|
0.116000
|
-1.70e-01
|
1.36e-01
|
2.87e-02
|
REACTOME EGFR INTERACTS WITH PHOSPHOLIPASE C GAMMA
|
9
|
6.83e-01
|
7.97e-01
|
0.20600
|
0.144000
|
1.48e-01
|
4.54e-01
|
4.43e-01
|
REACTOME ASSOCIATION OF TRIC CCT WITH TARGET PROTEINS DURING BIOSYNTHESIS
|
36
|
1.00e-02
|
5.13e-02
|
0.20600
|
0.150000
|
-1.41e-01
|
1.18e-01
|
1.44e-01
|
REACTOME DNA REPLICATION PRE INITIATION
|
96
|
5.74e-06
|
7.17e-05
|
0.20600
|
0.166000
|
-1.21e-01
|
4.87e-03
|
3.96e-02
|
REACTOME ACTIVATED TAK1 MEDIATES P38 MAPK ACTIVATION
|
20
|
8.57e-02
|
2.26e-01
|
0.20500
|
0.175000
|
-1.07e-01
|
1.74e-01
|
4.08e-01
|
REACTOME ACTIVATION OF AMPK DOWNSTREAM OF NMDARS
|
28
|
3.06e-01
|
4.92e-01
|
0.20500
|
0.153000
|
1.37e-01
|
1.61e-01
|
2.10e-01
|
REACTOME BASE EXCISION REPAIR AP SITE FORMATION
|
17
|
1.51e-01
|
3.22e-01
|
0.20500
|
0.194000
|
-6.81e-02
|
1.67e-01
|
6.27e-01
|
REACTOME GLUTATHIONE SYNTHESIS AND RECYCLING
|
12
|
5.47e-01
|
6.92e-01
|
0.20500
|
-0.092100
|
-1.83e-01
|
5.81e-01
|
2.72e-01
|
REACTOME UPTAKE AND FUNCTION OF DIPHTHERIA TOXIN
|
6
|
5.05e-01
|
6.61e-01
|
0.20500
|
0.077400
|
-1.90e-01
|
7.43e-01
|
4.21e-01
|
REACTOME ERCC6 CSB AND EHMT2 G9A POSITIVELY REGULATE RRNA EXPRESSION
|
15
|
5.31e-01
|
6.83e-01
|
0.20500
|
0.135000
|
1.54e-01
|
3.67e-01
|
3.01e-01
|
REACTOME RESOLUTION OF AP SITES VIA THE MULTIPLE NUCLEOTIDE PATCH REPLACEMENT PATHWAY
|
24
|
2.64e-01
|
4.58e-01
|
0.20500
|
0.191000
|
7.43e-02
|
1.06e-01
|
5.29e-01
|
REACTOME ENDOSOMAL SORTING COMPLEX REQUIRED FOR TRANSPORT ESCRT
|
31
|
1.06e-01
|
2.58e-01
|
0.20400
|
0.202000
|
2.75e-02
|
5.11e-02
|
7.91e-01
|
REACTOME HSF1 ACTIVATION
|
29
|
2.77e-02
|
1.07e-01
|
0.20400
|
0.167000
|
-1.18e-01
|
1.20e-01
|
2.71e-01
|
REACTOME RAF INDEPENDENT MAPK1 3 ACTIVATION
|
22
|
3.19e-01
|
4.97e-01
|
0.20400
|
0.186000
|
8.46e-02
|
1.31e-01
|
4.92e-01
|
REACTOME INFECTION WITH MYCOBACTERIUM TUBERCULOSIS
|
25
|
5.53e-02
|
1.69e-01
|
0.20400
|
0.185000
|
-8.54e-02
|
1.08e-01
|
4.60e-01
|
REACTOME REGULATION OF TP53 ACTIVITY
|
153
|
1.58e-04
|
1.53e-03
|
0.20400
|
0.193000
|
6.71e-02
|
3.82e-05
|
1.52e-01
|
REACTOME TRANSCRIPTION OF E2F TARGETS UNDER NEGATIVE CONTROL BY DREAM COMPLEX
|
19
|
1.32e-01
|
2.98e-01
|
0.20400
|
0.195000
|
-5.87e-02
|
1.41e-01
|
6.58e-01
|
REACTOME APOPTOSIS
|
164
|
2.53e-08
|
6.12e-07
|
0.20400
|
0.195000
|
-6.04e-02
|
1.69e-05
|
1.82e-01
|
REACTOME TCR SIGNALING
|
111
|
4.03e-06
|
5.15e-05
|
0.20400
|
0.189000
|
-7.58e-02
|
5.81e-04
|
1.68e-01
|
REACTOME SIGNALING BY NOTCH2
|
32
|
6.71e-02
|
1.92e-01
|
0.20400
|
0.204000
|
-2.98e-03
|
4.63e-02
|
9.77e-01
|
REACTOME DUAL INCISION IN GG NER
|
39
|
2.35e-02
|
9.62e-02
|
0.20300
|
0.201000
|
-3.21e-02
|
2.99e-02
|
7.29e-01
|
REACTOME NPAS4 REGULATES EXPRESSION OF TARGET GENES
|
20
|
3.14e-01
|
4.95e-01
|
0.20300
|
0.193000
|
6.43e-02
|
1.35e-01
|
6.18e-01
|
REACTOME CYP2E1 REACTIONS
|
10
|
6.20e-01
|
7.52e-01
|
0.20300
|
-0.178000
|
-9.74e-02
|
3.29e-01
|
5.94e-01
|
REACTOME APOPTOTIC CLEAVAGE OF CELLULAR PROTEINS
|
35
|
1.68e-01
|
3.46e-01
|
0.20300
|
0.184000
|
8.56e-02
|
5.93e-02
|
3.81e-01
|
REACTOME SUMOYLATION
|
163
|
1.25e-03
|
9.73e-03
|
0.20300
|
0.150000
|
1.37e-01
|
9.61e-04
|
2.52e-03
|
REACTOME SYNTHESIS OF DNA
|
118
|
1.48e-06
|
2.09e-05
|
0.20300
|
0.185000
|
-8.38e-02
|
5.19e-04
|
1.16e-01
|
REACTOME INTEGRATION OF ENERGY METABOLISM
|
105
|
1.30e-02
|
6.19e-02
|
0.20300
|
0.133000
|
1.53e-01
|
1.87e-02
|
6.56e-03
|
REACTOME CLEC7A DECTIN 1 SIGNALING
|
96
|
1.19e-05
|
1.39e-04
|
0.20300
|
0.176000
|
-1.01e-01
|
2.88e-03
|
8.81e-02
|
REACTOME SNRNP ASSEMBLY
|
51
|
1.95e-03
|
1.41e-02
|
0.20200
|
0.125000
|
-1.59e-01
|
1.23e-01
|
4.93e-02
|
REACTOME ACTIVATED NTRK3 SIGNALS THROUGH PI3K
|
6
|
7.83e-01
|
8.66e-01
|
0.20200
|
0.142000
|
1.43e-01
|
5.46e-01
|
5.43e-01
|
REACTOME RET SIGNALING
|
40
|
1.36e-01
|
3.02e-01
|
0.20200
|
0.086800
|
1.83e-01
|
3.42e-01
|
4.57e-02
|
REACTOME REGULATION OF IFNA IFNB SIGNALING
|
23
|
2.36e-01
|
4.28e-01
|
0.20200
|
-0.196000
|
-4.87e-02
|
1.03e-01
|
6.86e-01
|
REACTOME DNA REPLICATION
|
124
|
6.56e-07
|
1.03e-05
|
0.20100
|
0.178000
|
-9.37e-02
|
6.06e-04
|
7.16e-02
|
REACTOME G1 S SPECIFIC TRANSCRIPTION
|
28
|
4.37e-02
|
1.43e-01
|
0.20100
|
0.184000
|
-8.17e-02
|
9.20e-02
|
4.54e-01
|
REACTOME NR1H2 NR1H3 REGULATE GENE EXPRESSION LINKED TO GLUCONEOGENESIS
|
5
|
8.17e-01
|
8.87e-01
|
0.20100
|
-0.147000
|
-1.37e-01
|
5.70e-01
|
5.95e-01
|
REACTOME GLI PROTEINS BIND PROMOTERS OF HH RESPONSIVE GENES TO PROMOTE TRANSCRIPTION
|
7
|
6.13e-01
|
7.46e-01
|
0.20100
|
0.199000
|
2.77e-02
|
3.62e-01
|
8.99e-01
|
REACTOME ATTENUATION PHASE
|
27
|
4.17e-02
|
1.38e-01
|
0.20100
|
0.169000
|
-1.07e-01
|
1.28e-01
|
3.34e-01
|
REACTOME COBALAMIN CBL METABOLISM
|
6
|
5.19e-01
|
6.74e-01
|
0.20000
|
0.076900
|
-1.85e-01
|
7.44e-01
|
4.33e-01
|
REACTOME CHONDROITIN SULFATE DERMATAN SULFATE METABOLISM
|
45
|
1.55e-01
|
3.28e-01
|
0.20000
|
0.160000
|
1.20e-01
|
6.32e-02
|
1.63e-01
|
REACTOME DAG AND IP3 SIGNALING
|
39
|
1.33e-01
|
3.00e-01
|
0.20000
|
0.076700
|
1.85e-01
|
4.07e-01
|
4.57e-02
|
REACTOME INTERCONVERSION OF NUCLEOTIDE DI AND TRIPHOSPHATES
|
28
|
3.94e-02
|
1.34e-01
|
0.20000
|
0.173000
|
-1.01e-01
|
1.14e-01
|
3.57e-01
|
REACTOME ACTIVATION OF NIMA KINASES NEK9 NEK6 NEK7
|
7
|
4.73e-01
|
6.35e-01
|
0.20000
|
0.187000
|
-6.99e-02
|
3.91e-01
|
7.49e-01
|
REACTOME DNA DAMAGE BYPASS
|
45
|
3.01e-02
|
1.12e-01
|
0.20000
|
0.200000
|
5.59e-03
|
2.04e-02
|
9.48e-01
|
REACTOME MET RECEPTOR ACTIVATION
|
6
|
6.95e-01
|
8.05e-01
|
0.20000
|
-0.049500
|
-1.93e-01
|
8.34e-01
|
4.12e-01
|
REACTOME COOPERATION OF PDCL PHLP1 AND TRIC CCT IN G PROTEIN BETA FOLDING
|
38
|
4.41e-02
|
1.44e-01
|
0.20000
|
0.200000
|
-5.14e-03
|
3.32e-02
|
9.56e-01
|
REACTOME PROCESSING AND ACTIVATION OF SUMO
|
10
|
3.01e-01
|
4.90e-01
|
0.19900
|
0.145000
|
-1.37e-01
|
4.26e-01
|
4.55e-01
|
REACTOME RECEPTOR TYPE TYROSINE PROTEIN PHOSPHATASES
|
16
|
4.15e-01
|
5.88e-01
|
0.19900
|
0.064800
|
1.88e-01
|
6.54e-01
|
1.92e-01
|
REACTOME BUDDING AND MATURATION OF HIV VIRION
|
28
|
8.06e-02
|
2.18e-01
|
0.19900
|
0.197000
|
-2.66e-02
|
7.13e-02
|
8.07e-01
|
REACTOME CREB3 FACTORS ACTIVATE GENES
|
8
|
5.75e-01
|
7.18e-01
|
0.19900
|
-0.025500
|
-1.97e-01
|
9.00e-01
|
3.35e-01
|
REACTOME ACTIVATION OF PPARGC1A PGC 1ALPHA BY PHOSPHORYLATION
|
10
|
5.47e-01
|
6.92e-01
|
0.19800
|
0.192000
|
4.79e-02
|
2.92e-01
|
7.93e-01
|
REACTOME CELLULAR RESPONSE TO CHEMICAL STRESS
|
186
|
1.55e-09
|
5.65e-08
|
0.19800
|
0.179000
|
-8.49e-02
|
2.50e-05
|
4.58e-02
|
REACTOME COOPERATION OF PREFOLDIN AND TRIC CCT IN ACTIN AND TUBULIN FOLDING
|
32
|
2.62e-02
|
1.03e-01
|
0.19800
|
0.169000
|
-1.03e-01
|
9.80e-02
|
3.14e-01
|
REACTOME DISEASES ASSOCIATED WITH SURFACTANT METABOLISM
|
9
|
5.38e-01
|
6.87e-01
|
0.19800
|
-0.196000
|
-2.42e-02
|
3.08e-01
|
9.00e-01
|
REACTOME CELLULAR HEXOSE TRANSPORT
|
20
|
4.60e-01
|
6.23e-01
|
0.19700
|
-0.138000
|
-1.41e-01
|
2.86e-01
|
2.74e-01
|
REACTOME MTORC1 MEDIATED SIGNALLING
|
23
|
1.09e-01
|
2.61e-01
|
0.19700
|
0.192000
|
-4.72e-02
|
1.12e-01
|
6.95e-01
|
REACTOME MASTL FACILITATES MITOTIC PROGRESSION
|
10
|
3.20e-01
|
4.97e-01
|
0.19700
|
0.107000
|
-1.65e-01
|
5.57e-01
|
3.65e-01
|
REACTOME VITAMIN B1 THIAMIN METABOLISM
|
5
|
6.82e-01
|
7.97e-01
|
0.19700
|
0.197000
|
3.14e-03
|
4.46e-01
|
9.90e-01
|
REACTOME ERYTHROCYTES TAKE UP CARBON DIOXIDE AND RELEASE OXYGEN
|
13
|
4.41e-01
|
6.08e-01
|
0.19600
|
-0.037100
|
-1.93e-01
|
8.17e-01
|
2.29e-01
|
REACTOME CA2 ACTIVATED K CHANNELS
|
9
|
6.89e-01
|
8.02e-01
|
0.19600
|
-0.109000
|
-1.63e-01
|
5.72e-01
|
3.96e-01
|
REACTOME MET ACTIVATES PTK2 SIGNALING
|
30
|
1.54e-01
|
3.26e-01
|
0.19600
|
-0.192000
|
-3.82e-02
|
6.81e-02
|
7.17e-01
|
REACTOME DISEASES OF PROGRAMMED CELL DEATH
|
42
|
9.88e-03
|
5.11e-02
|
0.19600
|
0.172000
|
-9.46e-02
|
5.42e-02
|
2.89e-01
|
REACTOME SIGNALING BY HEDGEHOG
|
146
|
1.79e-05
|
2.05e-04
|
0.19600
|
0.196000
|
4.51e-03
|
4.41e-05
|
9.25e-01
|
REACTOME REGULATED NECROSIS
|
55
|
1.73e-03
|
1.29e-02
|
0.19600
|
0.140000
|
-1.37e-01
|
7.24e-02
|
7.92e-02
|
REACTOME CYTOSOLIC SENSORS OF PATHOGEN ASSOCIATED DNA
|
60
|
1.42e-03
|
1.07e-02
|
0.19600
|
0.093100
|
-1.72e-01
|
2.12e-01
|
2.10e-02
|
REACTOME BMAL1 CLOCK NPAS2 ACTIVATES CIRCADIAN GENE EXPRESSION
|
24
|
3.87e-01
|
5.66e-01
|
0.19600
|
0.156000
|
1.19e-01
|
1.87e-01
|
3.15e-01
|
REACTOME PHOSPHATE BOND HYDROLYSIS BY NUDT PROTEINS
|
7
|
4.61e-01
|
6.23e-01
|
0.19600
|
0.169000
|
-9.80e-02
|
4.38e-01
|
6.54e-01
|
REACTOME P75NTR REGULATES AXONOGENESIS
|
9
|
5.19e-01
|
6.74e-01
|
0.19600
|
-0.195000
|
-9.80e-03
|
3.10e-01
|
9.59e-01
|
REACTOME PKMTS METHYLATE HISTONE LYSINES
|
37
|
4.42e-02
|
1.44e-01
|
0.19500
|
-0.019600
|
1.94e-01
|
8.36e-01
|
4.08e-02
|
REACTOME SUMO IS PROTEOLYTICALLY PROCESSED
|
6
|
5.12e-01
|
6.69e-01
|
0.19500
|
0.165000
|
-1.05e-01
|
4.85e-01
|
6.57e-01
|
REACTOME DEADENYLATION DEPENDENT MRNA DECAY
|
50
|
3.23e-03
|
2.21e-02
|
0.19500
|
0.132000
|
-1.44e-01
|
1.07e-01
|
7.83e-02
|
REACTOME THE CITRIC ACID TCA CYCLE AND RESPIRATORY ELECTRON TRANSPORT
|
143
|
9.10e-08
|
1.71e-06
|
0.19500
|
0.123000
|
-1.51e-01
|
1.09e-02
|
1.83e-03
|
REACTOME COLLAGEN CHAIN TRIMERIZATION
|
42
|
4.42e-02
|
1.44e-01
|
0.19400
|
-0.194000
|
-3.86e-03
|
2.94e-02
|
9.65e-01
|
REACTOME G2 M CHECKPOINTS
|
126
|
8.60e-07
|
1.28e-05
|
0.19400
|
0.161000
|
-1.09e-01
|
1.84e-03
|
3.42e-02
|
REACTOME HEDGEHOG OFF STATE
|
110
|
2.81e-05
|
3.07e-04
|
0.19400
|
0.186000
|
-5.35e-02
|
7.38e-04
|
3.32e-01
|
REACTOME ELASTIC FIBRE FORMATION
|
44
|
1.10e-01
|
2.63e-01
|
0.19400
|
0.068800
|
1.81e-01
|
4.30e-01
|
3.77e-02
|
REACTOME ABC FAMILY PROTEINS MEDIATED TRANSPORT
|
98
|
3.18e-05
|
3.42e-04
|
0.19400
|
0.087900
|
-1.72e-01
|
1.33e-01
|
3.16e-03
|
REACTOME PRC2 METHYLATES HISTONES AND DNA
|
12
|
5.98e-01
|
7.35e-01
|
0.19300
|
0.094800
|
1.69e-01
|
5.70e-01
|
3.12e-01
|
REACTOME RRNA MODIFICATION IN THE NUCLEUS AND CYTOSOL
|
54
|
5.22e-03
|
3.22e-02
|
0.19300
|
0.059800
|
-1.84e-01
|
4.47e-01
|
1.94e-02
|
REACTOME BIOSYNTHESIS OF THE N GLYCAN PRECURSOR DOLICHOL LIPID LINKED OLIGOSACCHARIDE LLO AND TRANSFER TO A NASCENT PROTEIN
|
74
|
1.53e-02
|
6.94e-02
|
0.19300
|
0.187000
|
4.81e-02
|
5.42e-03
|
4.74e-01
|
REACTOME INTERLEUKIN 1 SIGNALING
|
109
|
1.18e-05
|
1.39e-04
|
0.19300
|
0.173000
|
-8.48e-02
|
1.77e-03
|
1.26e-01
|
REACTOME TRANSCRIPTION OF THE HIV GENOME
|
62
|
1.04e-03
|
8.23e-03
|
0.19300
|
0.153000
|
-1.17e-01
|
3.73e-02
|
1.10e-01
|
REACTOME METABOLISM OF AMINO ACIDS AND DERIVATIVES
|
340
|
2.31e-16
|
1.89e-14
|
0.19200
|
0.097700
|
-1.66e-01
|
1.94e-03
|
1.47e-07
|
REACTOME NEGATIVE REGULATORS OF DDX58 IFIH1 SIGNALING
|
33
|
2.55e-02
|
1.02e-01
|
0.19200
|
0.146000
|
-1.25e-01
|
1.47e-01
|
2.14e-01
|
REACTOME FC EPSILON RECEPTOR FCERI SIGNALING
|
126
|
6.87e-06
|
8.39e-05
|
0.19200
|
0.184000
|
-5.52e-02
|
3.59e-04
|
2.84e-01
|
REACTOME REGULATION OF SIGNALING BY NODAL
|
10
|
6.82e-01
|
7.97e-01
|
0.19200
|
0.115000
|
1.54e-01
|
5.29e-01
|
4.00e-01
|
REACTOME BIOLOGICAL OXIDATIONS
|
206
|
5.07e-04
|
4.36e-03
|
0.19200
|
-0.124000
|
-1.46e-01
|
2.17e-03
|
2.94e-04
|
REACTOME TRANSCRIPTIONAL REGULATION BY RUNX1
|
175
|
2.76e-04
|
2.56e-03
|
0.19200
|
0.176000
|
7.43e-02
|
5.57e-05
|
8.97e-02
|
REACTOME HIV INFECTION
|
216
|
1.43e-10
|
6.31e-09
|
0.19000
|
0.162000
|
-1.00e-01
|
4.00e-05
|
1.12e-02
|
REACTOME COMPLEX I BIOGENESIS
|
49
|
8.70e-03
|
4.65e-02
|
0.19000
|
0.067000
|
-1.78e-01
|
4.17e-01
|
3.10e-02
|
REACTOME APOPTOTIC CLEAVAGE OF CELL ADHESION PROTEINS
|
11
|
6.69e-01
|
7.87e-01
|
0.19000
|
0.123000
|
1.45e-01
|
4.78e-01
|
4.06e-01
|
REACTOME TERMINATION OF TRANSLESION DNA SYNTHESIS
|
31
|
7.03e-02
|
1.99e-01
|
0.19000
|
0.187000
|
-3.48e-02
|
7.19e-02
|
7.37e-01
|
REACTOME TRANSLATION OF REPLICASE AND ASSEMBLY OF THE REPLICATION TRANSCRIPTION COMPLEX
|
14
|
5.59e-01
|
7.03e-01
|
0.19000
|
0.166000
|
9.12e-02
|
2.81e-01
|
5.55e-01
|
REACTOME INHIBITION OF THE PROTEOLYTIC ACTIVITY OF APC C REQUIRED FOR THE ONSET OF ANAPHASE BY MITOTIC SPINDLE CHECKPOINT COMPONENTS
|
21
|
1.02e-01
|
2.53e-01
|
0.19000
|
0.135000
|
-1.33e-01
|
2.84e-01
|
2.91e-01
|
REACTOME PROGRAMMED CELL DEATH
|
194
|
2.62e-08
|
6.22e-07
|
0.19000
|
0.183000
|
-4.96e-02
|
1.10e-05
|
2.33e-01
|
REACTOME ZBP1 DAI MEDIATED INDUCTION OF TYPE I IFNS
|
20
|
1.42e-01
|
3.11e-01
|
0.18900
|
0.071700
|
-1.75e-01
|
5.79e-01
|
1.75e-01
|
REACTOME VITAMIN B5 PANTOTHENATE METABOLISM
|
16
|
4.19e-01
|
5.90e-01
|
0.18900
|
-0.047600
|
-1.83e-01
|
7.42e-01
|
2.05e-01
|
REACTOME GLYCOSAMINOGLYCAN METABOLISM
|
118
|
1.33e-02
|
6.27e-02
|
0.18900
|
0.116000
|
1.49e-01
|
2.90e-02
|
5.11e-03
|
REACTOME MRNA SPLICING
|
195
|
8.52e-10
|
3.24e-08
|
0.18900
|
0.129000
|
-1.38e-01
|
1.93e-03
|
8.58e-04
|
REACTOME BETA CATENIN INDEPENDENT WNT SIGNALING
|
144
|
4.70e-04
|
4.07e-03
|
0.18800
|
0.182000
|
4.86e-02
|
1.60e-04
|
3.14e-01
|
REACTOME DNA DOUBLE STRAND BREAK RESPONSE
|
39
|
9.86e-02
|
2.46e-01
|
0.18800
|
0.186000
|
3.09e-02
|
4.49e-02
|
7.38e-01
|
REACTOME INTRINSIC PATHWAY OF FIBRIN CLOT FORMATION
|
21
|
1.35e-01
|
3.02e-01
|
0.18800
|
-0.175000
|
6.87e-02
|
1.65e-01
|
5.85e-01
|
REACTOME GPCR LIGAND BINDING
|
439
|
8.75e-09
|
2.43e-07
|
0.18800
|
0.081700
|
1.69e-01
|
3.28e-03
|
1.13e-09
|
REACTOME HDACS DEACETYLATE HISTONES
|
29
|
9.87e-02
|
2.46e-01
|
0.18800
|
0.186000
|
-2.39e-02
|
8.25e-02
|
8.24e-01
|
REACTOME COMMON PATHWAY OF FIBRIN CLOT FORMATION
|
21
|
3.44e-01
|
5.24e-01
|
0.18800
|
-0.180000
|
-5.50e-02
|
1.54e-01
|
6.63e-01
|
REACTOME SIGNALING BY FGFR
|
85
|
4.19e-03
|
2.75e-02
|
0.18800
|
0.187000
|
1.62e-02
|
2.89e-03
|
7.96e-01
|
REACTOME ANDROGEN BIOSYNTHESIS
|
11
|
5.54e-01
|
6.99e-01
|
0.18700
|
-0.182000
|
-4.60e-02
|
2.97e-01
|
7.91e-01
|
REACTOME TRANSLESION SYNTHESIS BY Y FAMILY DNA POLYMERASES BYPASSES LESIONS ON DNA TEMPLATE
|
37
|
6.52e-02
|
1.89e-01
|
0.18700
|
0.187000
|
-8.94e-03
|
4.89e-02
|
9.25e-01
|
REACTOME INHIBITION OF DNA RECOMBINATION AT TELOMERE
|
19
|
1.47e-01
|
3.19e-01
|
0.18700
|
0.094700
|
-1.61e-01
|
4.75e-01
|
2.25e-01
|
REACTOME RUNX3 REGULATES YAP1 MEDIATED TRANSCRIPTION
|
7
|
6.81e-01
|
7.97e-01
|
0.18600
|
0.182000
|
4.06e-02
|
4.05e-01
|
8.52e-01
|
REACTOME RHOU GTPASE CYCLE
|
37
|
2.23e-01
|
4.14e-01
|
0.18600
|
0.087500
|
1.64e-01
|
3.57e-01
|
8.35e-02
|
REACTOME PTEN REGULATION
|
134
|
2.47e-04
|
2.31e-03
|
0.18600
|
0.185000
|
1.97e-02
|
2.13e-04
|
6.93e-01
|
REACTOME PI3K AKT SIGNALING IN CANCER
|
103
|
2.75e-02
|
1.07e-01
|
0.18600
|
0.143000
|
1.19e-01
|
1.23e-02
|
3.66e-02
|
REACTOME RNA POLYMERASE I TRANSCRIPTION
|
45
|
4.23e-02
|
1.40e-01
|
0.18500
|
0.185000
|
-3.37e-03
|
3.14e-02
|
9.69e-01
|
REACTOME SYNTHESIS OF PE
|
12
|
6.54e-01
|
7.77e-01
|
0.18500
|
0.147000
|
1.12e-01
|
3.77e-01
|
5.02e-01
|
REACTOME UB SPECIFIC PROCESSING PROTEASES
|
149
|
3.64e-06
|
4.76e-05
|
0.18500
|
0.180000
|
-4.36e-02
|
1.53e-04
|
3.59e-01
|
REACTOME NUCLEOTIDE BIOSYNTHESIS
|
12
|
4.18e-01
|
5.90e-01
|
0.18500
|
0.011000
|
-1.84e-01
|
9.47e-01
|
2.69e-01
|
REACTOME SEALING OF THE NUCLEAR ENVELOPE NE BY ESCRT III
|
31
|
3.31e-01
|
5.10e-01
|
0.18400
|
0.150000
|
1.06e-01
|
1.47e-01
|
3.06e-01
|
REACTOME SIGNALING BY FLT3 FUSION PROTEINS
|
19
|
4.99e-01
|
6.56e-01
|
0.18400
|
0.154000
|
1.01e-01
|
2.45e-01
|
4.47e-01
|
REACTOME RNA POLYMERASE II PRE TRANSCRIPTION EVENTS
|
72
|
8.95e-04
|
7.21e-03
|
0.18400
|
0.159000
|
-9.24e-02
|
1.96e-02
|
1.75e-01
|
REACTOME FGFR2 ALTERNATIVE SPLICING
|
27
|
6.53e-02
|
1.89e-01
|
0.18400
|
0.143000
|
-1.16e-01
|
1.99e-01
|
2.98e-01
|
REACTOME EXTRA NUCLEAR ESTROGEN SIGNALING
|
74
|
4.78e-02
|
1.50e-01
|
0.18300
|
0.166000
|
7.88e-02
|
1.37e-02
|
2.41e-01
|
REACTOME HSP90 CHAPERONE CYCLE FOR STEROID HORMONE RECEPTORS SHR IN THE PRESENCE OF LIGAND
|
55
|
7.90e-03
|
4.38e-02
|
0.18300
|
0.174000
|
-5.83e-02
|
2.56e-02
|
4.54e-01
|
REACTOME PEROXISOMAL LIPID METABOLISM
|
28
|
1.53e-01
|
3.26e-01
|
0.18300
|
-0.000741
|
-1.83e-01
|
9.95e-01
|
9.37e-02
|
REACTOME APOPTOTIC EXECUTION PHASE
|
43
|
1.40e-01
|
3.07e-01
|
0.18300
|
0.172000
|
6.09e-02
|
5.06e-02
|
4.90e-01
|
REACTOME FANCONI ANEMIA PATHWAY
|
34
|
9.19e-02
|
2.35e-01
|
0.18300
|
0.182000
|
-8.76e-03
|
6.56e-02
|
9.30e-01
|
REACTOME ENDOGENOUS STEROLS
|
25
|
4.36e-01
|
6.03e-01
|
0.18200
|
-0.135000
|
-1.22e-01
|
2.42e-01
|
2.91e-01
|
REACTOME EGR2 AND SOX10 MEDIATED INITIATION OF SCHWANN CELL MYELINATION
|
27
|
3.16e-01
|
4.95e-01
|
0.18200
|
0.070000
|
1.68e-01
|
5.29e-01
|
1.31e-01
|
REACTOME RNA POLYMERASE I TRANSCRIPTION INITIATION
|
42
|
4.89e-02
|
1.52e-01
|
0.18200
|
0.181000
|
-1.48e-02
|
4.20e-02
|
8.68e-01
|
REACTOME SYNTHESIS OF DIPHTHAMIDE EEF2
|
8
|
4.52e-01
|
6.17e-01
|
0.18200
|
0.142000
|
-1.14e-01
|
4.87e-01
|
5.77e-01
|
REACTOME BASE EXCISION REPAIR
|
44
|
8.07e-02
|
2.18e-01
|
0.18200
|
0.180000
|
2.51e-02
|
3.88e-02
|
7.73e-01
|
REACTOME ACTIVATION OF GENE EXPRESSION BY SREBF SREBP
|
41
|
2.16e-01
|
4.06e-01
|
0.18100
|
0.089700
|
1.57e-01
|
3.20e-01
|
8.10e-02
|
REACTOME TRAFFICKING OF AMPA RECEPTORS
|
29
|
1.88e-01
|
3.70e-01
|
0.18100
|
0.022800
|
1.80e-01
|
8.32e-01
|
9.39e-02
|
REACTOME ACTIVATION OF KAINATE RECEPTORS UPON GLUTAMATE BINDING
|
29
|
3.74e-01
|
5.55e-01
|
0.18100
|
0.144000
|
1.10e-01
|
1.79e-01
|
3.07e-01
|
REACTOME TRANSCRIPTIONAL REGULATION BY TP53
|
342
|
6.20e-10
|
2.48e-08
|
0.18100
|
0.181000
|
8.22e-03
|
8.88e-09
|
7.94e-01
|
REACTOME RIP MEDIATED NFKB ACTIVATION VIA ZBP1
|
16
|
2.06e-01
|
3.92e-01
|
0.18100
|
0.123000
|
-1.32e-01
|
3.94e-01
|
3.59e-01
|
REACTOME UNWINDING OF DNA
|
12
|
6.57e-01
|
7.79e-01
|
0.18100
|
0.150000
|
1.01e-01
|
3.68e-01
|
5.46e-01
|
REACTOME RNA POLYMERASE II TRANSCRIBES SNRNA GENES
|
74
|
7.05e-04
|
5.77e-03
|
0.18100
|
0.119000
|
-1.36e-01
|
7.77e-02
|
4.27e-02
|
REACTOME RNA POLYMERASE III TRANSCRIPTION
|
41
|
3.02e-02
|
1.13e-01
|
0.18100
|
0.171000
|
-5.74e-02
|
5.78e-02
|
5.25e-01
|
REACTOME UNFOLDED PROTEIN RESPONSE UPR
|
87
|
2.33e-04
|
2.20e-03
|
0.18000
|
0.148000
|
-1.04e-01
|
1.72e-02
|
9.50e-02
|
REACTOME GLYCEROPHOSPHOLIPID CATABOLISM
|
7
|
6.55e-01
|
7.77e-01
|
0.18000
|
-0.180000
|
-1.34e-02
|
4.10e-01
|
9.51e-01
|
REACTOME S PHASE
|
157
|
7.89e-07
|
1.18e-05
|
0.18000
|
0.164000
|
-7.42e-02
|
3.79e-04
|
1.09e-01
|
REACTOME VEGFR2 MEDIATED VASCULAR PERMEABILITY
|
26
|
1.72e-01
|
3.50e-01
|
0.18000
|
-0.007440
|
1.80e-01
|
9.48e-01
|
1.12e-01
|
REACTOME GPVI MEDIATED ACTIVATION CASCADE
|
34
|
2.36e-01
|
4.28e-01
|
0.18000
|
0.167000
|
6.69e-02
|
9.18e-02
|
5.00e-01
|
REACTOME SHC RELATED EVENTS TRIGGERED BY IGF1R
|
9
|
5.54e-01
|
6.99e-01
|
0.18000
|
0.180000
|
-1.60e-03
|
3.50e-01
|
9.93e-01
|
REACTOME FORMATION OF TC NER PRE INCISION COMPLEX
|
51
|
1.03e-02
|
5.26e-02
|
0.18000
|
0.163000
|
-7.55e-02
|
4.40e-02
|
3.51e-01
|
REACTOME IRAK4 DEFICIENCY TLR2 4
|
17
|
3.83e-01
|
5.63e-01
|
0.18000
|
-0.023200
|
-1.78e-01
|
8.69e-01
|
2.03e-01
|
REACTOME PROCESSING OF CAPPED INTRON CONTAINING PRE MRNA
|
259
|
1.49e-11
|
8.12e-10
|
0.17900
|
0.119000
|
-1.34e-01
|
9.44e-04
|
1.99e-04
|
REACTOME OXIDATIVE STRESS INDUCED SENESCENCE
|
65
|
1.03e-01
|
2.53e-01
|
0.17900
|
0.151000
|
9.66e-02
|
3.50e-02
|
1.78e-01
|
REACTOME ABERRANT REGULATION OF MITOTIC EXIT IN CANCER DUE TO RB1 DEFECTS
|
20
|
2.84e-01
|
4.77e-01
|
0.17900
|
0.179000
|
4.63e-03
|
1.65e-01
|
9.71e-01
|
REACTOME TRANSPORT OF NUCLEOSIDES AND FREE PURINE AND PYRIMIDINE BASES ACROSS THE PLASMA MEMBRANE
|
10
|
6.22e-01
|
7.53e-01
|
0.17900
|
-0.172000
|
-4.87e-02
|
3.46e-01
|
7.90e-01
|
REACTOME TRANSLATION OF SARS COV 2 STRUCTURAL PROTEINS
|
55
|
3.58e-02
|
1.26e-01
|
0.17900
|
0.179000
|
1.04e-02
|
2.18e-02
|
8.94e-01
|
REACTOME GLYCOGEN STORAGE DISEASES
|
14
|
2.93e-01
|
4.84e-01
|
0.17900
|
0.165000
|
-6.98e-02
|
2.86e-01
|
6.51e-01
|
REACTOME INTERLEUKIN 37 SIGNALING
|
20
|
4.97e-01
|
6.56e-01
|
0.17900
|
-0.095400
|
-1.51e-01
|
4.60e-01
|
2.42e-01
|
REACTOME NEDDYLATION
|
230
|
4.12e-08
|
9.10e-07
|
0.17900
|
0.176000
|
-2.90e-02
|
4.01e-06
|
4.48e-01
|
REACTOME TRNA PROCESSING
|
98
|
8.24e-05
|
8.29e-04
|
0.17800
|
0.129000
|
-1.24e-01
|
2.76e-02
|
3.44e-02
|
REACTOME POST CHAPERONIN TUBULIN FOLDING PATHWAY
|
23
|
4.82e-01
|
6.42e-01
|
0.17800
|
0.124000
|
1.28e-01
|
3.04e-01
|
2.87e-01
|
REACTOME TELOMERE EXTENSION BY TELOMERASE
|
22
|
2.88e-01
|
4.79e-01
|
0.17800
|
0.177000
|
2.04e-02
|
1.50e-01
|
8.69e-01
|
REACTOME METHYLATION
|
14
|
2.64e-01
|
4.58e-01
|
0.17800
|
0.111000
|
-1.40e-01
|
4.74e-01
|
3.66e-01
|
REACTOME SIGNAL ATTENUATION
|
10
|
7.24e-01
|
8.24e-01
|
0.17800
|
0.138000
|
1.12e-01
|
4.50e-01
|
5.38e-01
|
REACTOME CELLULAR RESPONSES TO STIMULI
|
706
|
8.45e-28
|
1.15e-25
|
0.17800
|
0.156000
|
-8.54e-02
|
1.40e-12
|
1.07e-04
|
REACTOME FCERI MEDIATED MAPK ACTIVATION
|
32
|
2.20e-01
|
4.09e-01
|
0.17800
|
0.172000
|
4.60e-02
|
9.30e-02
|
6.52e-01
|
REACTOME INTRINSIC PATHWAY FOR APOPTOSIS
|
52
|
2.98e-02
|
1.12e-01
|
0.17800
|
0.177000
|
-1.20e-02
|
2.71e-02
|
8.81e-01
|
REACTOME ANTIVIRAL MECHANISM BY IFN STIMULATED GENES
|
77
|
6.87e-04
|
5.67e-03
|
0.17800
|
0.136000
|
-1.14e-01
|
3.92e-02
|
8.29e-02
|
REACTOME MATURATION OF SARS COV 2 SPIKE PROTEIN
|
35
|
2.44e-01
|
4.37e-01
|
0.17700
|
0.163000
|
6.91e-02
|
9.44e-02
|
4.79e-01
|
REACTOME SIGNALING BY NTRK3 TRKC
|
17
|
5.18e-01
|
6.74e-01
|
0.17700
|
0.161000
|
7.49e-02
|
2.52e-01
|
5.93e-01
|
REACTOME REGULATION OF LOCALIZATION OF FOXO TRANSCRIPTION FACTORS
|
11
|
3.76e-01
|
5.56e-01
|
0.17700
|
-0.081200
|
1.57e-01
|
6.41e-01
|
3.66e-01
|
REACTOME INSERTION OF TAIL ANCHORED PROTEINS INTO THE ENDOPLASMIC RETICULUM MEMBRANE
|
18
|
4.81e-01
|
6.42e-01
|
0.17700
|
0.164000
|
6.64e-02
|
2.29e-01
|
6.26e-01
|
REACTOME RSK ACTIVATION
|
5
|
7.46e-01
|
8.37e-01
|
0.17600
|
0.010800
|
1.76e-01
|
9.67e-01
|
4.96e-01
|
REACTOME MEIOTIC RECOMBINATION
|
25
|
2.17e-01
|
4.07e-01
|
0.17600
|
0.176000
|
2.88e-03
|
1.28e-01
|
9.80e-01
|
REACTOME TP53 REGULATES TRANSCRIPTION OF CELL CYCLE GENES
|
48
|
1.99e-02
|
8.59e-02
|
0.17600
|
0.166000
|
-5.83e-02
|
4.68e-02
|
4.85e-01
|
REACTOME SIGNALING BY INSULIN RECEPTOR
|
80
|
8.57e-02
|
2.26e-01
|
0.17600
|
0.125000
|
1.24e-01
|
5.37e-02
|
5.55e-02
|
REACTOME REGULATION OF GLYCOLYSIS BY FRUCTOSE 2 6 BISPHOSPHATE METABOLISM
|
11
|
7.13e-01
|
8.17e-01
|
0.17600
|
0.128000
|
1.20e-01
|
4.62e-01
|
4.90e-01
|
REACTOME TP53 REGULATES TRANSCRIPTION OF ADDITIONAL CELL CYCLE GENES WHOSE EXACT ROLE IN THE P53 PATHWAY REMAIN UNCERTAIN
|
20
|
2.34e-01
|
4.26e-01
|
0.17500
|
0.172000
|
-3.17e-02
|
1.82e-01
|
8.06e-01
|
REACTOME RESPONSE OF MTB TO PHAGOCYTOSIS
|
22
|
1.34e-01
|
3.01e-01
|
0.17500
|
0.106000
|
-1.39e-01
|
3.89e-01
|
2.59e-01
|
REACTOME HIV TRANSCRIPTION ELONGATION
|
38
|
3.00e-02
|
1.12e-01
|
0.17500
|
0.124000
|
-1.23e-01
|
1.86e-01
|
1.88e-01
|
REACTOME COLLAGEN BIOSYNTHESIS AND MODIFYING ENZYMES
|
65
|
1.93e-02
|
8.44e-02
|
0.17500
|
-0.175000
|
-1.42e-03
|
1.48e-02
|
9.84e-01
|
REACTOME HATS ACETYLATE HISTONES
|
70
|
1.10e-01
|
2.63e-01
|
0.17400
|
0.140000
|
1.04e-01
|
4.27e-02
|
1.33e-01
|
REACTOME FCERI MEDIATED CA 2 MOBILIZATION
|
30
|
2.89e-01
|
4.80e-01
|
0.17400
|
0.164000
|
5.85e-02
|
1.20e-01
|
5.79e-01
|
REACTOME METALLOPROTEASE DUBS
|
16
|
4.39e-01
|
6.07e-01
|
0.17400
|
0.172000
|
2.69e-02
|
2.34e-01
|
8.52e-01
|
REACTOME SARS COV 2 HOST INTERACTIONS
|
184
|
4.43e-06
|
5.62e-05
|
0.17400
|
0.019200
|
-1.73e-01
|
6.53e-01
|
5.26e-05
|
REACTOME PREGNENOLONE BIOSYNTHESIS
|
10
|
7.38e-01
|
8.32e-01
|
0.17400
|
-0.131000
|
-1.14e-01
|
4.73e-01
|
5.32e-01
|
REACTOME FORMATION OF INCISION COMPLEX IN GG NER
|
40
|
4.53e-02
|
1.46e-01
|
0.17400
|
0.166000
|
-5.03e-02
|
6.91e-02
|
5.82e-01
|
REACTOME SIGNAL AMPLIFICATION
|
33
|
2.61e-01
|
4.55e-01
|
0.17300
|
0.163000
|
5.81e-02
|
1.06e-01
|
5.64e-01
|
REACTOME DOWNREGULATION OF TGF BETA RECEPTOR SIGNALING
|
26
|
2.12e-01
|
4.00e-01
|
0.17200
|
0.172000
|
3.96e-04
|
1.28e-01
|
9.97e-01
|
REACTOME RUNX3 REGULATES IMMUNE RESPONSE AND CELL MIGRATION
|
6
|
8.19e-01
|
8.87e-01
|
0.17200
|
0.148000
|
8.82e-02
|
5.30e-01
|
7.08e-01
|
REACTOME SIGNALING BY FGFR IN DISEASE
|
61
|
1.56e-01
|
3.28e-01
|
0.17200
|
0.136000
|
1.05e-01
|
6.55e-02
|
1.55e-01
|
REACTOME TANDEM PORE DOMAIN POTASSIUM CHANNELS
|
12
|
6.63e-01
|
7.83e-01
|
0.17200
|
0.151000
|
8.32e-02
|
3.66e-01
|
6.18e-01
|
REACTOME THE NLRP3 INFLAMMASOME
|
16
|
3.15e-01
|
4.95e-01
|
0.17200
|
0.037100
|
-1.68e-01
|
7.97e-01
|
2.44e-01
|
REACTOME ATTACHMENT OF GPI ANCHOR TO UPAR
|
7
|
6.66e-01
|
7.86e-01
|
0.17200
|
-0.004060
|
-1.72e-01
|
9.85e-01
|
4.31e-01
|
REACTOME TYROSINE CATABOLISM
|
5
|
8.53e-01
|
9.09e-01
|
0.17200
|
-0.143000
|
-9.59e-02
|
5.80e-01
|
7.10e-01
|
REACTOME CYCLIN A B1 B2 ASSOCIATED EVENTS DURING G2 M TRANSITION
|
24
|
1.19e-01
|
2.76e-01
|
0.17200
|
0.130000
|
-1.12e-01
|
2.71e-01
|
3.41e-01
|
REACTOME METHIONINE SALVAGE PATHWAY
|
6
|
6.48e-01
|
7.74e-01
|
0.17200
|
0.167000
|
-3.83e-02
|
4.78e-01
|
8.71e-01
|
REACTOME HIV TRANSCRIPTION INITIATION
|
43
|
2.29e-02
|
9.46e-02
|
0.17200
|
0.136000
|
-1.04e-01
|
1.21e-01
|
2.38e-01
|
REACTOME SYNTHESIS OF PROSTAGLANDINS PG AND THROMBOXANES TX
|
14
|
6.62e-01
|
7.83e-01
|
0.17100
|
-0.127000
|
-1.15e-01
|
4.10e-01
|
4.56e-01
|
REACTOME DEUBIQUITINATION
|
218
|
1.36e-06
|
1.93e-05
|
0.17100
|
0.171000
|
-9.91e-03
|
1.32e-05
|
8.01e-01
|
REACTOME IRON UPTAKE AND TRANSPORT
|
56
|
1.25e-02
|
6.02e-02
|
0.17100
|
0.160000
|
-6.01e-02
|
3.80e-02
|
4.37e-01
|
REACTOME PLATELET HOMEOSTASIS
|
82
|
9.15e-02
|
2.35e-01
|
0.17100
|
0.126000
|
1.16e-01
|
4.91e-02
|
6.94e-02
|
REACTOME FORMATION OF TUBULIN FOLDING INTERMEDIATES BY CCT TRIC
|
26
|
1.55e-01
|
3.28e-01
|
0.17100
|
0.167000
|
-3.84e-02
|
1.42e-01
|
7.34e-01
|
REACTOME POSITIVE EPIGENETIC REGULATION OF RRNA EXPRESSION
|
42
|
6.40e-02
|
1.86e-01
|
0.17100
|
0.169000
|
-2.03e-02
|
5.74e-02
|
8.20e-01
|
REACTOME TNFR1 INDUCED PROAPOPTOTIC SIGNALING
|
23
|
1.84e-01
|
3.66e-01
|
0.17000
|
0.046400
|
-1.64e-01
|
7.00e-01
|
1.74e-01
|
REACTOME SIGNALLING TO RAS
|
20
|
3.51e-01
|
5.33e-01
|
0.17000
|
0.169000
|
1.74e-02
|
1.90e-01
|
8.93e-01
|
REACTOME FORMATION OF RNA POL II ELONGATION COMPLEX
|
52
|
1.23e-02
|
6.02e-02
|
0.17000
|
0.144000
|
-9.11e-02
|
7.28e-02
|
2.56e-01
|
REACTOME PROCESSING OF INTRONLESS PRE MRNAS
|
19
|
2.53e-01
|
4.45e-01
|
0.17000
|
0.164000
|
-4.32e-02
|
2.15e-01
|
7.44e-01
|
REACTOME DNA METHYLATION
|
5
|
7.87e-01
|
8.67e-01
|
0.17000
|
0.029900
|
1.67e-01
|
9.08e-01
|
5.17e-01
|
REACTOME CELLULAR SENESCENCE
|
128
|
4.55e-03
|
2.92e-02
|
0.17000
|
0.163000
|
4.72e-02
|
1.44e-03
|
3.56e-01
|
REACTOME FGFR2B LIGAND BINDING AND ACTIVATION
|
10
|
6.55e-01
|
7.77e-01
|
0.17000
|
0.163000
|
4.71e-02
|
3.72e-01
|
7.96e-01
|
REACTOME NEGATIVE REGULATION OF THE PI3K AKT NETWORK
|
111
|
3.10e-02
|
1.14e-01
|
0.16900
|
0.143000
|
9.06e-02
|
9.13e-03
|
9.90e-02
|
REACTOME CLASS A 1 RHODOPSIN LIKE RECEPTORS
|
307
|
1.80e-05
|
2.05e-04
|
0.16900
|
0.068800
|
1.55e-01
|
3.78e-02
|
3.10e-06
|
REACTOME SIGNALING BY RECEPTOR TYROSINE KINASES
|
506
|
8.68e-08
|
1.67e-06
|
0.16900
|
0.147000
|
8.26e-02
|
1.27e-08
|
1.44e-03
|
REACTOME GLYCOSPHINGOLIPID METABOLISM
|
38
|
2.65e-01
|
4.59e-01
|
0.16900
|
0.153000
|
7.25e-02
|
1.03e-01
|
4.39e-01
|
REACTOME PEPTIDE HORMONE BIOSYNTHESIS
|
13
|
3.53e-01
|
5.34e-01
|
0.16900
|
-0.151000
|
7.48e-02
|
3.45e-01
|
6.40e-01
|
REACTOME LIPID PARTICLE ORGANIZATION
|
6
|
8.37e-01
|
8.98e-01
|
0.16900
|
-0.100000
|
-1.36e-01
|
6.71e-01
|
5.65e-01
|
REACTOME CYTOPROTECTION BY HMOX1
|
59
|
6.68e-03
|
3.86e-02
|
0.16800
|
0.129000
|
-1.08e-01
|
8.73e-02
|
1.50e-01
|
REACTOME SEPARATION OF SISTER CHROMATIDS
|
178
|
3.23e-07
|
5.45e-06
|
0.16800
|
0.133000
|
-1.02e-01
|
2.11e-03
|
1.85e-02
|
REACTOME INWARDLY RECTIFYING K CHANNELS
|
35
|
3.27e-01
|
5.05e-01
|
0.16800
|
0.146000
|
8.39e-02
|
1.36e-01
|
3.91e-01
|
REACTOME GLOBAL GENOME NUCLEOTIDE EXCISION REPAIR GG NER
|
81
|
4.64e-03
|
2.96e-02
|
0.16800
|
0.165000
|
-2.92e-02
|
1.00e-02
|
6.50e-01
|
REACTOME RESOLUTION OF D LOOP STRUCTURES THROUGH SYNTHESIS DEPENDENT STRAND ANNEALING SDSA
|
25
|
4.63e-01
|
6.25e-01
|
0.16800
|
0.142000
|
8.95e-02
|
2.19e-01
|
4.39e-01
|
REACTOME PECAM1 INTERACTIONS
|
12
|
6.99e-01
|
8.07e-01
|
0.16800
|
0.095100
|
1.38e-01
|
5.68e-01
|
4.08e-01
|
REACTOME BUTYROPHILIN BTN FAMILY INTERACTIONS
|
12
|
6.26e-01
|
7.56e-01
|
0.16700
|
0.158000
|
5.37e-02
|
3.42e-01
|
7.47e-01
|
REACTOME SIGNALING BY PDGF
|
57
|
1.97e-01
|
3.81e-01
|
0.16700
|
0.105000
|
1.30e-01
|
1.69e-01
|
8.93e-02
|
REACTOME P38MAPK EVENTS
|
13
|
3.73e-01
|
5.54e-01
|
0.16700
|
0.155000
|
-6.32e-02
|
3.35e-01
|
6.93e-01
|
REACTOME RHOV GTPASE CYCLE
|
36
|
3.12e-01
|
4.94e-01
|
0.16700
|
0.079000
|
1.47e-01
|
4.12e-01
|
1.27e-01
|
REACTOME ACETYLCHOLINE REGULATES INSULIN SECRETION
|
10
|
4.39e-01
|
6.07e-01
|
0.16700
|
-0.095800
|
1.36e-01
|
6.00e-01
|
4.55e-01
|
REACTOME RETINOID CYCLE DISEASE EVENTS
|
11
|
4.07e-01
|
5.83e-01
|
0.16700
|
-0.138000
|
9.30e-02
|
4.28e-01
|
5.93e-01
|
REACTOME SELECTIVE AUTOPHAGY
|
77
|
5.26e-03
|
3.24e-02
|
0.16600
|
0.162000
|
-3.86e-02
|
1.40e-02
|
5.58e-01
|
REACTOME PROCESSING OF DNA DOUBLE STRAND BREAK ENDS
|
58
|
4.27e-02
|
1.41e-01
|
0.16600
|
0.166000
|
3.53e-03
|
2.84e-02
|
9.63e-01
|
REACTOME TP53 REGULATES TRANSCRIPTION OF DNA REPAIR GENES
|
57
|
1.11e-02
|
5.56e-02
|
0.16600
|
0.146000
|
-7.97e-02
|
5.66e-02
|
2.98e-01
|
REACTOME ESR MEDIATED SIGNALING
|
157
|
7.20e-03
|
4.09e-02
|
0.16600
|
0.145000
|
8.17e-02
|
1.72e-03
|
7.73e-02
|
REACTOME ESTROGEN STIMULATED SIGNALING THROUGH PRKCZ
|
6
|
8.48e-01
|
9.05e-01
|
0.16600
|
0.117000
|
1.18e-01
|
6.20e-01
|
6.18e-01
|
REACTOME INCRETIN SYNTHESIS SECRETION AND INACTIVATION
|
23
|
5.32e-01
|
6.83e-01
|
0.16600
|
0.122000
|
1.12e-01
|
3.11e-01
|
3.51e-01
|
REACTOME ACYL CHAIN REMODELING OF CL
|
5
|
8.32e-01
|
8.96e-01
|
0.16500
|
-0.057700
|
-1.55e-01
|
8.23e-01
|
5.49e-01
|
REACTOME MEIOTIC SYNAPSIS
|
31
|
3.97e-01
|
5.75e-01
|
0.16500
|
0.088200
|
1.39e-01
|
3.95e-01
|
1.79e-01
|
REACTOME REGULATION OF INSULIN SECRETION
|
77
|
1.25e-01
|
2.86e-01
|
0.16500
|
0.116000
|
1.17e-01
|
7.85e-02
|
7.58e-02
|
REACTOME GPER1 SIGNALING
|
45
|
2.82e-01
|
4.76e-01
|
0.16500
|
0.098600
|
1.32e-01
|
2.52e-01
|
1.26e-01
|
REACTOME RND1 GTPASE CYCLE
|
41
|
3.17e-01
|
4.95e-01
|
0.16500
|
0.131000
|
9.91e-02
|
1.45e-01
|
2.72e-01
|
REACTOME NEF MEDIATED DOWNREGULATION OF MHC CLASS I COMPLEX CELL SURFACE EXPRESSION
|
9
|
6.16e-01
|
7.48e-01
|
0.16400
|
0.164000
|
8.81e-04
|
3.94e-01
|
9.96e-01
|
REACTOME NEGATIVE REGULATION OF TCF DEPENDENT SIGNALING BY DVL INTERACTING PROTEINS
|
5
|
7.36e-01
|
8.31e-01
|
0.16400
|
-0.022300
|
1.62e-01
|
9.31e-01
|
5.29e-01
|
REACTOME DOWNREGULATION OF ERBB2 ERBB3 SIGNALING
|
13
|
5.32e-01
|
6.83e-01
|
0.16400
|
0.163000
|
1.66e-02
|
3.08e-01
|
9.17e-01
|
REACTOME EXTENSION OF TELOMERES
|
48
|
1.39e-01
|
3.07e-01
|
0.16300
|
0.159000
|
3.91e-02
|
5.71e-02
|
6.39e-01
|
REACTOME NOTCH3 ACTIVATION AND TRANSMISSION OF SIGNAL TO THE NUCLEUS
|
25
|
1.39e-01
|
3.07e-01
|
0.16300
|
0.134000
|
-9.28e-02
|
2.45e-01
|
4.22e-01
|
REACTOME CONDENSATION OF PROPHASE CHROMOSOMES
|
11
|
4.96e-01
|
6.56e-01
|
0.16300
|
0.160000
|
-3.16e-02
|
3.58e-01
|
8.56e-01
|
REACTOME ERK MAPK TARGETS
|
20
|
2.86e-01
|
4.77e-01
|
0.16300
|
0.161000
|
-2.82e-02
|
2.14e-01
|
8.27e-01
|
REACTOME RAS ACTIVATION UPON CA2 INFLUX THROUGH NMDA RECEPTOR
|
19
|
5.98e-01
|
7.35e-01
|
0.16300
|
0.102000
|
1.27e-01
|
4.39e-01
|
3.39e-01
|
REACTOME CLEC7A DECTIN 1 INDUCES NFAT ACTIVATION
|
11
|
7.07e-01
|
8.12e-01
|
0.16300
|
0.074000
|
1.45e-01
|
6.71e-01
|
4.05e-01
|
REACTOME INTERLEUKIN 2 FAMILY SIGNALING
|
40
|
2.61e-01
|
4.55e-01
|
0.16300
|
-0.065200
|
-1.49e-01
|
4.75e-01
|
1.02e-01
|
REACTOME TRIGLYCERIDE BIOSYNTHESIS
|
12
|
5.03e-01
|
6.60e-01
|
0.16300
|
-0.162000
|
1.27e-02
|
3.31e-01
|
9.39e-01
|
REACTOME RESOLUTION OF D LOOP STRUCTURES
|
31
|
3.61e-01
|
5.42e-01
|
0.16200
|
0.148000
|
6.73e-02
|
1.54e-01
|
5.17e-01
|
REACTOME INTRACELLULAR SIGNALING BY SECOND MESSENGERS
|
297
|
3.79e-05
|
4.05e-04
|
0.16200
|
0.151000
|
5.97e-02
|
7.55e-06
|
7.65e-02
|
REACTOME DISEASES OF SIGNAL TRANSDUCTION BY GROWTH FACTOR RECEPTORS AND SECOND MESSENGERS
|
411
|
6.51e-08
|
1.31e-06
|
0.16200
|
0.158000
|
3.76e-02
|
3.84e-08
|
1.91e-01
|
REACTOME ESTROGEN DEPENDENT GENE EXPRESSION
|
87
|
6.28e-02
|
1.84e-01
|
0.16200
|
0.146000
|
7.04e-02
|
1.87e-02
|
2.56e-01
|
REACTOME UREA CYCLE
|
9
|
6.95e-01
|
8.05e-01
|
0.16100
|
0.036200
|
1.57e-01
|
8.51e-01
|
4.16e-01
|
REACTOME SUPPRESSION OF APOPTOSIS
|
7
|
7.51e-01
|
8.40e-01
|
0.16100
|
0.157000
|
3.41e-02
|
4.72e-01
|
8.76e-01
|
REACTOME SIGNALING BY ERBB2 ECD MUTANTS
|
15
|
4.68e-01
|
6.29e-01
|
0.16100
|
0.160000
|
3.39e-03
|
2.82e-01
|
9.82e-01
|
REACTOME INFLAMMASOMES
|
21
|
2.79e-01
|
4.72e-01
|
0.16100
|
0.028100
|
-1.58e-01
|
8.24e-01
|
2.10e-01
|
REACTOME RHOQ GTPASE CYCLE
|
57
|
4.77e-02
|
1.50e-01
|
0.16000
|
-0.005270
|
1.60e-01
|
9.45e-01
|
3.62e-02
|
REACTOME REGULATION OF HMOX1 EXPRESSION AND ACTIVITY
|
5
|
8.59e-01
|
9.12e-01
|
0.16000
|
0.143000
|
7.32e-02
|
5.81e-01
|
7.77e-01
|
REACTOME EPIGENETIC REGULATION OF GENE EXPRESSION
|
82
|
1.72e-02
|
7.75e-02
|
0.16000
|
0.160000
|
5.94e-03
|
1.22e-02
|
9.26e-01
|
REACTOME MRNA CAPPING
|
28
|
1.14e-01
|
2.70e-01
|
0.16000
|
0.108000
|
-1.18e-01
|
3.23e-01
|
2.79e-01
|
REACTOME DAP12 SIGNALING
|
27
|
1.40e-01
|
3.07e-01
|
0.16000
|
0.142000
|
-7.41e-02
|
2.02e-01
|
5.05e-01
|
REACTOME CHOLESTEROL BIOSYNTHESIS
|
24
|
3.90e-01
|
5.68e-01
|
0.16000
|
0.038900
|
1.55e-01
|
7.41e-01
|
1.88e-01
|
REACTOME CELL CYCLE CHECKPOINTS
|
243
|
1.65e-08
|
4.27e-07
|
0.16000
|
0.137000
|
-8.23e-02
|
2.25e-04
|
2.70e-02
|
REACTOME PROTEIN FOLDING
|
94
|
5.11e-03
|
3.17e-02
|
0.16000
|
0.159000
|
-1.58e-02
|
7.75e-03
|
7.91e-01
|
REACTOME MOLECULES ASSOCIATED WITH ELASTIC FIBRES
|
37
|
2.95e-01
|
4.85e-01
|
0.15900
|
0.060100
|
1.47e-01
|
5.27e-01
|
1.21e-01
|
REACTOME HIV LIFE CYCLE
|
139
|
2.54e-05
|
2.81e-04
|
0.15900
|
0.113000
|
-1.12e-01
|
2.13e-02
|
2.27e-02
|
REACTOME MITOTIC METAPHASE AND ANAPHASE
|
221
|
8.77e-08
|
1.67e-06
|
0.15900
|
0.132000
|
-8.82e-02
|
7.27e-04
|
2.38e-02
|
REACTOME LISTERIA MONOCYTOGENES ENTRY INTO HOST CELLS
|
19
|
4.22e-01
|
5.90e-01
|
0.15900
|
0.158000
|
1.61e-02
|
2.34e-01
|
9.03e-01
|
REACTOME TRANSCRIPTIONAL REGULATION BY E2F6
|
32
|
3.91e-01
|
5.69e-01
|
0.15800
|
0.140000
|
7.42e-02
|
1.71e-01
|
4.68e-01
|
REACTOME GLUCAGON TYPE LIGAND RECEPTORS
|
32
|
4.13e-01
|
5.87e-01
|
0.15800
|
0.135000
|
8.24e-02
|
1.87e-01
|
4.20e-01
|
REACTOME MET ACTIVATES PI3K AKT SIGNALING
|
6
|
7.60e-01
|
8.48e-01
|
0.15800
|
-0.012900
|
-1.57e-01
|
9.56e-01
|
5.05e-01
|
REACTOME NUCLEOTIDE EXCISION REPAIR
|
107
|
1.88e-03
|
1.38e-02
|
0.15800
|
0.155000
|
-2.86e-02
|
5.61e-03
|
6.09e-01
|
REACTOME FORMATION OF FIBRIN CLOT CLOTTING CASCADE
|
37
|
2.78e-01
|
4.71e-01
|
0.15700
|
-0.149000
|
-5.02e-02
|
1.16e-01
|
5.97e-01
|
REACTOME MITOTIC G2 G2 M PHASES
|
190
|
6.05e-06
|
7.50e-05
|
0.15700
|
0.150000
|
-4.59e-02
|
3.47e-04
|
2.75e-01
|
REACTOME SIGNALING BY RETINOIC ACID
|
41
|
1.61e-01
|
3.34e-01
|
0.15700
|
0.156000
|
1.52e-02
|
8.37e-02
|
8.67e-01
|
REACTOME O GLYCOSYLATION OF TSR DOMAIN CONTAINING PROTEINS
|
37
|
3.86e-01
|
5.66e-01
|
0.15700
|
0.091300
|
1.27e-01
|
3.37e-01
|
1.81e-01
|
REACTOME SIGNALING BY ALK
|
26
|
3.01e-01
|
4.90e-01
|
0.15600
|
0.156000
|
9.15e-03
|
1.68e-01
|
9.36e-01
|
REACTOME RUNX2 REGULATES OSTEOBLAST DIFFERENTIATION
|
22
|
4.43e-01
|
6.10e-01
|
0.15600
|
0.151000
|
3.92e-02
|
2.19e-01
|
7.50e-01
|
REACTOME ABORTIVE ELONGATION OF HIV 1 TRANSCRIPT IN THE ABSENCE OF TAT
|
23
|
1.92e-01
|
3.74e-01
|
0.15600
|
0.086300
|
-1.30e-01
|
4.74e-01
|
2.80e-01
|
REACTOME AZATHIOPRINE ADME
|
22
|
3.36e-01
|
5.17e-01
|
0.15600
|
0.002460
|
-1.56e-01
|
9.84e-01
|
2.06e-01
|
REACTOME REGULATION OF HSF1 MEDIATED HEAT SHOCK RESPONSE
|
78
|
4.27e-03
|
2.78e-02
|
0.15600
|
0.134000
|
-7.88e-02
|
4.03e-02
|
2.29e-01
|
REACTOME UBIQUINOL BIOSYNTHESIS
|
8
|
7.38e-01
|
8.32e-01
|
0.15500
|
0.151000
|
3.42e-02
|
4.58e-01
|
8.67e-01
|
REACTOME SYNAPTIC ADHESION LIKE MOLECULES
|
19
|
6.00e-01
|
7.35e-01
|
0.15500
|
0.133000
|
7.94e-02
|
3.15e-01
|
5.49e-01
|
REACTOME HYALURONAN UPTAKE AND DEGRADATION
|
12
|
7.12e-01
|
8.16e-01
|
0.15500
|
-0.071700
|
-1.37e-01
|
6.67e-01
|
4.10e-01
|
REACTOME RHO GTPASES ACTIVATE IQGAPS
|
31
|
4.20e-01
|
5.90e-01
|
0.15500
|
0.137000
|
7.29e-02
|
1.88e-01
|
4.82e-01
|
REACTOME LEISHMANIA INFECTION
|
156
|
2.21e-02
|
9.18e-02
|
0.15500
|
0.122000
|
9.55e-02
|
8.60e-03
|
3.95e-02
|
REACTOME TP53 REGULATES METABOLIC GENES
|
81
|
1.47e-02
|
6.81e-02
|
0.15500
|
0.154000
|
-1.32e-02
|
1.64e-02
|
8.38e-01
|
REACTOME DUAL INCISION IN TC NER
|
63
|
2.47e-02
|
9.93e-02
|
0.15500
|
0.151000
|
-3.54e-02
|
3.87e-02
|
6.27e-01
|
REACTOME CONSTITUTIVE SIGNALING BY EGFRVIII
|
15
|
4.35e-01
|
6.03e-01
|
0.15400
|
0.153000
|
-2.42e-02
|
3.06e-01
|
8.71e-01
|
REACTOME NR1H2 AND NR1H3 MEDIATED SIGNALING
|
46
|
6.73e-02
|
1.92e-01
|
0.15400
|
-0.035900
|
1.50e-01
|
6.74e-01
|
7.82e-02
|
REACTOME RHOBTB2 GTPASE CYCLE
|
22
|
2.35e-01
|
4.27e-01
|
0.15400
|
0.141000
|
-6.35e-02
|
2.54e-01
|
6.06e-01
|
REACTOME ZINC INFLUX INTO CELLS BY THE SLC39 GENE FAMILY
|
10
|
6.91e-01
|
8.04e-01
|
0.15400
|
0.035700
|
1.50e-01
|
8.45e-01
|
4.11e-01
|
REACTOME DEFECTS OF CONTACT ACTIVATION SYSTEM CAS AND KALLIKREIN KININ SYSTEM KKS
|
14
|
4.64e-01
|
6.26e-01
|
0.15400
|
-0.152000
|
2.30e-02
|
3.24e-01
|
8.82e-01
|
REACTOME DEFECTS IN COBALAMIN B12 METABOLISM
|
12
|
7.35e-01
|
8.31e-01
|
0.15400
|
0.129000
|
8.34e-02
|
4.38e-01
|
6.17e-01
|
REACTOME ION TRANSPORT BY P TYPE ATPASES
|
51
|
4.73e-02
|
1.50e-01
|
0.15400
|
-0.148000
|
4.15e-02
|
6.74e-02
|
6.08e-01
|
REACTOME SIGNALING BY FGFR2 IIIA TM
|
19
|
2.69e-01
|
4.63e-01
|
0.15300
|
0.084300
|
-1.28e-01
|
5.24e-01
|
3.34e-01
|
REACTOME INTERLEUKIN 4 AND INTERLEUKIN 13 SIGNALING
|
103
|
2.11e-03
|
1.51e-02
|
0.15300
|
0.147000
|
-4.31e-02
|
9.91e-03
|
4.49e-01
|
REACTOME PARASITE INFECTION
|
57
|
1.06e-01
|
2.58e-01
|
0.15300
|
0.151000
|
2.44e-02
|
4.90e-02
|
7.50e-01
|
REACTOME NUCLEAR IMPORT OF REV PROTEIN
|
32
|
1.76e-01
|
3.55e-01
|
0.15300
|
0.024700
|
-1.51e-01
|
8.09e-01
|
1.40e-01
|
REACTOME METABOLISM OF NITRIC OXIDE NOS3 ACTIVATION AND REGULATION
|
15
|
6.31e-01
|
7.60e-01
|
0.15200
|
0.142000
|
5.55e-02
|
3.41e-01
|
7.10e-01
|
REACTOME PURINE SALVAGE
|
12
|
5.43e-01
|
6.92e-01
|
0.15200
|
0.151000
|
-1.45e-02
|
3.64e-01
|
9.31e-01
|
REACTOME EXPORT OF VIRAL RIBONUCLEOPROTEINS FROM NUCLEUS
|
31
|
1.49e-01
|
3.21e-01
|
0.15200
|
0.051800
|
-1.43e-01
|
6.18e-01
|
1.69e-01
|
REACTOME ACTIVATION OF THE AP 1 FAMILY OF TRANSCRIPTION FACTORS
|
10
|
5.09e-01
|
6.66e-01
|
0.15100
|
0.127000
|
-8.33e-02
|
4.88e-01
|
6.48e-01
|
REACTOME SIGNALING BY ERBB2
|
49
|
1.89e-01
|
3.70e-01
|
0.15100
|
0.146000
|
4.07e-02
|
7.72e-02
|
6.22e-01
|
REACTOME SCAVENGING BY CLASS B RECEPTORS
|
6
|
7.16e-01
|
8.19e-01
|
0.15100
|
-0.148000
|
3.19e-02
|
5.30e-01
|
8.92e-01
|
REACTOME INTERLEUKIN 27 SIGNALING
|
11
|
7.57e-01
|
8.45e-01
|
0.15100
|
0.129000
|
7.84e-02
|
4.58e-01
|
6.52e-01
|
REACTOME ARACHIDONATE PRODUCTION FROM DAG
|
5
|
7.20e-01
|
8.21e-01
|
0.15100
|
-0.074300
|
1.31e-01
|
7.74e-01
|
6.11e-01
|
REACTOME NUCLEOTIDE CATABOLISM
|
35
|
4.25e-01
|
5.92e-01
|
0.15100
|
0.126000
|
8.27e-02
|
1.98e-01
|
3.97e-01
|
REACTOME N GLYCAN ANTENNAE ELONGATION IN THE MEDIAL TRANS GOLGI
|
26
|
4.66e-01
|
6.27e-01
|
0.15100
|
0.057200
|
1.39e-01
|
6.14e-01
|
2.19e-01
|
REACTOME TRANSCRIPTION COUPLED NUCLEOTIDE EXCISION REPAIR TC NER
|
76
|
1.51e-02
|
6.87e-02
|
0.15000
|
0.146000
|
-3.40e-02
|
2.76e-02
|
6.08e-01
|
REACTOME MATURATION OF SARS COV 2 NUCLEOPROTEIN
|
15
|
4.51e-01
|
6.16e-01
|
0.15000
|
0.148000
|
-2.65e-02
|
3.22e-01
|
8.59e-01
|
REACTOME RHO GTPASES ACTIVATE WASPS AND WAVES
|
34
|
1.50e-01
|
3.21e-01
|
0.15000
|
0.145000
|
-3.73e-02
|
1.44e-01
|
7.07e-01
|
REACTOME TERMINATION OF O GLYCAN BIOSYNTHESIS
|
23
|
4.47e-01
|
6.14e-01
|
0.14900
|
-0.146000
|
-3.33e-02
|
2.27e-01
|
7.82e-01
|
REACTOME CONVERSION FROM APC C CDC20 TO APC C CDH1 IN LATE ANAPHASE
|
20
|
3.39e-01
|
5.19e-01
|
0.14900
|
0.146000
|
-3.17e-02
|
2.59e-01
|
8.06e-01
|
REACTOME SIGNALLING TO ERKS
|
34
|
3.78e-01
|
5.58e-01
|
0.14900
|
0.137000
|
5.73e-02
|
1.65e-01
|
5.63e-01
|
REACTOME PROTEIN REPAIR
|
6
|
8.47e-01
|
9.05e-01
|
0.14900
|
-0.061100
|
-1.36e-01
|
7.96e-01
|
5.65e-01
|
REACTOME SUMOYLATION OF CHROMATIN ORGANIZATION PROTEINS
|
54
|
3.05e-01
|
4.92e-01
|
0.14900
|
0.105000
|
1.05e-01
|
1.81e-01
|
1.82e-01
|
REACTOME POLB DEPENDENT LONG PATCH BASE EXCISION REPAIR
|
7
|
7.76e-01
|
8.60e-01
|
0.14900
|
0.146000
|
2.75e-02
|
5.03e-01
|
9.00e-01
|
REACTOME REGULATION OF NF KAPPA B SIGNALING
|
17
|
3.71e-01
|
5.51e-01
|
0.14800
|
0.140000
|
-4.97e-02
|
3.18e-01
|
7.23e-01
|
REACTOME DETOXIFICATION OF REACTIVE OXYGEN SPECIES
|
34
|
1.07e-01
|
2.59e-01
|
0.14800
|
0.115000
|
-9.30e-02
|
2.45e-01
|
3.48e-01
|
REACTOME FORMYL PEPTIDE RECEPTORS BIND FORMYL PEPTIDES AND MANY OTHER LIGANDS
|
8
|
8.33e-01
|
8.96e-01
|
0.14800
|
-0.120000
|
-8.64e-02
|
5.58e-01
|
6.72e-01
|
REACTOME PHASE 2 PLATEAU PHASE
|
14
|
4.04e-01
|
5.81e-01
|
0.14700
|
-0.087300
|
1.19e-01
|
5.72e-01
|
4.41e-01
|
REACTOME MISMATCH REPAIR
|
15
|
7.17e-01
|
8.19e-01
|
0.14700
|
0.092200
|
1.15e-01
|
5.36e-01
|
4.40e-01
|
REACTOME GAP JUNCTION ASSEMBLY
|
36
|
4.07e-01
|
5.83e-01
|
0.14700
|
0.071600
|
1.29e-01
|
4.57e-01
|
1.81e-01
|
REACTOME G2 M DNA DAMAGE CHECKPOINT
|
55
|
7.02e-02
|
1.99e-01
|
0.14700
|
0.146000
|
-1.61e-02
|
6.03e-02
|
8.37e-01
|
REACTOME NR1H3 NR1H2 REGULATE GENE EXPRESSION LINKED TO CHOLESTEROL TRANSPORT AND EFFLUX
|
36
|
1.70e-01
|
3.49e-01
|
0.14700
|
-0.019100
|
1.46e-01
|
8.42e-01
|
1.30e-01
|
REACTOME INTERLEUKIN 1 FAMILY SIGNALING
|
145
|
1.01e-04
|
1.01e-03
|
0.14700
|
0.081700
|
-1.22e-01
|
8.92e-02
|
1.10e-02
|
REACTOME MAPK TARGETS NUCLEAR EVENTS MEDIATED BY MAP KINASES
|
29
|
1.81e-01
|
3.61e-01
|
0.14700
|
0.136000
|
-5.66e-02
|
2.06e-01
|
5.98e-01
|
REACTOME TRANSPORT OF MATURE TRANSCRIPT TO CYTOPLASM
|
75
|
7.88e-03
|
4.38e-02
|
0.14600
|
0.105000
|
-1.02e-01
|
1.15e-01
|
1.28e-01
|
REACTOME CREB1 PHOSPHORYLATION THROUGH NMDA RECEPTOR MEDIATED ACTIVATION OF RAS SIGNALING
|
25
|
5.19e-01
|
6.74e-01
|
0.14600
|
0.062200
|
1.32e-01
|
5.90e-01
|
2.52e-01
|
REACTOME INTERACTIONS OF REV WITH HOST CELLULAR PROTEINS
|
35
|
1.86e-01
|
3.68e-01
|
0.14600
|
0.017800
|
-1.45e-01
|
8.56e-01
|
1.37e-01
|
REACTOME VXPX CARGO TARGETING TO CILIUM
|
20
|
2.77e-01
|
4.70e-01
|
0.14600
|
-0.101000
|
1.06e-01
|
4.36e-01
|
4.13e-01
|
REACTOME HOMOLOGY DIRECTED REPAIR
|
96
|
2.57e-02
|
1.02e-01
|
0.14600
|
0.145000
|
1.51e-02
|
1.41e-02
|
7.98e-01
|
REACTOME KERATAN SULFATE BIOSYNTHESIS
|
28
|
3.17e-01
|
4.96e-01
|
0.14600
|
0.005400
|
1.46e-01
|
9.61e-01
|
1.83e-01
|
REACTOME CYTOCHROME P450 ARRANGED BY SUBSTRATE TYPE
|
62
|
2.70e-01
|
4.64e-01
|
0.14500
|
-0.107000
|
-9.90e-02
|
1.47e-01
|
1.78e-01
|
REACTOME PRE NOTCH PROCESSING IN GOLGI
|
18
|
6.41e-01
|
7.67e-01
|
0.14500
|
0.068200
|
1.28e-01
|
6.17e-01
|
3.46e-01
|
REACTOME SYNTHESIS OF VERY LONG CHAIN FATTY ACYL COAS
|
23
|
5.79e-01
|
7.19e-01
|
0.14500
|
0.073500
|
1.25e-01
|
5.42e-01
|
2.98e-01
|
REACTOME DISEASES OF CARBOHYDRATE METABOLISM
|
30
|
3.79e-01
|
5.59e-01
|
0.14500
|
0.141000
|
3.50e-02
|
1.82e-01
|
7.40e-01
|
REACTOME PRE NOTCH EXPRESSION AND PROCESSING
|
59
|
1.06e-01
|
2.58e-01
|
0.14500
|
0.014000
|
1.44e-01
|
8.53e-01
|
5.54e-02
|
REACTOME CREB PHOSPHORYLATION
|
6
|
8.81e-01
|
9.26e-01
|
0.14400
|
-0.111000
|
-9.28e-02
|
6.39e-01
|
6.94e-01
|
REACTOME INTERLEUKIN 3 INTERLEUKIN 5 AND GM CSF SIGNALING
|
45
|
6.71e-02
|
1.92e-01
|
0.14400
|
0.073000
|
-1.24e-01
|
3.97e-01
|
1.49e-01
|
REACTOME TRNA AMINOACYLATION
|
24
|
3.19e-01
|
4.97e-01
|
0.14400
|
0.020800
|
-1.43e-01
|
8.60e-01
|
2.27e-01
|
REACTOME SIGNALING BY MAPK MUTANTS
|
6
|
7.32e-01
|
8.28e-01
|
0.14400
|
0.139000
|
-3.70e-02
|
5.55e-01
|
8.75e-01
|
REACTOME INTERACTIONS OF VPR WITH HOST CELLULAR PROTEINS
|
33
|
1.96e-01
|
3.79e-01
|
0.14400
|
0.027300
|
-1.41e-01
|
7.86e-01
|
1.60e-01
|
REACTOME TOLL LIKE RECEPTOR 9 TLR9 CASCADE
|
100
|
1.41e-02
|
6.61e-02
|
0.14400
|
0.144000
|
-3.95e-03
|
1.29e-02
|
9.46e-01
|
REACTOME SARS COV 1 TARGETS HOST INTRACELLULAR SIGNALLING AND REGULATORY PATHWAYS
|
16
|
3.77e-01
|
5.57e-01
|
0.14400
|
0.119000
|
-8.08e-02
|
4.10e-01
|
5.76e-01
|
REACTOME RHOB GTPASE CYCLE
|
65
|
5.55e-02
|
1.69e-01
|
0.14400
|
-0.011000
|
1.43e-01
|
8.78e-01
|
4.60e-02
|
REACTOME COSTIMULATION BY THE CD28 FAMILY
|
64
|
1.85e-01
|
3.68e-01
|
0.14300
|
0.132000
|
5.57e-02
|
6.76e-02
|
4.41e-01
|
REACTOME MEIOSIS
|
55
|
2.86e-01
|
4.77e-01
|
0.14300
|
0.123000
|
7.44e-02
|
1.16e-01
|
3.40e-01
|
REACTOME TRANSPORT OF RCBL WITHIN THE BODY
|
8
|
7.37e-01
|
8.32e-01
|
0.14300
|
0.010900
|
1.43e-01
|
9.57e-01
|
4.84e-01
|
REACTOME DEFECTS IN VITAMIN AND COFACTOR METABOLISM
|
20
|
6.58e-01
|
7.79e-01
|
0.14300
|
0.111000
|
8.99e-02
|
3.88e-01
|
4.86e-01
|
REACTOME EPHRIN SIGNALING
|
17
|
6.02e-01
|
7.37e-01
|
0.14300
|
0.137000
|
4.05e-02
|
3.27e-01
|
7.73e-01
|
REACTOME RUNX1 REGULATES TRANSCRIPTION OF GENES INVOLVED IN INTERLEUKIN SIGNALING
|
5
|
8.94e-01
|
9.31e-01
|
0.14300
|
0.121000
|
7.57e-02
|
6.39e-01
|
7.69e-01
|
REACTOME TELOMERE MAINTENANCE
|
61
|
7.37e-02
|
2.05e-01
|
0.14300
|
0.143000
|
-6.71e-03
|
5.42e-02
|
9.28e-01
|
REACTOME POTENTIAL THERAPEUTICS FOR SARS
|
92
|
7.20e-02
|
2.02e-01
|
0.14300
|
0.136000
|
4.44e-02
|
2.46e-02
|
4.62e-01
|
REACTOME FCGAMMA RECEPTOR FCGR DEPENDENT PHAGOCYTOSIS
|
81
|
1.21e-01
|
2.80e-01
|
0.14200
|
0.131000
|
5.43e-02
|
4.11e-02
|
3.98e-01
|
REACTOME LATE SARS COV 2 INFECTION EVENTS
|
67
|
1.16e-01
|
2.71e-01
|
0.14200
|
0.139000
|
2.91e-02
|
4.93e-02
|
6.81e-01
|
REACTOME LATE ENDOSOMAL MICROAUTOPHAGY
|
33
|
2.51e-01
|
4.43e-01
|
0.14200
|
0.141000
|
-5.82e-03
|
1.59e-01
|
9.54e-01
|
REACTOME SIGNALING BY TGF BETA RECEPTOR COMPLEX
|
91
|
3.85e-02
|
1.32e-01
|
0.14200
|
0.141000
|
1.53e-02
|
2.03e-02
|
8.01e-01
|
REACTOME RND2 GTPASE CYCLE
|
40
|
4.50e-01
|
6.16e-01
|
0.14100
|
0.104000
|
9.56e-02
|
2.54e-01
|
2.96e-01
|
REACTOME DNA DAMAGE TELOMERE STRESS INDUCED SENESCENCE
|
27
|
2.33e-01
|
4.25e-01
|
0.14100
|
0.131000
|
-5.26e-02
|
2.38e-01
|
6.36e-01
|
REACTOME CYTOSOLIC IRON SULFUR CLUSTER ASSEMBLY
|
10
|
8.17e-01
|
8.87e-01
|
0.14100
|
0.109000
|
8.94e-02
|
5.51e-01
|
6.24e-01
|
REACTOME MYD88 INDEPENDENT TLR4 CASCADE
|
103
|
4.21e-03
|
2.76e-02
|
0.14100
|
0.132000
|
-5.00e-02
|
2.08e-02
|
3.80e-01
|
REACTOME INTERLEUKIN 1 PROCESSING
|
9
|
7.18e-01
|
8.20e-01
|
0.14100
|
-0.140000
|
-1.12e-02
|
4.65e-01
|
9.54e-01
|
REACTOME TRANSPORT OF THE SLBP DEPENDANT MATURE MRNA
|
34
|
1.49e-01
|
3.20e-01
|
0.14100
|
0.063700
|
-1.26e-01
|
5.20e-01
|
2.05e-01
|
REACTOME TRNA MODIFICATION IN THE NUCLEUS AND CYTOSOL
|
38
|
1.06e-01
|
2.58e-01
|
0.14100
|
0.113000
|
-8.43e-02
|
2.29e-01
|
3.68e-01
|
REACTOME GLYOXYLATE METABOLISM AND GLYCINE DEGRADATION
|
30
|
3.15e-01
|
4.95e-01
|
0.14100
|
-0.004780
|
-1.41e-01
|
9.64e-01
|
1.82e-01
|
REACTOME ACTIVATION OF BH3 ONLY PROTEINS
|
30
|
4.22e-01
|
5.90e-01
|
0.14100
|
0.135000
|
3.99e-02
|
2.01e-01
|
7.05e-01
|
REACTOME EPHB MEDIATED FORWARD SIGNALING
|
41
|
1.31e-01
|
2.96e-01
|
0.14000
|
0.136000
|
-3.63e-02
|
1.33e-01
|
6.88e-01
|
REACTOME TELOMERE C STRAND LAGGING STRAND SYNTHESIS
|
32
|
3.38e-01
|
5.19e-01
|
0.14000
|
0.139000
|
2.04e-02
|
1.74e-01
|
8.42e-01
|
REACTOME SIGNALING BY TGFB FAMILY MEMBERS
|
119
|
2.40e-02
|
9.75e-02
|
0.14000
|
0.137000
|
2.93e-02
|
9.62e-03
|
5.80e-01
|
REACTOME PD 1 SIGNALING
|
21
|
3.95e-01
|
5.73e-01
|
0.14000
|
0.016200
|
-1.39e-01
|
8.97e-01
|
2.68e-01
|
REACTOME TRANSCRIPTIONAL REGULATION OF WHITE ADIPOCYTE DIFFERENTIATION
|
81
|
7.44e-02
|
2.07e-01
|
0.14000
|
0.138000
|
2.63e-02
|
3.21e-02
|
6.82e-01
|
REACTOME MTOR SIGNALLING
|
40
|
4.11e-01
|
5.87e-01
|
0.14000
|
0.121000
|
7.00e-02
|
1.84e-01
|
4.43e-01
|
REACTOME O LINKED GLYCOSYLATION
|
105
|
3.87e-02
|
1.32e-01
|
0.14000
|
0.030200
|
1.37e-01
|
5.93e-01
|
1.54e-02
|
REACTOME ESTROGEN DEPENDENT NUCLEAR EVENTS DOWNSTREAM OF ESR MEMBRANE SIGNALING
|
23
|
5.85e-01
|
7.25e-01
|
0.14000
|
0.125000
|
6.37e-02
|
3.01e-01
|
5.97e-01
|
REACTOME HDR THROUGH MMEJ ALT NHEJ
|
11
|
6.42e-01
|
7.68e-01
|
0.14000
|
0.140000
|
-3.87e-03
|
4.23e-01
|
9.82e-01
|
REACTOME SULFUR AMINO ACID METABOLISM
|
26
|
3.07e-01
|
4.92e-01
|
0.13900
|
0.137000
|
-2.38e-02
|
2.27e-01
|
8.34e-01
|
REACTOME FORMATION OF THE EARLY ELONGATION COMPLEX
|
32
|
1.55e-01
|
3.28e-01
|
0.13900
|
0.099100
|
-9.73e-02
|
3.32e-01
|
3.41e-01
|
REACTOME ACTIVATED NOTCH1 TRANSMITS SIGNAL TO THE NUCLEUS
|
30
|
2.71e-01
|
4.64e-01
|
0.13900
|
0.138000
|
-1.69e-02
|
1.91e-01
|
8.72e-01
|
REACTOME ADHERENS JUNCTIONS INTERACTIONS
|
28
|
5.81e-01
|
7.21e-01
|
0.13900
|
0.106000
|
8.98e-02
|
3.33e-01
|
4.11e-01
|
REACTOME HIGHLY CALCIUM PERMEABLE POSTSYNAPTIC NICOTINIC ACETYLCHOLINE RECEPTORS
|
11
|
6.33e-01
|
7.61e-01
|
0.13900
|
0.138000
|
-1.04e-02
|
4.27e-01
|
9.52e-01
|
REACTOME SIGNALING BY NOTCH
|
180
|
2.44e-03
|
1.72e-02
|
0.13800
|
0.137000
|
1.74e-02
|
1.48e-03
|
6.88e-01
|
REACTOME HSF1 DEPENDENT TRANSACTIVATION
|
37
|
1.23e-01
|
2.82e-01
|
0.13800
|
0.112000
|
-8.11e-02
|
2.39e-01
|
3.93e-01
|
REACTOME RHOBTB GTPASE CYCLE
|
34
|
1.61e-01
|
3.34e-01
|
0.13800
|
0.123000
|
-6.27e-02
|
2.15e-01
|
5.27e-01
|
REACTOME MIRO GTPASE CYCLE
|
8
|
8.35e-01
|
8.97e-01
|
0.13800
|
0.063000
|
1.23e-01
|
7.58e-01
|
5.48e-01
|
REACTOME AUTOPHAGY
|
142
|
9.55e-03
|
4.98e-02
|
0.13800
|
0.137000
|
1.92e-02
|
4.94e-03
|
6.93e-01
|
REACTOME DNA DOUBLE STRAND BREAK REPAIR
|
126
|
1.24e-02
|
6.02e-02
|
0.13800
|
0.137000
|
1.12e-02
|
7.76e-03
|
8.28e-01
|
REACTOME CELLULAR RESPONSE TO HEAT STRESS
|
96
|
4.81e-03
|
3.05e-02
|
0.13800
|
0.115000
|
-7.59e-02
|
5.17e-02
|
1.99e-01
|
REACTOME OPIOID SIGNALLING
|
88
|
1.74e-01
|
3.52e-01
|
0.13800
|
0.112000
|
8.01e-02
|
6.94e-02
|
1.94e-01
|
REACTOME NUCLEOTIDE BINDING DOMAIN LEUCINE RICH REPEAT CONTAINING RECEPTOR NLR SIGNALING PATHWAYS
|
53
|
5.44e-02
|
1.67e-01
|
0.13800
|
0.071100
|
-1.18e-01
|
3.70e-01
|
1.38e-01
|
REACTOME DAP12 INTERACTIONS
|
37
|
1.45e-01
|
3.15e-01
|
0.13800
|
0.055800
|
-1.26e-01
|
5.57e-01
|
1.86e-01
|
REACTOME SYNTHESIS SECRETION AND DEACYLATION OF GHRELIN
|
19
|
4.09e-01
|
5.84e-01
|
0.13700
|
0.133000
|
-3.35e-02
|
3.14e-01
|
8.00e-01
|
REACTOME SIGNALING BY GPCR
|
666
|
6.41e-08
|
1.31e-06
|
0.13700
|
0.047300
|
1.29e-01
|
3.68e-02
|
1.31e-08
|
REACTOME INTERLEUKIN 23 SIGNALING
|
9
|
8.40e-01
|
9.00e-01
|
0.13700
|
0.108000
|
8.43e-02
|
5.74e-01
|
6.61e-01
|
REACTOME NEGATIVE REGULATION OF MET ACTIVITY
|
20
|
3.66e-01
|
5.46e-01
|
0.13700
|
0.129000
|
-4.80e-02
|
3.20e-01
|
7.10e-01
|
REACTOME MAPK FAMILY SIGNALING CASCADES
|
311
|
2.06e-05
|
2.32e-04
|
0.13700
|
0.137000
|
9.79e-03
|
3.27e-05
|
7.66e-01
|
REACTOMEMATURATION OF SARS COV 1 NUCLEOPROTEIN
|
11
|
5.79e-01
|
7.19e-01
|
0.13700
|
0.129000
|
-4.55e-02
|
4.58e-01
|
7.94e-01
|
REACTOME E2F ENABLED INHIBITION OF PRE REPLICATION COMPLEX FORMATION
|
9
|
6.96e-01
|
8.05e-01
|
0.13700
|
-0.137000
|
9.07e-03
|
4.77e-01
|
9.62e-01
|
REACTOME TP53 REGULATES TRANSCRIPTION OF GENES INVOLVED IN CYTOCHROME C RELEASE
|
19
|
3.80e-01
|
5.59e-01
|
0.13700
|
0.127000
|
-5.13e-02
|
3.38e-01
|
6.98e-01
|
REACTOME RHOH GTPASE CYCLE
|
35
|
2.63e-01
|
4.58e-01
|
0.13700
|
0.137000
|
-1.82e-03
|
1.61e-01
|
9.85e-01
|
REACTOME SIGNALING BY ALK IN CANCER
|
51
|
9.37e-02
|
2.38e-01
|
0.13700
|
0.133000
|
-3.29e-02
|
1.01e-01
|
6.85e-01
|
REACTOME G ALPHA Q SIGNALLING EVENTS
|
205
|
1.25e-02
|
6.02e-02
|
0.13700
|
0.066300
|
1.20e-01
|
1.02e-01
|
3.11e-03
|
REACTOME NICOTINATE METABOLISM
|
29
|
5.76e-01
|
7.18e-01
|
0.13700
|
0.106000
|
8.64e-02
|
3.23e-01
|
4.20e-01
|
REACTOME SEMA4D INDUCED CELL MIGRATION AND GROWTH CONE COLLAPSE
|
20
|
6.60e-01
|
7.81e-01
|
0.13700
|
0.070900
|
1.17e-01
|
5.83e-01
|
3.65e-01
|
REACTOME AGGREPHAGY
|
41
|
1.26e-01
|
2.87e-01
|
0.13700
|
0.127000
|
-5.07e-02
|
1.60e-01
|
5.74e-01
|
REACTOME G ALPHA I SIGNALLING EVENTS
|
303
|
1.31e-04
|
1.27e-03
|
0.13700
|
0.028100
|
1.34e-01
|
4.00e-01
|
6.24e-05
|
REACTOME SIGNALING BY INTERLEUKINS
|
432
|
4.08e-11
|
2.09e-09
|
0.13600
|
0.099900
|
-9.30e-02
|
3.61e-04
|
9.06e-04
|
REACTOME INTERLEUKIN 10 SIGNALING
|
43
|
2.84e-01
|
4.77e-01
|
0.13600
|
-0.030000
|
-1.33e-01
|
7.33e-01
|
1.31e-01
|
REACTOME RAB GEFS EXCHANGE GTP FOR GDP ON RABS
|
80
|
8.75e-02
|
2.29e-01
|
0.13600
|
0.025100
|
1.34e-01
|
6.98e-01
|
3.82e-02
|
REACTOME COLLAGEN DEGRADATION
|
61
|
6.26e-02
|
1.84e-01
|
0.13600
|
-0.132000
|
3.21e-02
|
7.51e-02
|
6.65e-01
|
REACTOME HEME SIGNALING
|
46
|
4.13e-01
|
5.87e-01
|
0.13500
|
0.077600
|
1.10e-01
|
3.63e-01
|
1.95e-01
|
REACTOME SODIUM PROTON EXCHANGERS
|
7
|
7.00e-01
|
8.08e-01
|
0.13500
|
-0.057900
|
1.22e-01
|
7.91e-01
|
5.77e-01
|
REACTOME SURFACTANT METABOLISM
|
27
|
5.36e-01
|
6.85e-01
|
0.13500
|
0.124000
|
5.35e-02
|
2.65e-01
|
6.30e-01
|
REACTOME MRNA EDITING
|
10
|
5.95e-01
|
7.33e-01
|
0.13400
|
0.065800
|
-1.17e-01
|
7.18e-01
|
5.21e-01
|
REACTOME STRIATED MUSCLE CONTRACTION
|
35
|
3.89e-01
|
5.67e-01
|
0.13400
|
-0.130000
|
-3.51e-02
|
1.84e-01
|
7.19e-01
|
REACTOME CHROMATIN MODIFYING ENZYMES
|
183
|
3.54e-02
|
1.25e-01
|
0.13400
|
0.104000
|
8.44e-02
|
1.48e-02
|
4.89e-02
|
REACTOME COBALAMIN CBL VITAMIN B12 TRANSPORT AND METABOLISM
|
20
|
5.28e-01
|
6.81e-01
|
0.13400
|
0.015500
|
1.33e-01
|
9.04e-01
|
3.02e-01
|
REACTOME TRANSLOCATION OF SLC2A4 GLUT4 TO THE PLASMA MEMBRANE
|
71
|
2.40e-01
|
4.31e-01
|
0.13400
|
0.115000
|
6.84e-02
|
9.27e-02
|
3.19e-01
|
REACTOME TNFR1 INDUCED NFKAPPAB SIGNALING PATHWAY
|
29
|
2.14e-01
|
4.03e-01
|
0.13400
|
0.077100
|
-1.09e-01
|
4.72e-01
|
3.07e-01
|
REACTOME HDR THROUGH HOMOLOGOUS RECOMBINATION HRR
|
64
|
7.49e-02
|
2.08e-01
|
0.13400
|
0.133000
|
-1.70e-02
|
6.61e-02
|
8.14e-01
|
REACTOME HYALURONAN METABOLISM
|
17
|
7.37e-01
|
8.32e-01
|
0.13400
|
0.090000
|
9.90e-02
|
5.20e-01
|
4.80e-01
|
REACTOME NR1H2 NR1H3 REGULATE GENE EXPRESSION TO LIMIT CHOLESTEROL UPTAKE
|
5
|
8.95e-01
|
9.31e-01
|
0.13400
|
-0.055700
|
-1.22e-01
|
8.29e-01
|
6.38e-01
|
REACTOME SARS COV 2 MODULATES AUTOPHAGY
|
11
|
7.05e-01
|
8.11e-01
|
0.13300
|
-0.015100
|
-1.33e-01
|
9.31e-01
|
4.46e-01
|
REACTOME SYNTHESIS OF IP2 IP AND INS IN THE CYTOSOL
|
13
|
7.82e-01
|
8.66e-01
|
0.13300
|
0.110000
|
7.52e-02
|
4.92e-01
|
6.39e-01
|
REACTOME ACETYLCHOLINE BINDING AND DOWNSTREAM EVENTS
|
14
|
4.93e-01
|
6.52e-01
|
0.13300
|
0.117000
|
-6.28e-02
|
4.47e-01
|
6.84e-01
|
REACTOME INFECTIOUS DISEASE
|
843
|
4.52e-19
|
3.89e-17
|
0.13300
|
0.113000
|
-7.06e-02
|
2.44e-08
|
4.78e-04
|
REACTOME SIGNALING BY NUCLEAR RECEPTORS
|
230
|
8.72e-03
|
4.65e-02
|
0.13300
|
0.118000
|
6.20e-02
|
2.08e-03
|
1.05e-01
|
REACTOME RESPONSE TO ELEVATED PLATELET CYTOSOLIC CA2
|
120
|
1.15e-01
|
2.70e-01
|
0.13300
|
-0.082600
|
-1.04e-01
|
1.18e-01
|
4.83e-02
|
REACTOME INACTIVATION OF CDC42 AND RAC1
|
8
|
7.83e-01
|
8.66e-01
|
0.13300
|
0.018700
|
1.32e-01
|
9.27e-01
|
5.19e-01
|
REACTOME SYNTHESIS OF PYROPHOSPHATES IN THE CYTOSOL
|
7
|
7.45e-01
|
8.37e-01
|
0.13300
|
-0.130000
|
2.52e-02
|
5.50e-01
|
9.08e-01
|
REACTOME HS GAG BIOSYNTHESIS
|
28
|
4.92e-01
|
6.52e-01
|
0.13300
|
0.039200
|
1.27e-01
|
7.19e-01
|
2.46e-01
|
REACTOME SIGNALING BY NOTCH1 HD DOMAIN MUTANTS IN CANCER
|
15
|
4.53e-01
|
6.18e-01
|
0.13300
|
0.103000
|
-8.37e-02
|
4.90e-01
|
5.75e-01
|
REACTOME SYNTHESIS OF UDP N ACETYL GLUCOSAMINE
|
7
|
8.83e-01
|
9.27e-01
|
0.13200
|
0.081100
|
1.04e-01
|
7.10e-01
|
6.35e-01
|
REACTOME AMINO ACID TRANSPORT ACROSS THE PLASMA MEMBRANE
|
30
|
3.03e-01
|
4.90e-01
|
0.13200
|
-0.019200
|
1.30e-01
|
8.55e-01
|
2.17e-01
|
REACTOME VIRAL MESSENGER RNA SYNTHESIS
|
42
|
1.73e-01
|
3.52e-01
|
0.13100
|
0.027600
|
-1.28e-01
|
7.57e-01
|
1.50e-01
|
REACTOME ANTIGEN PROCESSING UBIQUITINATION PROTEASOME DEGRADATION
|
291
|
4.16e-05
|
4.39e-04
|
0.13100
|
0.131000
|
-1.59e-03
|
1.16e-04
|
9.63e-01
|
REACTOME DARPP 32 EVENTS
|
24
|
3.59e-01
|
5.40e-01
|
0.13100
|
0.127000
|
-3.14e-02
|
2.80e-01
|
7.90e-01
|
REACTOME TBC RABGAPS
|
40
|
3.00e-01
|
4.89e-01
|
0.13100
|
0.130000
|
1.67e-02
|
1.54e-01
|
8.55e-01
|
REACTOME REACTIONS SPECIFIC TO THE COMPLEX N GLYCAN SYNTHESIS PATHWAY
|
10
|
6.06e-01
|
7.39e-01
|
0.13100
|
-0.069000
|
1.11e-01
|
7.05e-01
|
5.42e-01
|
REACTOME SHC1 EVENTS IN EGFR SIGNALING
|
14
|
7.19e-01
|
8.20e-01
|
0.13100
|
0.123000
|
4.38e-02
|
4.24e-01
|
7.76e-01
|
REACTOME DEFECTS IN BIOTIN BTN METABOLISM
|
8
|
8.71e-01
|
9.18e-01
|
0.13100
|
0.084800
|
9.96e-02
|
6.78e-01
|
6.26e-01
|
REACTOME MITOCHONDRIAL BIOGENESIS
|
68
|
7.87e-02
|
2.14e-01
|
0.13000
|
0.130000
|
-1.24e-02
|
6.40e-02
|
8.60e-01
|
REACTOME TP53 REGULATES TRANSCRIPTION OF CELL DEATH GENES
|
42
|
3.41e-01
|
5.21e-01
|
0.13000
|
0.126000
|
3.31e-02
|
1.57e-01
|
7.10e-01
|
REACTOME TP53 REGULATES TRANSCRIPTION OF GENES INVOLVED IN G2 CELL CYCLE ARREST
|
18
|
4.04e-01
|
5.81e-01
|
0.13000
|
0.076000
|
-1.06e-01
|
5.77e-01
|
4.38e-01
|
REACTOME COLLAGEN FORMATION
|
88
|
2.13e-02
|
8.99e-02
|
0.13000
|
-0.123000
|
3.99e-02
|
4.52e-02
|
5.17e-01
|
REACTOME KETONE BODY METABOLISM
|
9
|
6.85e-01
|
7.98e-01
|
0.13000
|
-0.032600
|
1.26e-01
|
8.66e-01
|
5.14e-01
|
REACTOME SENSORY PROCESSING OF SOUND BY OUTER HAIR CELLS OF THE COCHLEA
|
49
|
4.05e-01
|
5.82e-01
|
0.13000
|
-0.110000
|
-6.87e-02
|
1.83e-01
|
4.05e-01
|
REACTOME MUSCARINIC ACETYLCHOLINE RECEPTORS
|
5
|
8.29e-01
|
8.94e-01
|
0.12900
|
-0.128000
|
1.54e-02
|
6.19e-01
|
9.52e-01
|
REACTOME INTERLEUKIN 17 SIGNALING
|
66
|
8.72e-02
|
2.29e-01
|
0.12900
|
0.128000
|
-1.37e-02
|
7.13e-02
|
8.48e-01
|
REACTOME PROCESSIVE SYNTHESIS ON THE C STRAND OF THE TELOMERE
|
19
|
5.95e-01
|
7.33e-01
|
0.12900
|
0.127000
|
2.32e-02
|
3.39e-01
|
8.61e-01
|
REACTOME SYNTHESIS OF IP3 AND IP4 IN THE CYTOSOL
|
25
|
4.23e-01
|
5.91e-01
|
0.12900
|
-0.129000
|
4.43e-03
|
2.66e-01
|
9.69e-01
|
REACTOME ASPARTATE AND ASPARAGINE METABOLISM
|
11
|
6.00e-01
|
7.35e-01
|
0.12800
|
0.115000
|
-5.71e-02
|
5.09e-01
|
7.43e-01
|
REACTOME KERATAN SULFATE KERATIN METABOLISM
|
34
|
4.54e-01
|
6.18e-01
|
0.12800
|
0.039800
|
1.22e-01
|
6.88e-01
|
2.18e-01
|
REACTOME HDR THROUGH SINGLE STRAND ANNEALING SSA
|
36
|
2.29e-01
|
4.20e-01
|
0.12800
|
0.124000
|
-3.15e-02
|
1.97e-01
|
7.44e-01
|
REACTOME MAP2K AND MAPK ACTIVATION
|
38
|
4.16e-01
|
5.89e-01
|
0.12800
|
-0.039900
|
-1.22e-01
|
6.70e-01
|
1.94e-01
|
REACTOME RIBAVIRIN ADME
|
11
|
7.85e-01
|
8.67e-01
|
0.12800
|
0.120000
|
4.49e-02
|
4.92e-01
|
7.97e-01
|
REACTOME C TYPE LECTIN RECEPTORS CLRS
|
135
|
1.37e-03
|
1.04e-02
|
0.12800
|
0.098700
|
-8.13e-02
|
4.77e-02
|
1.03e-01
|
REACTOME SUMOYLATION OF DNA DAMAGE RESPONSE AND REPAIR PROTEINS
|
71
|
3.13e-01
|
4.94e-01
|
0.12800
|
0.096100
|
8.41e-02
|
1.61e-01
|
2.20e-01
|
REACTOME NOD1 2 SIGNALING PATHWAY
|
33
|
2.01e-01
|
3.86e-01
|
0.12800
|
0.077900
|
-1.01e-01
|
4.39e-01
|
3.15e-01
|
REACTOME ARACHIDONIC ACID METABOLISM
|
56
|
3.00e-01
|
4.89e-01
|
0.12700
|
-0.045800
|
-1.19e-01
|
5.54e-01
|
1.24e-01
|
REACTOME FORMATION OF SENESCENCE ASSOCIATED HETEROCHROMATIN FOCI SAHF
|
11
|
8.37e-01
|
8.98e-01
|
0.12700
|
0.088200
|
9.16e-02
|
6.12e-01
|
5.99e-01
|
REACTOME METABOLISM OF WATER SOLUBLE VITAMINS AND COFACTORS
|
118
|
1.03e-01
|
2.53e-01
|
0.12700
|
0.114000
|
5.72e-02
|
3.31e-02
|
2.83e-01
|
REACTOME DISEASES OF MISMATCH REPAIR MMR
|
5
|
9.20e-01
|
9.50e-01
|
0.12700
|
0.077700
|
1.01e-01
|
7.64e-01
|
6.97e-01
|
REACTOME STIMULI SENSING CHANNELS
|
100
|
2.32e-02
|
9.54e-02
|
0.12700
|
-0.125000
|
2.14e-02
|
3.06e-02
|
7.12e-01
|
REACTOME RECOGNITION AND ASSOCIATION OF DNA GLYCOSYLASE WITH SITE CONTAINING AN AFFECTED PURINE
|
10
|
6.32e-01
|
7.60e-01
|
0.12700
|
0.112000
|
-5.98e-02
|
5.40e-01
|
7.43e-01
|
REACTOME HOMOLOGOUS DNA PAIRING AND STRAND EXCHANGE
|
41
|
2.95e-01
|
4.85e-01
|
0.12700
|
0.126000
|
9.45e-03
|
1.62e-01
|
9.17e-01
|
REACTOME RHOBTB1 GTPASE CYCLE
|
22
|
3.95e-01
|
5.73e-01
|
0.12700
|
0.120000
|
-4.15e-02
|
3.32e-01
|
7.36e-01
|
REACTOME AMYLOID FIBER FORMATION
|
50
|
9.07e-02
|
2.34e-01
|
0.12600
|
0.081600
|
-9.66e-02
|
3.18e-01
|
2.37e-01
|
REACTOME PLATELET SENSITIZATION BY LDL
|
17
|
4.40e-01
|
6.07e-01
|
0.12600
|
0.088600
|
-9.02e-02
|
5.27e-01
|
5.20e-01
|
REACTOME SIGNALING BY CSF1 M CSF IN MYELOID CELLS
|
30
|
2.85e-01
|
4.77e-01
|
0.12600
|
0.120000
|
-4.03e-02
|
2.56e-01
|
7.02e-01
|
REACTOME PROLACTIN RECEPTOR SIGNALING
|
15
|
7.64e-01
|
8.51e-01
|
0.12600
|
-0.063700
|
-1.09e-01
|
6.69e-01
|
4.65e-01
|
REACTOME NRAGE SIGNALS DEATH THROUGH JNK
|
53
|
1.67e-01
|
3.45e-01
|
0.12600
|
-0.126000
|
6.93e-03
|
1.12e-01
|
9.30e-01
|
REACTOME DISEASES OF DNA REPAIR
|
49
|
2.27e-01
|
4.18e-01
|
0.12500
|
0.125000
|
4.87e-03
|
1.30e-01
|
9.53e-01
|
REACTOME INTERLEUKIN 15 SIGNALING
|
13
|
6.95e-01
|
8.05e-01
|
0.12500
|
0.124000
|
1.30e-02
|
4.39e-01
|
9.35e-01
|
REACTOME FOXO MEDIATED TRANSCRIPTION
|
64
|
1.35e-01
|
3.02e-01
|
0.12500
|
0.125000
|
-5.58e-04
|
8.49e-02
|
9.94e-01
|
REACTOME MITOCHONDRIAL CALCIUM ION TRANSPORT
|
20
|
7.28e-01
|
8.26e-01
|
0.12400
|
0.098100
|
7.66e-02
|
4.48e-01
|
5.53e-01
|
REACTOME A TETRASACCHARIDE LINKER SEQUENCE IS REQUIRED FOR GAG SYNTHESIS
|
23
|
6.83e-01
|
7.98e-01
|
0.12400
|
0.069900
|
1.03e-01
|
5.62e-01
|
3.92e-01
|
REACTOME RHO GTPASES ACTIVATE CIT
|
19
|
5.68e-01
|
7.12e-01
|
0.12400
|
0.124000
|
5.24e-03
|
3.48e-01
|
9.68e-01
|
REACTOME POLYMERASE SWITCHING
|
13
|
6.46e-01
|
7.72e-01
|
0.12400
|
0.010400
|
-1.24e-01
|
9.48e-01
|
4.39e-01
|
REACTOME TNF SIGNALING
|
53
|
8.55e-02
|
2.26e-01
|
0.12400
|
0.083700
|
-9.16e-02
|
2.92e-01
|
2.49e-01
|
REACTOME NERVOUS SYSTEM DEVELOPMENT
|
547
|
1.40e-10
|
6.31e-09
|
0.12400
|
0.113000
|
-5.02e-02
|
5.66e-06
|
4.44e-02
|
REACTOME SIGNALING BY NOTCH1 T 7 9 NOTCH1 M1580 K2555 TRANSLOCATION MUTANT
|
7
|
8.83e-01
|
9.27e-01
|
0.12400
|
0.109000
|
5.90e-02
|
6.18e-01
|
7.87e-01
|
REACTOME PIWI INTERACTING RNA PIRNA BIOGENESIS
|
29
|
6.38e-01
|
7.64e-01
|
0.12400
|
-0.095100
|
-7.93e-02
|
3.76e-01
|
4.60e-01
|
REACTOME CASPASE ACTIVATION VIA DEPENDENCE RECEPTORS IN THE ABSENCE OF LIGAND
|
9
|
8.15e-01
|
8.86e-01
|
0.12400
|
0.119000
|
3.32e-02
|
5.36e-01
|
8.63e-01
|
REACTOME RHO GTPASES ACTIVATE ROCKS
|
19
|
7.46e-01
|
8.37e-01
|
0.12300
|
0.095400
|
7.80e-02
|
4.71e-01
|
5.56e-01
|
REACTOME TOLL LIKE RECEPTOR CASCADES
|
157
|
4.89e-03
|
3.07e-02
|
0.12300
|
0.122000
|
-1.45e-02
|
8.14e-03
|
7.54e-01
|
REACTOME NS1 MEDIATED EFFECTS ON HOST PATHWAYS
|
39
|
2.38e-01
|
4.29e-01
|
0.12300
|
0.026700
|
-1.20e-01
|
7.73e-01
|
1.95e-01
|
REACTOME GLYCOGEN BREAKDOWN GLYCOGENOLYSIS
|
11
|
6.79e-01
|
7.96e-01
|
0.12300
|
-0.121000
|
1.96e-02
|
4.86e-01
|
9.11e-01
|
REACTOME GAMMA CARBOXYLATION HYPUSINE FORMATION AND ARYLSULFATASE ACTIVATION
|
34
|
5.99e-01
|
7.35e-01
|
0.12300
|
0.085700
|
8.81e-02
|
3.87e-01
|
3.74e-01
|
REACTOME NETRIN 1 SIGNALING
|
48
|
4.15e-01
|
5.88e-01
|
0.12300
|
0.111000
|
5.31e-02
|
1.85e-01
|
5.25e-01
|
REACTOME INDUCTION OF CELL CELL FUSION
|
12
|
6.16e-01
|
7.48e-01
|
0.12200
|
-0.044000
|
1.14e-01
|
7.92e-01
|
4.93e-01
|
REACTOME SIGNALLING TO P38 VIA RIT AND RIN
|
5
|
8.54e-01
|
9.09e-01
|
0.12200
|
0.122000
|
-6.09e-03
|
6.36e-01
|
9.81e-01
|
REACTOME PEPTIDE LIGAND BINDING RECEPTORS
|
188
|
3.81e-02
|
1.31e-01
|
0.12200
|
0.057200
|
1.08e-01
|
1.76e-01
|
1.06e-02
|
REACTOME DNA REPAIR
|
270
|
5.44e-04
|
4.64e-03
|
0.12200
|
0.122000
|
7.63e-03
|
5.56e-04
|
8.29e-01
|
REACTOME SENSORY PROCESSING OF SOUND
|
69
|
3.59e-01
|
5.40e-01
|
0.12200
|
-0.088300
|
-8.44e-02
|
2.04e-01
|
2.26e-01
|
REACTOME TGF BETA RECEPTOR SIGNALING ACTIVATES SMADS
|
46
|
1.91e-01
|
3.73e-01
|
0.12200
|
0.119000
|
-2.53e-02
|
1.61e-01
|
7.66e-01
|
REACTOME ASSEMBLY OF COLLAGEN FIBRILS AND OTHER MULTIMERIC STRUCTURES
|
59
|
7.28e-02
|
2.03e-01
|
0.12200
|
-0.074600
|
9.65e-02
|
3.21e-01
|
2.00e-01
|
REACTOME PI METABOLISM
|
78
|
2.62e-01
|
4.55e-01
|
0.12200
|
0.058000
|
1.07e-01
|
3.76e-01
|
1.02e-01
|
REACTOME CHROMOSOME MAINTENANCE
|
83
|
4.95e-02
|
1.54e-01
|
0.12200
|
0.119000
|
-2.70e-02
|
6.14e-02
|
6.70e-01
|
REACTOME SIGNALING BY MRAS COMPLEX MUTANTS
|
7
|
8.95e-01
|
9.31e-01
|
0.12100
|
0.067500
|
1.01e-01
|
7.57e-01
|
6.44e-01
|
REACTOME DNA STRAND ELONGATION
|
31
|
5.43e-01
|
6.92e-01
|
0.12100
|
0.113000
|
4.23e-02
|
2.75e-01
|
6.84e-01
|
REACTOME GLUTATHIONE CONJUGATION
|
33
|
3.60e-01
|
5.42e-01
|
0.12100
|
0.006460
|
-1.21e-01
|
9.49e-01
|
2.30e-01
|
REACTOME CELL CYCLE MITOTIC
|
473
|
4.24e-08
|
9.25e-07
|
0.12100
|
0.117000
|
-3.03e-02
|
1.26e-05
|
2.58e-01
|
REACTOME PYRIMIDINE CATABOLISM
|
12
|
8.39e-01
|
8.99e-01
|
0.12000
|
0.078100
|
9.16e-02
|
6.40e-01
|
5.83e-01
|
REACTOME PENTOSE PHOSPHATE PATHWAY
|
12
|
7.03e-01
|
8.10e-01
|
0.12000
|
0.120000
|
-1.63e-03
|
4.72e-01
|
9.92e-01
|
REACTOME METABOLISM OF STEROIDS
|
147
|
1.06e-01
|
2.58e-01
|
0.12000
|
-0.099200
|
-6.74e-02
|
3.78e-02
|
1.58e-01
|
REACTOME SMOOTH MUSCLE CONTRACTION
|
40
|
5.39e-01
|
6.88e-01
|
0.12000
|
-0.066400
|
-9.99e-02
|
4.67e-01
|
2.74e-01
|
REACTOME SEMAPHORIN INTERACTIONS
|
61
|
3.75e-01
|
5.55e-01
|
0.12000
|
0.103000
|
6.11e-02
|
1.64e-01
|
4.09e-01
|
REACTOME TRANSPORT OF VITAMINS NUCLEOSIDES AND RELATED MOLECULES
|
38
|
5.35e-01
|
6.85e-01
|
0.11900
|
-0.105000
|
-5.73e-02
|
2.64e-01
|
5.41e-01
|
REACTOME METABOLISM OF AMINE DERIVED HORMONES
|
17
|
6.05e-01
|
7.39e-01
|
0.11900
|
-0.119000
|
3.89e-03
|
3.95e-01
|
9.78e-01
|
REACTOME CYTOKINE SIGNALING IN IMMUNE SYSTEM
|
671
|
6.48e-13
|
4.08e-11
|
0.11900
|
0.086700
|
-8.17e-02
|
1.23e-04
|
2.98e-04
|
REACTOME REGULATION OF GLUCOKINASE BY GLUCOKINASE REGULATORY PROTEIN
|
30
|
3.87e-01
|
5.66e-01
|
0.11900
|
0.013700
|
-1.18e-01
|
8.97e-01
|
2.63e-01
|
REACTOME RAC2 GTPASE CYCLE
|
79
|
3.12e-01
|
4.94e-01
|
0.11900
|
0.069700
|
9.62e-02
|
2.84e-01
|
1.39e-01
|
REACTOME TIGHT JUNCTION INTERACTIONS
|
27
|
5.83e-01
|
7.24e-01
|
0.11900
|
0.036600
|
1.13e-01
|
7.42e-01
|
3.09e-01
|
REACTOME RHOT1 GTPASE CYCLE
|
5
|
9.19e-01
|
9.50e-01
|
0.11900
|
0.053600
|
1.06e-01
|
8.36e-01
|
6.82e-01
|
REACTOME RHOJ GTPASE CYCLE
|
50
|
3.13e-01
|
4.94e-01
|
0.11900
|
0.021000
|
1.17e-01
|
7.97e-01
|
1.54e-01
|
REACTOME RHO GTPASES ACTIVATE KTN1
|
11
|
7.72e-01
|
8.57e-01
|
0.11800
|
0.117000
|
1.93e-02
|
5.03e-01
|
9.12e-01
|
REACTOME BASIGIN INTERACTIONS
|
24
|
6.35e-01
|
7.62e-01
|
0.11800
|
0.111000
|
4.02e-02
|
3.47e-01
|
7.33e-01
|
REACTOME METABOLISM OF NUCLEOTIDES
|
92
|
4.36e-02
|
1.43e-01
|
0.11800
|
0.115000
|
-2.68e-02
|
5.70e-02
|
6.56e-01
|
REACTOME ACTIVATION OF MATRIX METALLOPROTEINASES
|
30
|
3.99e-01
|
5.76e-01
|
0.11800
|
-0.117000
|
1.22e-02
|
2.68e-01
|
9.08e-01
|
REACTOME AQUAPORIN MEDIATED TRANSPORT
|
51
|
4.94e-01
|
6.54e-01
|
0.11700
|
0.078100
|
8.77e-02
|
3.35e-01
|
2.79e-01
|
REACTOME POSTMITOTIC NUCLEAR PORE COMPLEX NPC REFORMATION
|
26
|
3.71e-01
|
5.51e-01
|
0.11700
|
0.048400
|
-1.07e-01
|
6.69e-01
|
3.45e-01
|
REACTOME SPHINGOLIPID METABOLISM
|
79
|
3.00e-01
|
4.89e-01
|
0.11700
|
0.100000
|
6.03e-02
|
1.23e-01
|
3.54e-01
|
REACTOME CA DEPENDENT EVENTS
|
35
|
4.84e-01
|
6.43e-01
|
0.11700
|
0.029600
|
1.13e-01
|
7.62e-01
|
2.46e-01
|
REACTOME VEGF LIGAND RECEPTOR INTERACTIONS
|
7
|
8.59e-01
|
9.12e-01
|
0.11700
|
0.024600
|
1.14e-01
|
9.10e-01
|
6.00e-01
|
REACTOME BLOOD GROUP SYSTEMS BIOSYNTHESIS
|
21
|
6.77e-01
|
7.95e-01
|
0.11700
|
-0.040000
|
-1.10e-01
|
7.51e-01
|
3.83e-01
|
REACTOME BIOTIN TRANSPORT AND METABOLISM
|
10
|
8.44e-01
|
9.03e-01
|
0.11600
|
0.047800
|
1.06e-01
|
7.93e-01
|
5.61e-01
|
REACTOME MET PROMOTES CELL MOTILITY
|
41
|
3.43e-01
|
5.24e-01
|
0.11600
|
-0.116000
|
-4.64e-03
|
1.98e-01
|
9.59e-01
|
REACTOME INTERFERON ALPHA BETA SIGNALING
|
70
|
7.82e-02
|
2.14e-01
|
0.11600
|
0.042600
|
-1.08e-01
|
5.38e-01
|
1.18e-01
|
REACTOME RUNX2 REGULATES BONE DEVELOPMENT
|
29
|
4.50e-01
|
6.16e-01
|
0.11600
|
0.116000
|
-2.19e-03
|
2.80e-01
|
9.84e-01
|
REACTOME CELL CYCLE
|
594
|
1.57e-08
|
4.20e-07
|
0.11600
|
0.115000
|
-1.70e-02
|
1.72e-06
|
4.79e-01
|
REACTOME HDL REMODELING
|
10
|
7.51e-01
|
8.40e-01
|
0.11600
|
-0.116000
|
7.28e-03
|
5.26e-01
|
9.68e-01
|
REACTOME OVARIAN TUMOR DOMAIN PROTEASES
|
35
|
3.44e-01
|
5.24e-01
|
0.11600
|
0.115000
|
-1.53e-02
|
2.40e-01
|
8.76e-01
|
REACTOME AMINO ACIDS REGULATE MTORC1
|
50
|
4.36e-01
|
6.03e-01
|
0.11600
|
0.105000
|
4.85e-02
|
1.98e-01
|
5.53e-01
|
REACTOME NONHOMOLOGOUS END JOINING NHEJ
|
29
|
6.67e-01
|
7.86e-01
|
0.11600
|
0.093600
|
6.80e-02
|
3.83e-01
|
5.26e-01
|
REACTOME GLUCOSE METABOLISM
|
87
|
1.06e-01
|
2.58e-01
|
0.11500
|
-0.003860
|
-1.15e-01
|
9.50e-01
|
6.29e-02
|
REACTOME NITRIC OXIDE STIMULATES GUANYLATE CYCLASE
|
19
|
7.69e-01
|
8.56e-01
|
0.11500
|
-0.068500
|
-9.26e-02
|
6.05e-01
|
4.85e-01
|
REACTOME CLASS I MHC MEDIATED ANTIGEN PROCESSING PRESENTATION
|
356
|
1.14e-05
|
1.35e-04
|
0.11500
|
0.112000
|
-2.61e-02
|
2.84e-04
|
3.98e-01
|
REACTOME DEGRADATION OF THE EXTRACELLULAR MATRIX
|
134
|
7.49e-03
|
4.23e-02
|
0.11500
|
-0.104000
|
4.83e-02
|
3.72e-02
|
3.34e-01
|
REACTOME RUNX3 REGULATES CDKN1A TRANSCRIPTION
|
7
|
8.02e-01
|
8.78e-01
|
0.11500
|
0.022300
|
-1.12e-01
|
9.19e-01
|
6.07e-01
|
REACTOME REGULATION OF CHOLESTEROL BIOSYNTHESIS BY SREBP SREBF
|
53
|
4.36e-01
|
6.03e-01
|
0.11500
|
0.051500
|
1.02e-01
|
5.17e-01
|
1.98e-01
|
REACTOME METAL ION SLC TRANSPORTERS
|
23
|
7.40e-01
|
8.33e-01
|
0.11400
|
0.075600
|
8.57e-02
|
5.30e-01
|
4.77e-01
|
REACTOME INTRA GOLGI TRAFFIC
|
43
|
5.30e-01
|
6.83e-01
|
0.11400
|
0.098900
|
5.70e-02
|
2.62e-01
|
5.18e-01
|
REACTOME MITOTIC SPINDLE CHECKPOINT
|
105
|
1.79e-02
|
7.97e-02
|
0.11400
|
0.094300
|
-6.43e-02
|
9.49e-02
|
2.55e-01
|
REACTOME PROTON COUPLED MONOCARBOXYLATE TRANSPORT
|
6
|
8.85e-01
|
9.28e-01
|
0.11400
|
0.025400
|
1.11e-01
|
9.14e-01
|
6.37e-01
|
REACTOME TRANSCRIPTIONAL ACTIVATION OF MITOCHONDRIAL BIOGENESIS
|
50
|
1.55e-01
|
3.28e-01
|
0.11400
|
0.098400
|
-5.70e-02
|
2.29e-01
|
4.86e-01
|
REACTOME TOLL LIKE RECEPTOR TLR1 TLR2 CASCADE
|
109
|
1.79e-02
|
7.97e-02
|
0.11400
|
0.099000
|
-5.55e-02
|
7.39e-02
|
3.17e-01
|
REACTOME NCAM1 INTERACTIONS
|
41
|
2.98e-01
|
4.88e-01
|
0.11300
|
-0.017000
|
1.12e-01
|
8.51e-01
|
2.15e-01
|
REACTOME SYNTHESIS OF KETONE BODIES
|
8
|
8.14e-01
|
8.86e-01
|
0.11300
|
-0.000424
|
1.13e-01
|
9.98e-01
|
5.80e-01
|
REACTOME SYNDECAN INTERACTIONS
|
26
|
5.34e-01
|
6.84e-01
|
0.11300
|
-0.112000
|
-5.79e-03
|
3.21e-01
|
9.59e-01
|
REACTOME EGFR TRANSACTIVATION BY GASTRIN
|
9
|
8.92e-01
|
9.30e-01
|
0.11200
|
0.083700
|
7.50e-02
|
6.64e-01
|
6.97e-01
|
REACTOME MET ACTIVATES RAP1 AND RAC1
|
11
|
7.12e-01
|
8.16e-01
|
0.11200
|
0.109000
|
-2.53e-02
|
5.30e-01
|
8.85e-01
|
REACTOME TNFR1 MEDIATED CERAMIDE PRODUCTION
|
5
|
8.30e-01
|
8.95e-01
|
0.11200
|
0.092500
|
-6.35e-02
|
7.20e-01
|
8.06e-01
|
REACTOME METABOLISM OF FOLATE AND PTERINES
|
16
|
5.44e-01
|
6.92e-01
|
0.11200
|
0.078400
|
-8.03e-02
|
5.87e-01
|
5.78e-01
|
REACTOME RA BIOSYNTHESIS PATHWAY
|
22
|
5.98e-01
|
7.35e-01
|
0.11200
|
0.112000
|
8.34e-03
|
3.64e-01
|
9.46e-01
|
REACTOME DISORDERS OF TRANSMEMBRANE TRANSPORTERS
|
167
|
1.94e-03
|
1.41e-02
|
0.11200
|
0.070100
|
-8.74e-02
|
1.18e-01
|
5.13e-02
|
REACTOME SARS COV 2 INFECTION
|
274
|
8.26e-05
|
8.29e-04
|
0.11200
|
0.045900
|
-1.02e-01
|
1.90e-01
|
3.62e-03
|
REACTOME SARS COV 2 ACTIVATES MODULATES INNATE AND ADAPTIVE IMMUNE RESPONSES
|
113
|
1.57e-01
|
3.30e-01
|
0.11200
|
-0.041300
|
-1.04e-01
|
4.48e-01
|
5.63e-02
|
REACTOME DSCAM INTERACTIONS
|
11
|
7.35e-01
|
8.31e-01
|
0.11100
|
0.014300
|
-1.10e-01
|
9.35e-01
|
5.27e-01
|
REACTOME COPII MEDIATED VESICLE TRANSPORT
|
66
|
2.05e-01
|
3.91e-01
|
0.11100
|
-0.002650
|
-1.11e-01
|
9.70e-01
|
1.20e-01
|
REACTOME TELOMERE C STRAND SYNTHESIS INITIATION
|
11
|
6.81e-01
|
7.97e-01
|
0.11100
|
0.097200
|
-5.27e-02
|
5.77e-01
|
7.62e-01
|
REACTOME TRYPTOPHAN CATABOLISM
|
12
|
7.30e-01
|
8.27e-01
|
0.11000
|
-0.110000
|
7.79e-03
|
5.09e-01
|
9.63e-01
|
REACTOME ION CHANNEL TRANSPORT
|
172
|
6.93e-03
|
3.99e-02
|
0.11000
|
-0.108000
|
2.22e-02
|
1.49e-02
|
6.15e-01
|
REACTOME RHO GTPASES ACTIVATE RHOTEKIN AND RHOPHILINS
|
9
|
7.29e-01
|
8.26e-01
|
0.11000
|
0.058300
|
-9.29e-02
|
7.62e-01
|
6.29e-01
|
REACTOME CELL EXTRACELLULAR MATRIX INTERACTIONS
|
16
|
5.60e-01
|
7.04e-01
|
0.10900
|
0.074800
|
-7.99e-02
|
6.04e-01
|
5.80e-01
|
REACTOME IRS ACTIVATION
|
5
|
9.42e-01
|
9.67e-01
|
0.10900
|
0.076200
|
7.85e-02
|
7.68e-01
|
7.61e-01
|
REACTOME NUCLEAR PORE COMPLEX NPC DISASSEMBLY
|
34
|
3.44e-01
|
5.24e-01
|
0.10900
|
0.035800
|
-1.03e-01
|
7.18e-01
|
2.98e-01
|
REACTOME TRANSCRIPTIONAL REGULATION BY SMALL RNAS
|
45
|
2.16e-01
|
4.06e-01
|
0.10900
|
0.052800
|
-9.53e-02
|
5.40e-01
|
2.69e-01
|
REACTOME NUCLEAR ENVELOPE NE REASSEMBLY
|
73
|
9.82e-02
|
2.46e-01
|
0.10900
|
0.102000
|
-3.88e-02
|
1.33e-01
|
5.66e-01
|
REACTOME RECEPTOR MEDIATED MITOPHAGY
|
10
|
8.19e-01
|
8.87e-01
|
0.10900
|
0.017500
|
1.07e-01
|
9.24e-01
|
5.57e-01
|
REACTOME POST TRANSLATIONAL PROTEIN MODIFICATION
|
1280
|
1.79e-10
|
7.51e-09
|
0.10900
|
0.106000
|
2.48e-02
|
1.61e-10
|
1.34e-01
|
REACTOME MITOCHONDRIAL TRNA AMINOACYLATION
|
18
|
5.31e-01
|
6.83e-01
|
0.10900
|
0.065400
|
-8.68e-02
|
6.31e-01
|
5.24e-01
|
REACTOME M PHASE
|
332
|
2.97e-05
|
3.22e-04
|
0.10800
|
0.101000
|
-4.03e-02
|
1.62e-03
|
2.06e-01
|
REACTOME CAMK IV MEDIATED PHOSPHORYLATION OF CREB
|
10
|
7.18e-01
|
8.20e-01
|
0.10800
|
-0.048300
|
9.69e-02
|
7.91e-01
|
5.96e-01
|
REACTOME INTEGRIN CELL SURFACE INTERACTIONS
|
83
|
1.88e-01
|
3.70e-01
|
0.10800
|
-0.107000
|
-1.51e-02
|
9.21e-02
|
8.13e-01
|
REACTOME ACTIVATED PKN1 STIMULATES TRANSCRIPTION OF AR ANDROGEN RECEPTOR REGULATED GENES KLK2 AND KLK3
|
6
|
8.10e-01
|
8.83e-01
|
0.10800
|
-0.079400
|
7.28e-02
|
7.36e-01
|
7.58e-01
|
REACTOME SARS COV INFECTIONS
|
385
|
1.67e-06
|
2.32e-05
|
0.10800
|
0.078200
|
-7.41e-02
|
8.37e-03
|
1.25e-02
|
REACTOME TAK1 DEPENDENT IKK AND NF KAPPA B ACTIVATION
|
41
|
2.39e-01
|
4.31e-01
|
0.10800
|
0.079900
|
-7.21e-02
|
3.76e-01
|
4.24e-01
|
REACTOME SYNTHESIS SECRETION AND INACTIVATION OF GLUCAGON LIKE PEPTIDE 1 GLP 1
|
20
|
7.95e-01
|
8.72e-01
|
0.10700
|
0.077200
|
7.43e-02
|
5.50e-01
|
5.65e-01
|
REACTOME O LINKED GLYCOSYLATION OF MUCINS
|
60
|
1.87e-01
|
3.68e-01
|
0.10700
|
-0.024100
|
1.04e-01
|
7.47e-01
|
1.63e-01
|
REACTOME TRANSFERRIN ENDOCYTOSIS AND RECYCLING
|
30
|
5.66e-01
|
7.10e-01
|
0.10600
|
0.104000
|
1.64e-02
|
3.22e-01
|
8.76e-01
|
REACTOME RAC3 GTPASE CYCLE
|
83
|
3.57e-01
|
5.38e-01
|
0.10600
|
0.054500
|
9.06e-02
|
3.90e-01
|
1.54e-01
|
REACTOME NOTCH HLH TRANSCRIPTION PATHWAY
|
24
|
6.54e-01
|
7.77e-01
|
0.10600
|
0.022600
|
1.03e-01
|
8.48e-01
|
3.82e-01
|
REACTOME SYNTHESIS OF PIPS AT THE PLASMA MEMBRANE
|
48
|
5.03e-01
|
6.60e-01
|
0.10500
|
0.040700
|
9.73e-02
|
6.26e-01
|
2.43e-01
|
REACTOME G ALPHA S SIGNALLING EVENTS
|
153
|
1.19e-01
|
2.77e-01
|
0.10500
|
0.041500
|
9.62e-02
|
3.75e-01
|
3.99e-02
|
REACTOME RHO GTPASES ACTIVATE PKNS
|
33
|
6.95e-01
|
8.05e-01
|
0.10500
|
0.079000
|
6.87e-02
|
4.32e-01
|
4.95e-01
|
REACTOME INNATE IMMUNE SYSTEM
|
989
|
2.96e-09
|
9.69e-08
|
0.10400
|
-0.005770
|
-1.04e-01
|
7.58e-01
|
2.68e-08
|
REACTOME SYNTHESIS OF PIPS AT THE GOLGI MEMBRANE
|
17
|
7.97e-01
|
8.73e-01
|
0.10400
|
0.044100
|
9.42e-02
|
7.53e-01
|
5.01e-01
|
REACTOME BRANCHED CHAIN AMINO ACID CATABOLISM
|
20
|
6.67e-01
|
7.86e-01
|
0.10400
|
-0.006800
|
-1.04e-01
|
9.58e-01
|
4.22e-01
|
REACTOME SIGNALING BY FGFR4 IN DISEASE
|
11
|
8.87e-01
|
9.29e-01
|
0.10400
|
0.079500
|
6.66e-02
|
6.48e-01
|
7.02e-01
|
REACTOME OTHER INTERLEUKIN SIGNALING
|
24
|
4.98e-01
|
6.56e-01
|
0.10400
|
0.038700
|
-9.61e-02
|
7.43e-01
|
4.15e-01
|
REACTOME GLYCEROPHOSPHOLIPID BIOSYNTHESIS
|
114
|
5.75e-02
|
1.75e-01
|
0.10300
|
-0.101000
|
1.84e-02
|
6.12e-02
|
7.35e-01
|
REACTOME HDMS DEMETHYLATE HISTONES
|
17
|
8.30e-01
|
8.95e-01
|
0.10300
|
0.062200
|
8.20e-02
|
6.57e-01
|
5.58e-01
|
REACTOME ACTIVATION OF PUMA AND TRANSLOCATION TO MITOCHONDRIA
|
9
|
8.57e-01
|
9.12e-01
|
0.10300
|
0.020000
|
1.01e-01
|
9.17e-01
|
6.00e-01
|
REACTOME NUCLEOTIDE SALVAGE
|
21
|
5.55e-01
|
6.99e-01
|
0.10300
|
0.035100
|
-9.65e-02
|
7.80e-01
|
4.44e-01
|
REACTOME G PROTEIN MEDIATED EVENTS
|
52
|
3.49e-01
|
5.30e-01
|
0.10300
|
0.004180
|
1.02e-01
|
9.58e-01
|
2.01e-01
|
REACTOME L1CAM INTERACTIONS
|
112
|
3.06e-01
|
4.92e-01
|
0.10200
|
-0.078900
|
-6.49e-02
|
1.49e-01
|
2.36e-01
|
REACTOME HCMV LATE EVENTS
|
52
|
3.57e-01
|
5.38e-01
|
0.10200
|
0.102000
|
5.23e-03
|
2.04e-01
|
9.48e-01
|
REACTOME INTERFERON SIGNALING
|
190
|
3.62e-03
|
2.43e-02
|
0.10200
|
0.051000
|
-8.78e-02
|
2.25e-01
|
3.68e-02
|
REACTOME PYRUVATE METABOLISM AND CITRIC ACID TCA CYCLE
|
52
|
2.75e-01
|
4.69e-01
|
0.10000
|
0.097300
|
-2.38e-02
|
2.25e-01
|
7.67e-01
|
REACTOME GAP JUNCTION TRAFFICKING AND REGULATION
|
49
|
5.69e-01
|
7.13e-01
|
0.09980
|
0.048000
|
8.75e-02
|
5.61e-01
|
2.89e-01
|
REACTOME CELL CELL JUNCTION ORGANIZATION
|
57
|
5.17e-01
|
6.74e-01
|
0.09960
|
0.047000
|
8.78e-02
|
5.39e-01
|
2.51e-01
|
REACTOME REGULATION OF PLK1 ACTIVITY AT G2 M TRANSITION
|
83
|
1.36e-01
|
3.02e-01
|
0.09960
|
0.097300
|
-2.13e-02
|
1.25e-01
|
7.38e-01
|
REACTOME MICRORNA MIRNA BIOGENESIS
|
25
|
7.14e-01
|
8.18e-01
|
0.09890
|
0.093300
|
3.27e-02
|
4.19e-01
|
7.77e-01
|
REACTOME NON INTEGRIN MEMBRANE ECM INTERACTIONS
|
55
|
2.01e-01
|
3.87e-01
|
0.09880
|
-0.078400
|
6.02e-02
|
3.15e-01
|
4.40e-01
|
REACTOME RHO GTPASES ACTIVATE FORMINS
|
131
|
3.27e-02
|
1.18e-01
|
0.09880
|
0.092300
|
-3.54e-02
|
6.81e-02
|
4.84e-01
|
REACTOME INTEGRIN SIGNALING
|
27
|
7.49e-01
|
8.39e-01
|
0.09880
|
-0.083700
|
-5.25e-02
|
4.52e-01
|
6.37e-01
|
REACTOME METABOLISM OF INGESTED SEMET SEC MESEC INTO H2SE
|
7
|
8.17e-01
|
8.87e-01
|
0.09880
|
0.080900
|
-5.67e-02
|
7.11e-01
|
7.95e-01
|
REACTOME GAB1 SIGNALOSOME
|
17
|
7.87e-01
|
8.67e-01
|
0.09850
|
0.094300
|
2.82e-02
|
5.01e-01
|
8.40e-01
|
REACTOME PYRUVATE METABOLISM
|
29
|
7.53e-01
|
8.42e-01
|
0.09830
|
0.075100
|
6.35e-02
|
4.84e-01
|
5.54e-01
|
REACTOME RAB REGULATION OF TRAFFICKING
|
109
|
3.06e-01
|
4.92e-01
|
0.09820
|
0.049400
|
8.49e-02
|
3.73e-01
|
1.26e-01
|
REACTOME ASPARAGINE N LINKED GLYCOSYLATION
|
296
|
6.75e-04
|
5.63e-03
|
0.09820
|
0.093700
|
-2.93e-02
|
5.51e-03
|
3.85e-01
|
REACTOME DEADENYLATION OF MRNA
|
22
|
5.28e-01
|
6.81e-01
|
0.09820
|
0.064800
|
-7.38e-02
|
5.99e-01
|
5.49e-01
|
REACTOME TRANSPORT OF MATURE MRNAS DERIVED FROM INTRONLESS TRANSCRIPTS
|
41
|
3.07e-01
|
4.92e-01
|
0.09800
|
0.075500
|
-6.24e-02
|
4.03e-01
|
4.89e-01
|
REACTOME PROCESSING OF SMDT1
|
13
|
7.01e-01
|
8.09e-01
|
0.09740
|
-0.084900
|
4.79e-02
|
5.96e-01
|
7.65e-01
|
REACTOME DEFECTIVE F9 ACTIVATION
|
5
|
8.69e-01
|
9.18e-01
|
0.09730
|
-0.079700
|
5.58e-02
|
7.58e-01
|
8.29e-01
|
REACTOME ROLE OF LAT2 NTAL LAB ON CALCIUM MOBILIZATION
|
16
|
8.39e-01
|
8.99e-01
|
0.09710
|
0.085500
|
4.60e-02
|
5.54e-01
|
7.50e-01
|
REACTOME NEUTROPHIL DEGRANULATION
|
455
|
2.70e-05
|
2.97e-04
|
0.09690
|
0.024600
|
-9.37e-02
|
3.68e-01
|
6.02e-04
|
REACTOME TRANS GOLGI NETWORK VESICLE BUDDING
|
67
|
1.86e-01
|
3.68e-01
|
0.09660
|
0.090000
|
-3.51e-02
|
2.02e-01
|
6.20e-01
|
REACTOME ACTIVATION OF BAD AND TRANSLOCATION TO MITOCHONDRIA
|
15
|
7.15e-01
|
8.18e-01
|
0.09640
|
0.094500
|
-1.94e-02
|
5.26e-01
|
8.96e-01
|
REACTOME GROWTH HORMONE RECEPTOR SIGNALING
|
24
|
5.94e-01
|
7.33e-01
|
0.09560
|
0.017500
|
-9.40e-02
|
8.82e-01
|
4.25e-01
|
REACTOME ION HOMEOSTASIS
|
52
|
2.59e-01
|
4.54e-01
|
0.09550
|
-0.084200
|
4.50e-02
|
2.94e-01
|
5.74e-01
|
REACTOME JNK C JUN KINASES PHOSPHORYLATION AND ACTIVATION MEDIATED BY ACTIVATED HUMAN TAK1
|
19
|
6.06e-01
|
7.40e-01
|
0.09540
|
0.048100
|
-8.24e-02
|
7.17e-01
|
5.34e-01
|
REACTOME GLYCOGEN METABOLISM
|
22
|
7.85e-01
|
8.67e-01
|
0.09530
|
0.085600
|
4.19e-02
|
4.87e-01
|
7.34e-01
|
REACTOME SEMA4D IN SEMAPHORIN SIGNALING
|
24
|
8.04e-01
|
8.79e-01
|
0.09510
|
0.072000
|
6.20e-02
|
5.41e-01
|
5.99e-01
|
REACTOME INTERFERON GAMMA SIGNALING
|
88
|
9.16e-02
|
2.35e-01
|
0.09500
|
0.070800
|
-6.34e-02
|
2.51e-01
|
3.04e-01
|
REACTOME RESOLUTION OF SISTER CHROMATID COHESION
|
115
|
4.87e-02
|
1.52e-01
|
0.09500
|
0.080400
|
-5.06e-02
|
1.36e-01
|
3.48e-01
|
REACTOME SUMOYLATION OF SUMOYLATION PROTEINS
|
33
|
4.48e-01
|
6.15e-01
|
0.09500
|
0.034700
|
-8.84e-02
|
7.30e-01
|
3.79e-01
|
REACTOME GLYCOLYSIS
|
68
|
3.15e-01
|
4.95e-01
|
0.09480
|
-0.005400
|
-9.47e-02
|
9.39e-01
|
1.77e-01
|
REACTOME ECM PROTEOGLYCANS
|
73
|
2.19e-01
|
4.09e-01
|
0.09450
|
-0.093300
|
1.52e-02
|
1.68e-01
|
8.22e-01
|
REACTOME PROTEIN METHYLATION
|
14
|
7.80e-01
|
8.64e-01
|
0.09420
|
-0.000377
|
-9.42e-02
|
9.98e-01
|
5.42e-01
|
REACTOME SYNTHESIS OF PG
|
8
|
8.89e-01
|
9.29e-01
|
0.09420
|
0.016500
|
9.27e-02
|
9.36e-01
|
6.50e-01
|
REACTOME CALCINEURIN ACTIVATES NFAT
|
9
|
8.92e-01
|
9.30e-01
|
0.09400
|
0.089900
|
2.74e-02
|
6.41e-01
|
8.87e-01
|
REACTOME FATTY ACYL COA BIOSYNTHESIS
|
36
|
6.87e-01
|
8.01e-01
|
0.09360
|
0.083400
|
4.26e-02
|
3.87e-01
|
6.58e-01
|
REACTOME POLYMERASE SWITCHING ON THE C STRAND OF THE TELOMERE
|
24
|
5.47e-01
|
6.92e-01
|
0.09270
|
0.078300
|
-4.96e-02
|
5.07e-01
|
6.74e-01
|
REACTOME ADAPTIVE IMMUNE SYSTEM
|
721
|
1.50e-06
|
2.10e-05
|
0.09250
|
0.091900
|
-1.03e-02
|
2.49e-05
|
6.36e-01
|
REACTOME RECRUITMENT OF NUMA TO MITOTIC CENTROSOMES
|
88
|
4.76e-01
|
6.36e-01
|
0.09180
|
0.060600
|
6.90e-02
|
3.26e-01
|
2.63e-01
|
REACTOME RAF ACTIVATION
|
32
|
7.28e-01
|
8.26e-01
|
0.09180
|
0.042400
|
8.13e-02
|
6.78e-01
|
4.26e-01
|
REACTOME DEGRADATION OF CYSTEINE AND HOMOCYSTEINE
|
14
|
7.04e-01
|
8.10e-01
|
0.09130
|
0.060300
|
-6.86e-02
|
6.96e-01
|
6.57e-01
|
REACTOME ACTIVATION OF ATR IN RESPONSE TO REPLICATION STRESS
|
37
|
4.25e-01
|
5.92e-01
|
0.09110
|
0.082400
|
-3.89e-02
|
3.86e-01
|
6.82e-01
|
REACTOME NFE2L2 REGULATING ANTI OXIDANT DETOXIFICATION ENZYMES
|
17
|
6.53e-01
|
7.77e-01
|
0.09110
|
0.066100
|
-6.26e-02
|
6.37e-01
|
6.55e-01
|
REACTOME LAMININ INTERACTIONS
|
28
|
5.44e-01
|
6.92e-01
|
0.09100
|
-0.029200
|
8.62e-02
|
7.89e-01
|
4.30e-01
|
REACTOME TRAF6 MEDIATED NF KB ACTIVATION
|
23
|
5.65e-01
|
7.09e-01
|
0.09070
|
0.065100
|
-6.31e-02
|
5.89e-01
|
6.01e-01
|
REACTOME LAGGING STRAND SYNTHESIS
|
19
|
7.47e-01
|
8.37e-01
|
0.09020
|
0.090100
|
5.41e-03
|
4.97e-01
|
9.67e-01
|
REACTOME DISEASES OF BASE EXCISION REPAIR
|
5
|
8.97e-01
|
9.32e-01
|
0.08960
|
0.083100
|
-3.35e-02
|
7.48e-01
|
8.97e-01
|
REACTOME DISEASES ASSOCIATED WITH GLYCOSAMINOGLYCAN METABOLISM
|
38
|
7.24e-01
|
8.24e-01
|
0.08910
|
-0.074100
|
-4.95e-02
|
4.29e-01
|
5.98e-01
|
REACTOME DEFECTIVE FACTOR IX CAUSES HEMOPHILIA B
|
7
|
8.48e-01
|
9.05e-01
|
0.08840
|
-0.059900
|
6.50e-02
|
7.84e-01
|
7.66e-01
|
REACTOME EARLY SARS COV 2 INFECTION EVENTS
|
34
|
7.28e-01
|
8.26e-01
|
0.08830
|
0.078900
|
3.96e-02
|
4.26e-01
|
6.89e-01
|
REACTOME PLATELET ADHESION TO EXPOSED COLLAGEN
|
15
|
8.06e-01
|
8.80e-01
|
0.08820
|
0.007060
|
8.79e-02
|
9.62e-01
|
5.55e-01
|
REACTOME LOSS OF MECP2 BINDING ABILITY TO THE NCOR SMRT COMPLEX
|
5
|
8.92e-01
|
9.30e-01
|
0.08810
|
-0.072900
|
4.95e-02
|
7.78e-01
|
8.48e-01
|
REACTOME EXTRACELLULAR MATRIX ORGANIZATION
|
291
|
1.84e-03
|
1.35e-02
|
0.08810
|
-0.078700
|
3.95e-02
|
2.07e-02
|
2.46e-01
|
REACTOME MEMBRANE TRAFFICKING
|
600
|
3.91e-03
|
2.59e-02
|
0.08800
|
0.079400
|
3.79e-02
|
8.74e-04
|
1.12e-01
|
REACTOME RETROGRADE TRANSPORT AT THE TRANS GOLGI NETWORK
|
47
|
3.63e-01
|
5.43e-01
|
0.08720
|
0.077200
|
-4.05e-02
|
3.60e-01
|
6.31e-01
|
REACTOME MITOTIC TELOPHASE CYTOKINESIS
|
10
|
7.97e-01
|
8.73e-01
|
0.08670
|
-0.065200
|
5.71e-02
|
7.21e-01
|
7.54e-01
|
REACTOME SYNTHESIS OF PC
|
27
|
6.57e-01
|
7.79e-01
|
0.08640
|
0.003310
|
-8.63e-02
|
9.76e-01
|
4.37e-01
|
REACTOME INTERLEUKIN 35 SIGNALLING
|
12
|
8.19e-01
|
8.87e-01
|
0.08610
|
0.085600
|
-1.01e-02
|
6.08e-01
|
9.52e-01
|
REACTOME NCAM SIGNALING FOR NEURITE OUT GROWTH
|
62
|
2.78e-01
|
4.71e-01
|
0.08500
|
-0.041200
|
7.43e-02
|
5.74e-01
|
3.12e-01
|
REACTOME COPI INDEPENDENT GOLGI TO ER RETROGRADE TRAFFIC
|
52
|
6.75e-01
|
7.93e-01
|
0.08490
|
0.069100
|
4.93e-02
|
3.89e-01
|
5.39e-01
|
REACTOME DEPOSITION OF NEW CENPA CONTAINING NUCLEOSOMES AT THE CENTROMERE
|
23
|
6.13e-01
|
7.46e-01
|
0.08410
|
0.054200
|
-6.43e-02
|
6.53e-01
|
5.93e-01
|
REACTOME NUCLEOTIDE LIKE PURINERGIC RECEPTORS
|
13
|
7.92e-01
|
8.71e-01
|
0.08410
|
-0.080900
|
2.28e-02
|
6.13e-01
|
8.87e-01
|
REACTOME INSULIN PROCESSING
|
24
|
8.46e-01
|
9.05e-01
|
0.08360
|
0.059200
|
5.91e-02
|
6.16e-01
|
6.16e-01
|
REACTOME WAX AND PLASMALOGEN BIOSYNTHESIS
|
5
|
9.64e-01
|
9.82e-01
|
0.08320
|
0.068000
|
4.79e-02
|
7.92e-01
|
8.53e-01
|
REACTOME RHO GTPASE EFFECTORS
|
247
|
2.80e-02
|
1.08e-01
|
0.08290
|
0.082700
|
-4.85e-03
|
2.51e-02
|
8.95e-01
|
REACTOME GOLGI ASSOCIATED VESICLE BIOGENESIS
|
51
|
4.20e-01
|
5.90e-01
|
0.08280
|
0.080400
|
-1.99e-02
|
3.21e-01
|
8.06e-01
|
REACTOME NUCLEAR ENVELOPE BREAKDOWN
|
50
|
4.72e-01
|
6.34e-01
|
0.08240
|
0.008270
|
-8.20e-02
|
9.19e-01
|
3.16e-01
|
REACTOME SEMA3A PAK DEPENDENT AXON REPULSION
|
14
|
8.07e-01
|
8.80e-01
|
0.08230
|
0.081700
|
-1.05e-02
|
5.97e-01
|
9.46e-01
|
REACTOME IMMUNOREGULATORY INTERACTIONS BETWEEN A LYMPHOID AND A NON LYMPHOID CELL
|
120
|
1.17e-01
|
2.74e-01
|
0.08200
|
0.028500
|
-7.68e-02
|
5.89e-01
|
1.46e-01
|
REACTOME CONSTITUTIVE SIGNALING BY AKT1 E17K IN CANCER
|
25
|
6.25e-01
|
7.55e-01
|
0.08170
|
-0.036400
|
7.31e-02
|
7.52e-01
|
5.27e-01
|
REACTOME LYSINE CATABOLISM
|
12
|
8.37e-01
|
8.98e-01
|
0.08100
|
0.010100
|
-8.04e-02
|
9.52e-01
|
6.30e-01
|
REACTOME CTLA4 INHIBITORY SIGNALING
|
21
|
7.93e-01
|
8.71e-01
|
0.08090
|
0.079800
|
1.29e-02
|
5.27e-01
|
9.19e-01
|
REACTOME MET ACTIVATES RAS SIGNALING
|
11
|
8.08e-01
|
8.81e-01
|
0.08020
|
0.058900
|
-5.44e-02
|
7.35e-01
|
7.55e-01
|
REACTOME ROS AND RNS PRODUCTION IN PHAGOCYTES
|
34
|
6.33e-01
|
7.61e-01
|
0.08000
|
0.079900
|
-3.66e-03
|
4.20e-01
|
9.70e-01
|
REACTOME TRANSPORT OF INORGANIC CATIONS ANIONS AND AMINO ACIDS OLIGOPEPTIDES
|
101
|
1.44e-01
|
3.13e-01
|
0.07990
|
-0.057400
|
5.56e-02
|
3.19e-01
|
3.34e-01
|
REACTOME DISEASES OF IMMUNE SYSTEM
|
29
|
6.29e-01
|
7.59e-01
|
0.07950
|
0.021000
|
-7.67e-02
|
8.45e-01
|
4.75e-01
|
REACTOME RHOC GTPASE CYCLE
|
68
|
2.90e-01
|
4.80e-01
|
0.07950
|
-0.068600
|
4.02e-02
|
3.28e-01
|
5.67e-01
|
REACTOME SYNTHESIS OF LEUKOTRIENES LT AND EOXINS EX
|
21
|
8.70e-01
|
9.18e-01
|
0.07930
|
-0.045900
|
-6.46e-02
|
7.16e-01
|
6.08e-01
|
REACTOME INHIBITION OF REPLICATION INITIATION OF DAMAGED DNA BY RB1 E2F1
|
11
|
8.88e-01
|
9.29e-01
|
0.07880
|
0.078000
|
1.08e-02
|
6.54e-01
|
9.50e-01
|
REACTOME HS GAG DEGRADATION
|
19
|
8.80e-01
|
9.26e-01
|
0.07870
|
0.066000
|
4.29e-02
|
6.18e-01
|
7.46e-01
|
REACTOME DISEASES ASSOCIATED WITH O GLYCOSYLATION OF PROTEINS
|
64
|
3.07e-01
|
4.92e-01
|
0.07860
|
-0.048600
|
6.17e-02
|
5.01e-01
|
3.93e-01
|
REACTOME MITOCHONDRIAL FATTY ACID BETA OXIDATION
|
35
|
5.90e-01
|
7.29e-01
|
0.07820
|
0.076000
|
-1.82e-02
|
4.36e-01
|
8.52e-01
|
REACTOME WNT MEDIATED ACTIVATION OF DVL
|
8
|
8.63e-01
|
9.14e-01
|
0.07790
|
-0.054300
|
5.59e-02
|
7.90e-01
|
7.84e-01
|
REACTOME SEMA3A PLEXIN REPULSION SIGNALING BY INHIBITING INTEGRIN ADHESION
|
13
|
7.88e-01
|
8.67e-01
|
0.07790
|
-0.055900
|
5.43e-02
|
7.27e-01
|
7.35e-01
|
REACTOME G ALPHA 12 13 SIGNALLING EVENTS
|
74
|
3.16e-01
|
4.95e-01
|
0.07750
|
-0.023700
|
7.38e-02
|
7.24e-01
|
2.72e-01
|
REACTOME PRESYNAPTIC DEPOLARIZATION AND CALCIUM CHANNEL OPENING
|
11
|
8.62e-01
|
9.14e-01
|
0.07710
|
-0.076400
|
1.01e-02
|
6.61e-01
|
9.54e-01
|
REACTOME ADVANCED GLYCOSYLATION ENDPRODUCT RECEPTOR SIGNALING
|
13
|
8.21e-01
|
8.88e-01
|
0.07690
|
0.073600
|
-2.22e-02
|
6.46e-01
|
8.90e-01
|
REACTOME VITAMIN B2 RIBOFLAVIN METABOLISM
|
7
|
8.86e-01
|
9.28e-01
|
0.07680
|
0.064700
|
-4.14e-02
|
7.67e-01
|
8.50e-01
|
REACTOME SIGNALING BY MODERATE KINASE ACTIVITY BRAF MUTANTS
|
42
|
7.85e-01
|
8.67e-01
|
0.07600
|
-0.054000
|
-5.35e-02
|
5.45e-01
|
5.49e-01
|
REACTOME PHENYLALANINE AND TYROSINE METABOLISM
|
10
|
9.42e-01
|
9.67e-01
|
0.07550
|
0.044300
|
6.12e-02
|
8.08e-01
|
7.38e-01
|
REACTOME BETA OXIDATION OF PRISTANOYL COA
|
9
|
9.45e-01
|
9.69e-01
|
0.07510
|
-0.064400
|
-3.86e-02
|
7.38e-01
|
8.41e-01
|
REACTOME INTRA GOLGI AND RETROGRADE GOLGI TO ER TRAFFIC
|
198
|
1.01e-01
|
2.50e-01
|
0.07420
|
0.074100
|
-3.94e-03
|
7.19e-02
|
9.24e-01
|
REACTOME ESTABLISHMENT OF SISTER CHROMATID COHESION
|
8
|
9.57e-01
|
9.77e-01
|
0.07420
|
-0.056000
|
-4.87e-02
|
7.84e-01
|
8.11e-01
|
REACTOME HCMV INFECTION
|
94
|
3.86e-01
|
5.66e-01
|
0.07420
|
0.073900
|
5.99e-03
|
2.15e-01
|
9.20e-01
|
REACTOME RHOF GTPASE CYCLE
|
40
|
7.91e-01
|
8.70e-01
|
0.07420
|
0.041700
|
6.13e-02
|
6.48e-01
|
5.02e-01
|
REACTOME RND3 GTPASE CYCLE
|
41
|
7.69e-01
|
8.55e-01
|
0.07380
|
0.034000
|
6.55e-02
|
7.06e-01
|
4.68e-01
|
REACTOME RECRUITMENT OF MITOTIC CENTROSOME PROTEINS AND COMPLEXES
|
75
|
6.18e-01
|
7.50e-01
|
0.07370
|
0.065500
|
3.39e-02
|
3.27e-01
|
6.12e-01
|
REACTOME REGULATION OF INSULIN LIKE GROWTH FACTOR IGF TRANSPORT AND UPTAKE BY INSULIN LIKE GROWTH FACTOR BINDING PROTEINS IGFBPS
|
116
|
4.80e-01
|
6.41e-01
|
0.07360
|
-0.065100
|
-3.43e-02
|
2.26e-01
|
5.24e-01
|
REACTOME AURKA ACTIVATION BY TPX2
|
68
|
4.14e-01
|
5.88e-01
|
0.07270
|
0.070800
|
-1.64e-02
|
3.12e-01
|
8.15e-01
|
REACTOME MITOTIC PROPHASE
|
77
|
3.10e-01
|
4.94e-01
|
0.07150
|
0.057300
|
-4.28e-02
|
3.85e-01
|
5.16e-01
|
REACTOME SPHINGOLIPID DE NOVO BIOSYNTHESIS
|
41
|
8.13e-01
|
8.86e-01
|
0.07110
|
0.051600
|
4.88e-02
|
5.67e-01
|
5.88e-01
|
REACTOME ER TO GOLGI ANTEROGRADE TRANSPORT
|
152
|
1.62e-01
|
3.35e-01
|
0.07050
|
0.014700
|
-6.90e-02
|
7.55e-01
|
1.42e-01
|
REACTOME METABOLIC DISORDERS OF BIOLOGICAL OXIDATION ENZYMES
|
32
|
7.40e-01
|
8.33e-01
|
0.07050
|
-0.004120
|
-7.04e-02
|
9.68e-01
|
4.91e-01
|
REACTOME COPI MEDIATED ANTEROGRADE TRANSPORT
|
101
|
2.26e-01
|
4.17e-01
|
0.07000
|
0.051800
|
-4.71e-02
|
3.68e-01
|
4.13e-01
|
REACTOME PTK6 REGULATES RHO GTPASES RAS GTPASE AND MAP KINASES
|
14
|
9.34e-01
|
9.61e-01
|
0.06970
|
0.050800
|
4.77e-02
|
7.42e-01
|
7.57e-01
|
REACTOME CARGO TRAFFICKING TO THE PERICILIARY MEMBRANE
|
49
|
5.76e-01
|
7.18e-01
|
0.06950
|
0.011400
|
-6.85e-02
|
8.91e-01
|
4.07e-01
|
REACTOME SLC MEDIATED TRANSMEMBRANE TRANSPORT
|
235
|
8.50e-02
|
2.25e-01
|
0.06900
|
-0.068600
|
7.24e-03
|
6.97e-02
|
8.48e-01
|
REACTOME INSULIN RECEPTOR RECYCLING
|
29
|
6.92e-01
|
8.04e-01
|
0.06900
|
0.024100
|
-6.47e-02
|
8.22e-01
|
5.47e-01
|
REACTOME IONOTROPIC ACTIVITY OF KAINATE RECEPTORS
|
9
|
9.58e-01
|
9.78e-01
|
0.06860
|
0.043500
|
5.30e-02
|
8.21e-01
|
7.83e-01
|
REACTOME UPTAKE AND ACTIONS OF BACTERIAL TOXINS
|
29
|
7.16e-01
|
8.19e-01
|
0.06830
|
0.016000
|
-6.64e-02
|
8.82e-01
|
5.36e-01
|
REACTOME CDC42 GTPASE CYCLE
|
142
|
1.42e-01
|
3.11e-01
|
0.06780
|
-0.042500
|
5.29e-02
|
3.82e-01
|
2.76e-01
|
REACTOME TIE2 SIGNALING
|
18
|
8.26e-01
|
8.92e-01
|
0.06780
|
0.009960
|
-6.71e-02
|
9.42e-01
|
6.22e-01
|
REACTOME RAC1 GTPASE CYCLE
|
168
|
1.12e-01
|
2.66e-01
|
0.06760
|
-0.059400
|
3.24e-02
|
1.84e-01
|
4.69e-01
|
REACTOME PHOSPHOLIPID METABOLISM
|
191
|
7.83e-02
|
2.14e-01
|
0.06760
|
-0.037200
|
5.65e-02
|
3.76e-01
|
1.78e-01
|
REACTOME DISSOLUTION OF FIBRIN CLOT
|
13
|
8.92e-01
|
9.30e-01
|
0.06740
|
-0.002290
|
-6.74e-02
|
9.89e-01
|
6.74e-01
|
REACTOME SIGNALING BY RHO GTPASES MIRO GTPASES AND RHOBTB3
|
612
|
4.13e-02
|
1.38e-01
|
0.06720
|
0.059600
|
3.10e-02
|
1.16e-02
|
1.90e-01
|
REACTOME SUMOYLATION OF RNA BINDING PROTEINS
|
45
|
5.50e-01
|
6.95e-01
|
0.06680
|
0.039800
|
-5.36e-02
|
6.44e-01
|
5.34e-01
|
REACTOME MITOTIC PROMETAPHASE
|
186
|
1.39e-01
|
3.07e-01
|
0.06670
|
0.065400
|
-1.31e-02
|
1.24e-01
|
7.58e-01
|
REACTOME TRP CHANNELS
|
27
|
6.98e-01
|
8.07e-01
|
0.06640
|
-0.043400
|
5.03e-02
|
6.96e-01
|
6.51e-01
|
REACTOME VESICLE MEDIATED TRANSPORT
|
639
|
2.51e-02
|
1.01e-01
|
0.06600
|
0.062000
|
2.26e-02
|
7.36e-03
|
3.28e-01
|
REACTOME PHOSPHATE BOND HYDROLYSIS BY NTPDASE PROTEINS
|
8
|
9.66e-01
|
9.83e-01
|
0.06550
|
0.048200
|
4.43e-02
|
8.13e-01
|
8.28e-01
|
REACTOME TRIGLYCERIDE METABOLISM
|
35
|
6.74e-01
|
7.92e-01
|
0.06500
|
-0.060800
|
2.29e-02
|
5.34e-01
|
8.15e-01
|
REACTOME CELL CELL COMMUNICATION
|
117
|
5.46e-01
|
6.92e-01
|
0.06470
|
0.027000
|
5.88e-02
|
6.14e-01
|
2.72e-01
|
REACTOME DCC MEDIATED ATTRACTIVE SIGNALING
|
14
|
9.34e-01
|
9.61e-01
|
0.06450
|
-0.057200
|
-2.97e-02
|
7.11e-01
|
8.48e-01
|
REACTOME FACTORS INVOLVED IN MEGAKARYOCYTE DEVELOPMENT AND PLATELET PRODUCTION
|
147
|
3.21e-01
|
4.98e-01
|
0.06390
|
0.003360
|
6.39e-02
|
9.44e-01
|
1.81e-01
|
REACTOME RAP1 SIGNALLING
|
16
|
8.96e-01
|
9.32e-01
|
0.06300
|
0.062400
|
8.99e-03
|
6.66e-01
|
9.50e-01
|
REACTOME REGULATION OF PYRUVATE DEHYDROGENASE PDH COMPLEX
|
14
|
8.50e-01
|
9.06e-01
|
0.06260
|
0.051000
|
-3.64e-02
|
7.41e-01
|
8.14e-01
|
REACTOME SIGNALING BY VEGF
|
102
|
5.16e-01
|
6.73e-01
|
0.06240
|
0.010500
|
6.15e-02
|
8.54e-01
|
2.83e-01
|
REACTOME RHO GTPASES ACTIVATE NADPH OXIDASES
|
21
|
8.86e-01
|
9.28e-01
|
0.06210
|
0.059900
|
1.63e-02
|
6.35e-01
|
8.97e-01
|
REACTOME SEMA4D MEDIATED INHIBITION OF CELL ATTACHMENT AND MIGRATION
|
8
|
9.62e-01
|
9.81e-01
|
0.06200
|
-0.056700
|
-2.51e-02
|
7.81e-01
|
9.02e-01
|
REACTOME INTERLEUKIN 20 FAMILY SIGNALING
|
24
|
8.99e-01
|
9.33e-01
|
0.06120
|
0.027800
|
5.45e-02
|
8.13e-01
|
6.44e-01
|
REACTOME ZINC TRANSPORTERS
|
15
|
8.71e-01
|
9.18e-01
|
0.06120
|
0.059500
|
-1.42e-02
|
6.90e-01
|
9.24e-01
|
REACTOME INTRAFLAGELLAR TRANSPORT
|
49
|
6.49e-01
|
7.74e-01
|
0.06100
|
0.059900
|
-1.13e-02
|
4.68e-01
|
8.91e-01
|
REACTOME GASTRIN CREB SIGNALLING PATHWAY VIA PKC AND MAPK
|
17
|
9.33e-01
|
9.61e-01
|
0.06000
|
0.029800
|
5.20e-02
|
8.32e-01
|
7.10e-01
|
REACTOME TYSND1 CLEAVES PEROXISOMAL PROTEINS
|
7
|
9.76e-01
|
9.88e-01
|
0.05930
|
0.042400
|
4.14e-02
|
8.46e-01
|
8.49e-01
|
REACTOME RHOG GTPASE CYCLE
|
69
|
7.87e-01
|
8.67e-01
|
0.05870
|
0.037900
|
4.48e-02
|
5.86e-01
|
5.20e-01
|
REACTOME TRANSPORT OF BILE SALTS AND ORGANIC ACIDS METAL IONS AND AMINE COMPOUNDS
|
82
|
4.54e-01
|
6.18e-01
|
0.05860
|
-0.052600
|
2.58e-02
|
4.10e-01
|
6.87e-01
|
REACTOME MISCELLANEOUS TRANSPORT AND BINDING EVENTS
|
23
|
8.58e-01
|
9.12e-01
|
0.05780
|
0.000401
|
5.78e-02
|
9.97e-01
|
6.32e-01
|
REACTOME SODIUM CALCIUM EXCHANGERS
|
11
|
8.99e-01
|
9.33e-01
|
0.05760
|
-0.049000
|
3.02e-02
|
7.78e-01
|
8.62e-01
|
REACTOME RHO GTPASE CYCLE
|
414
|
2.60e-01
|
4.54e-01
|
0.05680
|
0.034900
|
4.48e-02
|
2.23e-01
|
1.18e-01
|
REACTOME CARDIAC CONDUCTION
|
125
|
4.00e-01
|
5.76e-01
|
0.05660
|
-0.008130
|
5.61e-02
|
8.75e-01
|
2.79e-01
|
REACTOME METABOLISM OF CARBOHYDRATES
|
276
|
2.71e-01
|
4.64e-01
|
0.05590
|
0.054200
|
1.36e-02
|
1.21e-01
|
6.97e-01
|
REACTOME DDX58 IFIH1 MEDIATED INDUCTION OF INTERFERON ALPHA BETA
|
75
|
6.46e-01
|
7.72e-01
|
0.05480
|
-0.001840
|
-5.48e-02
|
9.78e-01
|
4.12e-01
|
REACTOME SUMOYLATION OF IMMUNE RESPONSE PROTEINS
|
10
|
9.19e-01
|
9.50e-01
|
0.05370
|
0.045700
|
-2.82e-02
|
8.02e-01
|
8.77e-01
|
REACTOME PURINERGIC SIGNALING IN LEISHMANIASIS INFECTION
|
26
|
8.06e-01
|
8.80e-01
|
0.05340
|
0.027400
|
-4.58e-02
|
8.09e-01
|
6.86e-01
|
REACTOME CHL1 INTERACTIONS
|
9
|
9.30e-01
|
9.59e-01
|
0.05340
|
0.024200
|
-4.76e-02
|
9.00e-01
|
8.05e-01
|
REACTOME ORGANELLE BIOGENESIS AND MAINTENANCE
|
256
|
2.17e-01
|
4.07e-01
|
0.05320
|
0.053100
|
-3.06e-03
|
1.43e-01
|
9.33e-01
|
REACTOME RECYCLING PATHWAY OF L1
|
43
|
8.70e-01
|
9.18e-01
|
0.05310
|
0.046500
|
2.55e-02
|
5.98e-01
|
7.72e-01
|
REACTOME CYTOSOLIC SULFONATION OF SMALL MOLECULES
|
21
|
8.65e-01
|
9.16e-01
|
0.05250
|
-0.050800
|
1.31e-02
|
6.87e-01
|
9.17e-01
|
REACTOME PROCESSIVE SYNTHESIS ON THE LAGGING STRAND
|
14
|
9.63e-01
|
9.81e-01
|
0.05210
|
0.036000
|
3.77e-02
|
8.16e-01
|
8.07e-01
|
REACTOME POST TRANSLATIONAL MODIFICATION SYNTHESIS OF GPI ANCHORED PROTEINS
|
89
|
7.40e-01
|
8.33e-01
|
0.05160
|
-0.020600
|
-4.74e-02
|
7.37e-01
|
4.40e-01
|
REACTOME BETA OXIDATION OF VERY LONG CHAIN FATTY ACIDS
|
10
|
9.26e-01
|
9.55e-01
|
0.05090
|
0.030300
|
-4.09e-02
|
8.68e-01
|
8.23e-01
|
REACTOME METABOLISM OF VITAMINS AND COFACTORS
|
181
|
3.63e-01
|
5.43e-01
|
0.05050
|
0.050200
|
-5.04e-03
|
2.43e-01
|
9.07e-01
|
REACTOME MUSCLE CONTRACTION
|
194
|
3.29e-01
|
5.08e-01
|
0.05050
|
-0.050000
|
6.43e-03
|
2.29e-01
|
8.77e-01
|
REACTOME DEVELOPMENTAL BIOLOGY
|
1056
|
1.35e-03
|
1.03e-02
|
0.04980
|
0.047000
|
-1.62e-02
|
9.53e-03
|
3.71e-01
|
REACTOME GAP JUNCTION DEGRADATION
|
12
|
9.16e-01
|
9.49e-01
|
0.04940
|
0.030300
|
-3.90e-02
|
8.56e-01
|
8.15e-01
|
REACTOME FATTY ACID METABOLISM
|
168
|
3.02e-01
|
4.90e-01
|
0.04880
|
0.031200
|
-3.75e-02
|
4.84e-01
|
4.01e-01
|
REACTOME HCMV EARLY EVENTS
|
70
|
6.14e-01
|
7.47e-01
|
0.04830
|
0.029700
|
-3.80e-02
|
6.67e-01
|
5.82e-01
|
REACTOME SIGNALING BY BRAF AND RAF1 FUSIONS
|
62
|
8.23e-01
|
8.89e-01
|
0.04810
|
-0.045200
|
-1.63e-02
|
5.38e-01
|
8.24e-01
|
REACTOME GOLGI TO ER RETROGRADE TRANSPORT
|
132
|
6.37e-01
|
7.64e-01
|
0.04710
|
0.045800
|
1.12e-02
|
3.64e-01
|
8.24e-01
|
REACTOME COPI DEPENDENT GOLGI TO ER RETROGRADE TRAFFIC
|
98
|
6.64e-01
|
7.83e-01
|
0.04610
|
0.046100
|
8.22e-04
|
4.30e-01
|
9.89e-01
|
REACTOME RHOA GTPASE CYCLE
|
138
|
4.18e-01
|
5.90e-01
|
0.04610
|
-0.028300
|
3.64e-02
|
5.66e-01
|
4.60e-01
|
REACTOME NR1H2 NR1H3 REGULATE GENE EXPRESSION LINKED TO TRIGLYCERIDE LIPOLYSIS IN ADIPOSE
|
5
|
9.88e-01
|
9.93e-01
|
0.04590
|
0.024200
|
3.90e-02
|
9.25e-01
|
8.80e-01
|
REACTOME SUMOYLATION OF DNA REPLICATION PROTEINS
|
44
|
8.14e-01
|
8.86e-01
|
0.04570
|
0.005290
|
-4.53e-02
|
9.52e-01
|
6.03e-01
|
REACTOME PYROPTOSIS
|
26
|
8.51e-01
|
9.07e-01
|
0.04540
|
0.029500
|
-3.46e-02
|
7.95e-01
|
7.60e-01
|
REACTOME ABACAVIR ADME
|
9
|
9.68e-01
|
9.83e-01
|
0.04540
|
-0.045000
|
-5.83e-03
|
8.15e-01
|
9.76e-01
|
REACTOME OTHER SEMAPHORIN INTERACTIONS
|
18
|
8.96e-01
|
9.32e-01
|
0.04500
|
-0.033400
|
3.01e-02
|
8.06e-01
|
8.25e-01
|
REACTOME SIGNAL TRANSDUCTION BY L1
|
20
|
9.14e-01
|
9.47e-01
|
0.04480
|
-0.005380
|
4.45e-02
|
9.67e-01
|
7.31e-01
|
REACTOME DEATH RECEPTOR SIGNALING
|
142
|
5.04e-01
|
6.60e-01
|
0.04450
|
0.009990
|
-4.34e-02
|
8.37e-01
|
3.72e-01
|
REACTOME PTK6 PROMOTES HIF1A STABILIZATION
|
6
|
9.71e-01
|
9.85e-01
|
0.04360
|
0.013100
|
-4.16e-02
|
9.56e-01
|
8.60e-01
|
REACTOME ATTACHMENT AND ENTRY
|
16
|
9.43e-01
|
9.68e-01
|
0.04260
|
-0.042600
|
1.48e-05
|
7.68e-01
|
1.00e+00
|
REACTOME NEUROFASCIN INTERACTIONS
|
6
|
9.71e-01
|
9.85e-01
|
0.04200
|
0.038600
|
-1.64e-02
|
8.70e-01
|
9.44e-01
|
REACTOME TRANSPORT TO THE GOLGI AND SUBSEQUENT MODIFICATION
|
183
|
3.87e-01
|
5.66e-01
|
0.04180
|
0.025900
|
-3.28e-02
|
5.46e-01
|
4.44e-01
|
REACTOME ACTIVATION OF THE PRE REPLICATIVE COMPLEX
|
31
|
9.47e-01
|
9.70e-01
|
0.04150
|
0.032000
|
2.65e-02
|
7.58e-01
|
7.99e-01
|
REACTOME MHC CLASS II ANTIGEN PRESENTATION
|
121
|
5.49e-01
|
6.95e-01
|
0.04130
|
0.021900
|
-3.50e-02
|
6.78e-01
|
5.06e-01
|
REACTOME ALK MUTANTS BIND TKIS
|
12
|
9.41e-01
|
9.67e-01
|
0.04120
|
0.031900
|
-2.61e-02
|
8.48e-01
|
8.76e-01
|
REACTOME PLASMA LIPOPROTEIN ASSEMBLY REMODELING AND CLEARANCE
|
73
|
6.95e-01
|
8.05e-01
|
0.04070
|
-0.026500
|
3.09e-02
|
6.95e-01
|
6.48e-01
|
REACTOME TP53 REGULATES TRANSCRIPTION OF SEVERAL ADDITIONAL CELL DEATH GENES WHOSE SPECIFIC ROLES IN P53 DEPENDENT APOPTOSIS REMAIN UNCERTAIN
|
13
|
9.79e-01
|
9.90e-01
|
0.04030
|
-0.028300
|
-2.88e-02
|
8.60e-01
|
8.57e-01
|
REACTOME RHOD GTPASE CYCLE
|
48
|
9.23e-01
|
9.53e-01
|
0.03990
|
0.023600
|
3.22e-02
|
7.77e-01
|
7.00e-01
|
REACTOME CELL JUNCTION ORGANIZATION
|
82
|
7.70e-01
|
8.56e-01
|
0.03960
|
-0.000603
|
3.96e-02
|
9.92e-01
|
5.35e-01
|
REACTOME REPRODUCTION
|
81
|
8.71e-01
|
9.18e-01
|
0.03940
|
-0.033400
|
-2.09e-02
|
6.03e-01
|
7.46e-01
|
REACTOME PLATELET ACTIVATION SIGNALING AND AGGREGATION
|
247
|
4.85e-01
|
6.44e-01
|
0.03770
|
0.037700
|
-1.26e-03
|
3.07e-01
|
9.73e-01
|
REACTOME HEMOSTASIS
|
571
|
4.59e-01
|
6.22e-01
|
0.03730
|
0.024800
|
2.79e-02
|
3.11e-01
|
2.54e-01
|
REACTOME IRE1ALPHA ACTIVATES CHAPERONES
|
47
|
8.31e-01
|
8.95e-01
|
0.03620
|
0.024600
|
-2.65e-02
|
7.70e-01
|
7.53e-01
|
REACTOME PHASE 1 INACTIVATION OF FAST NA CHANNELS
|
6
|
9.89e-01
|
9.93e-01
|
0.03540
|
-0.010500
|
-3.38e-02
|
9.64e-01
|
8.86e-01
|
REACTOME SARS COV 2 TARGETS HOST INTRACELLULAR SIGNALLING AND REGULATORY PATHWAYS
|
12
|
9.66e-01
|
9.83e-01
|
0.03530
|
-0.004900
|
3.49e-02
|
9.77e-01
|
8.34e-01
|
REACTOME SIGNAL REGULATORY PROTEIN FAMILY INTERACTIONS
|
15
|
9.49e-01
|
9.70e-01
|
0.03420
|
0.025100
|
-2.32e-02
|
8.66e-01
|
8.77e-01
|
REACTOME SIGNALING BY HIPPO
|
19
|
9.40e-01
|
9.66e-01
|
0.03410
|
0.015300
|
-3.04e-02
|
9.08e-01
|
8.18e-01
|
REACTOME INOSITOL PHOSPHATE METABOLISM
|
44
|
8.63e-01
|
9.14e-01
|
0.03330
|
-0.024300
|
2.27e-02
|
7.80e-01
|
7.94e-01
|
REACTOME PLATELET AGGREGATION PLUG FORMATION
|
39
|
8.79e-01
|
9.26e-01
|
0.03310
|
-0.025200
|
2.15e-02
|
7.85e-01
|
8.16e-01
|
REACTOME DISEASES OF METABOLISM
|
232
|
6.00e-01
|
7.35e-01
|
0.03250
|
0.032400
|
-1.59e-03
|
3.95e-01
|
9.67e-01
|
REACTOME ANCHORING OF THE BASAL BODY TO THE PLASMA MEMBRANE
|
92
|
8.67e-01
|
9.17e-01
|
0.03210
|
0.031100
|
8.17e-03
|
6.07e-01
|
8.92e-01
|
REACTOME TRANSPORT OF SMALL MOLECULES
|
690
|
3.23e-01
|
5.00e-01
|
0.03110
|
-0.030800
|
-4.15e-03
|
1.67e-01
|
8.52e-01
|
REACTOME NICOTINAMIDE SALVAGING
|
17
|
9.84e-01
|
9.91e-01
|
0.03110
|
0.022000
|
2.19e-02
|
8.75e-01
|
8.76e-01
|
REACTOME P75 NTR RECEPTOR MEDIATED SIGNALLING
|
89
|
9.16e-01
|
9.49e-01
|
0.03090
|
-0.024700
|
-1.85e-02
|
6.86e-01
|
7.62e-01
|
REACTOME CHYLOMICRON CLEARANCE
|
5
|
9.89e-01
|
9.93e-01
|
0.03060
|
-0.004270
|
3.03e-02
|
9.87e-01
|
9.07e-01
|
REACTOME REGULATION OF LIPID METABOLISM BY PPARALPHA
|
114
|
7.73e-01
|
8.58e-01
|
0.03050
|
0.029800
|
-6.52e-03
|
5.82e-01
|
9.04e-01
|
REACTOME SIGNALING BY MET
|
78
|
8.22e-01
|
8.89e-01
|
0.03020
|
0.027600
|
-1.22e-02
|
6.73e-01
|
8.52e-01
|
REACTOME TRANSPORT AND SYNTHESIS OF PAPS
|
6
|
9.94e-01
|
9.96e-01
|
0.03000
|
0.026600
|
1.37e-02
|
9.10e-01
|
9.54e-01
|
REACTOME TRAF3 DEPENDENT IRF ACTIVATION PATHWAY
|
14
|
9.68e-01
|
9.83e-01
|
0.02970
|
0.028100
|
-9.48e-03
|
8.55e-01
|
9.51e-01
|
REACTOME TRIGLYCERIDE CATABOLISM
|
23
|
9.51e-01
|
9.73e-01
|
0.02930
|
-0.007910
|
2.82e-02
|
9.48e-01
|
8.15e-01
|
REACTOME DEPOLYMERISATION OF THE NUCLEAR LAMINA
|
14
|
9.88e-01
|
9.93e-01
|
0.02860
|
-0.018100
|
-2.22e-02
|
9.06e-01
|
8.86e-01
|
REACTOME PEPTIDE HORMONE METABOLISM
|
83
|
8.63e-01
|
9.14e-01
|
0.02830
|
-0.003170
|
2.81e-02
|
9.60e-01
|
6.58e-01
|
REACTOME IKBA VARIANT LEADS TO EDA ID
|
6
|
9.89e-01
|
9.93e-01
|
0.02800
|
-0.005270
|
2.75e-02
|
9.82e-01
|
9.07e-01
|
REACTOME SUMOYLATION OF UBIQUITINYLATION PROTEINS
|
37
|
9.19e-01
|
9.50e-01
|
0.02750
|
0.021300
|
-1.74e-02
|
8.23e-01
|
8.54e-01
|
REACTOME CILIUM ASSEMBLY
|
188
|
7.94e-01
|
8.72e-01
|
0.02490
|
0.024900
|
3.44e-04
|
5.55e-01
|
9.94e-01
|
REACTOME PTK6 EXPRESSION
|
5
|
9.97e-01
|
9.98e-01
|
0.02430
|
-0.019200
|
-1.48e-02
|
9.41e-01
|
9.54e-01
|
REACTOME AFLATOXIN ACTIVATION AND DETOXIFICATION
|
19
|
9.89e-01
|
9.93e-01
|
0.02420
|
-0.016000
|
-1.81e-02
|
9.04e-01
|
8.91e-01
|
REACTOME SIGNALING BY BMP
|
27
|
9.57e-01
|
9.77e-01
|
0.02330
|
-0.017000
|
1.60e-02
|
8.79e-01
|
8.86e-01
|
REACTOME MITOCHONDRIAL FATTY ACID BETA OXIDATION OF SATURATED FATTY ACIDS
|
11
|
9.84e-01
|
9.91e-01
|
0.02310
|
0.010100
|
-2.08e-02
|
9.54e-01
|
9.05e-01
|
REACTOME CELL DEATH SIGNALLING VIA NRAGE NRIF AND NADE
|
69
|
9.63e-01
|
9.81e-01
|
0.02270
|
-0.012500
|
-1.89e-02
|
8.57e-01
|
7.86e-01
|
REACTOME CARBOXYTERMINAL POST TRANSLATIONAL MODIFICATIONS OF TUBULIN
|
45
|
9.47e-01
|
9.70e-01
|
0.02260
|
0.022300
|
-3.87e-03
|
7.96e-01
|
9.64e-01
|
REACTOME AKT PHOSPHORYLATES TARGETS IN THE CYTOSOL
|
14
|
9.81e-01
|
9.90e-01
|
0.02120
|
0.015800
|
-1.42e-02
|
9.19e-01
|
9.27e-01
|
REACTOME E2F MEDIATED REGULATION OF DNA REPLICATION
|
20
|
9.75e-01
|
9.88e-01
|
0.02120
|
-0.018600
|
1.00e-02
|
8.85e-01
|
9.38e-01
|
REACTOME KINESINS
|
59
|
9.77e-01
|
9.89e-01
|
0.01940
|
-0.016000
|
-1.09e-02
|
8.32e-01
|
8.85e-01
|
REACTOME FOXO MEDIATED TRANSCRIPTION OF OXIDATIVE STRESS METABOLIC AND NEURONAL GENES
|
28
|
9.81e-01
|
9.90e-01
|
0.01780
|
0.001240
|
-1.78e-02
|
9.91e-01
|
8.71e-01
|
REACTOME CELL SURFACE INTERACTIONS AT THE VASCULAR WALL
|
128
|
9.80e-01
|
9.90e-01
|
0.01240
|
0.007680
|
9.80e-03
|
8.81e-01
|
8.48e-01
|
REACTOME DEFECTIVE B4GALT7 CAUSES EDS PROGEROID TYPE
|
17
|
9.95e-01
|
9.97e-01
|
0.01010
|
-0.008980
|
4.62e-03
|
9.49e-01
|
9.74e-01
|
REACTOME METABOLISM OF LIPIDS
|
688
|
8.86e-01
|
9.28e-01
|
0.00960
|
-0.009600
|
-2.15e-04
|
6.67e-01
|
9.92e-01
|
REACTOME ONCOGENIC MAPK SIGNALING
|
77
|
9.84e-01
|
9.91e-01
|
0.00844
|
-0.005610
|
6.31e-03
|
9.32e-01
|
9.24e-01
|
REACTOME DISEASES OF GLYCOSYLATION
|
135
|
9.81e-01
|
9.90e-01
|
0.00683
|
0.005140
|
-4.50e-03
|
9.18e-01
|
9.28e-01
|
REACTOME SLC TRANSPORTER DISORDERS
|
92
|
9.93e-01
|
9.96e-01
|
0.00672
|
0.000967
|
6.65e-03
|
9.87e-01
|
9.12e-01
|
REACTOME GP1B IX V ACTIVATION SIGNALLING
|
11
|
9.99e-01
|
1.00e+00
|
0.00595
|
-0.000979
|
-5.87e-03
|
9.96e-01
|
9.73e-01
|
REACTOME GENE SILENCING BY RNA
|
78
|
1.00e+00
|
1.00e+00
|
0.00146
|
-0.000679
|
-1.30e-03
|
9.92e-01
|
9.84e-01
|